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Abstract
Recent advances in fluorescent probes, microscopy, and imaging platforms have revolutionized biology
and medicine, generating multi-dimensional image datasets at unprecedented scales. Traditional, lowthroughput methods of image analysis are inadequate to handle the increased “volume, velocity, and
variety” that characterize the realm of big data. Thus, biomedical imaging requires a new set of tools,
which include advanced computer vision and machine learning algorithms. In this work, we develop
computational image analysis solutions to biological questions at the level of single-molecules, cells, and
tissues. At the molecular level, we dissect the regulation of dynein-dynactin transport initiation using in
vitro reconstitution, single-particle tracking, super-resolution microscopy, live-cell imaging in neurons, and
computational modeling. We show that at least two mechanisms regulate dynein transport initiation
neurons: (1) cytoplasmic linker proteins, which are regulated by phosphorylation, increase the capture
radius around the microtubule, thus reducing the time cargo spends in a diffusive search; and (2) a spatial
gradient of tyrosinated alpha-tubulin enriched in the distal axon increases the affinity of dynein-dynactin
for microtubules. Together, these mechanisms support a multi-modal recruitment model where
interacting layers of regulation provide efficient, robust, and spatiotemporal control of transport initiation.
At the cellular level, we develop and train deep residual convolutional neural networks on a large and
diverse set of cellular microscopy images. Then, we apply networks trained for one task as deep feature
extractors for unsupervised phenotypic profiling in a different task. We show that neural networks trained
on one dataset encode robust image phenotypes that are sufficient to cluster subcellular structures by
type and separate drug compounds by the mechanism of action, without additional training, supporting
the strength and flexibility of this approach. Future applications include phenotypic profiling in imagebased screens, where clustering genetic or drug treatments by image phenotypes may reveal novel
relationships among genetic or pharmacologic pathways. Finally, at the tissue level, we apply deep
learning pipelines in digital pathology to segment cardiac tissue and classify clinical heart failure using
whole-slide images of cardiac histopathology. Together, these results demonstrate the power and
promise of computational image analysis, computer vision, and deep learning in biological image
analysis.
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ABSTRACT

COMPUTATIONAL IMAGE ANALYSIS FOR AXONAL TRANSPORT,
PHENOTYPIC PROFILING, AND DIGITAL PATHOLOGY

Jeffrey John Nirschl
Dr. Erika L. F. Holzbaur

Recent advances in fluorescent probes, microscopy, and imaging platforms have revolutionized
biology and medicine, generating multi-dimensional image datasets at unprecedented scales.
Traditional, low-throughput methods of image analysis are inadequate to handle the increased
“volume, velocity, and variety” that characterize the realm of big data. Thus, biomedical imaging
requires a new set of tools, which include advanced computer vision and machine learning
algorithms. In this work, we develop computational image analysis solutions to biological
questions at the level of single-molecules, cells, and tissues. At the molecular level, we dissect
the regulation of dynein-dynactin transport initiation using in vitro reconstitution, single-particle
tracking, super-resolution microscopy, live-cell imaging in neurons, and computational modeling.
We show that at least two mechanisms regulate dynein transport initiation neurons:
(1) cytoplasmic linker proteins, which are regulated by phosphorylation, increase the capture
radius around the microtubule, thus reducing the time cargo spends in a diffusive search; and
(2) a spatial gradient of tyrosinated alpha-tubulin enriched in the distal axon increases the affinity
of dynein-dynactin for microtubules. Together, these mechanisms support a multi-modal
recruitment model where interacting layers of regulation provide efficient, robust, and
spatiotemporal control of transport initiation. At the cellular level, we develop and train deep
residual convolutional neural networks on a large and diverse set of cellular microscopy images.
Then, we apply networks trained for one task as deep feature extractors for unsupervised
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phenotypic profiling in a different task. We show that neural networks trained on one dataset
encode robust image phenotypes that are sufficient to cluster subcellular structures by type and
separate drug compounds by the mechanism of action, without additional training, supporting the
strength and flexibility of this approach. Future applications include phenotypic profiling in imagebased screens, where clustering genetic or drug treatments by image phenotypes may reveal
novel relationships among genetic or pharmacologic pathways. Finally, at the tissue level, we
apply deep learning pipelines in digital pathology to segment cardiac tissue and classify clinical
heart failure using whole-slide images of cardiac histopathology. Together, these results
demonstrate the power and promise of computational image analysis, computer vision, and
deep learning in biological image analysis.
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PREFACE
This body of work represents research conducted under the supervision of Professor
Erika L. F. Holzbaur. I have also included research performed as part of the University of
Pennsylvania M.D. / Ph.D. Clinical Connections Program, under the supervision of
Professors Michael D. Feldman and Anant Madabhushi, because this work follows the
paradigm of applying computational image analysis to biomedical images. In addition,
this work was critical training for me to develop my own neural network toolbox for
cellular microscopy images in Chapter 4, one of my final thesis projects.

When I joined the Erika’s lab in 2013, I had no idea that computational image analysis
would be a central theme in my graduate research. Rather, it emerged organically
through a synthesis of my own interests and strengths as well as the biological questions
we were investigating. The trajectory is obvious in hindsight, as it usually is, and the
story began for me prior to graduate school.

As an undergraduate at the University of Iowa I worked with Dr. Chun-Fang Wu on a
team to develop software to automatically track Drosophila locomotion and behavior
from movies. During my graduate school rotation in the Holzbaur lab, I created a
package for semi-automated kymograph analysis of axonal transport. Then, I went on to
take a course in computational image analysis at the Marine Biological Laboratory
in Woods Hole, MA.

xvi

I continued to develop these interests throughout my graduate career. I created image
analysis pipelines for single-particle tracking in order to extract more information from my
single-molecule TIRF data. I explored the limits of optical imaging by applying recent
advances in super-resolution microscopy. I also paid attention to advances in computer
vision and machine learning, applying them to my research whenever possible. Finally,
my love for microscopy and image analysis made pathology an attractive future career
prospect. I was sold after learning about digital pathology and image informatics from
Drs. Feldman and Madabhushi.

I have structured this dissertation according to the scale of investigation, which ranges
from single-molecules to cells and tissues. However, the organization also reflects my
career development. My dissertation begins with axonal transport, mechanistic neuronal
cell biology and image analysis, as my training began. My dissertation concludes with
image analysis applied to digital pathology images, representing the trajectory for my
next phase in training, a residency in pathology. Together, these experiences have
refined the mission I envision for my future lab; I plan to synthesize mechanistic,
experimental cell biology with my clinical work in neuropathology as I investigate
neurodegenerative diseases at the molecular, cellular, and tissue-level. As with my
Ph.D. training, the common theme will be applying computational image analysis in
order to better understand the cellular and molecular basis of disease.

xvii

1.

1

CHAPTER 1: Introduction 1

This chapter contains sections that were adapted from:
Nirschl JJ*, Ghiretti AE*, & Holzbaur ELF. (2017). The impact of cytoskeletal
organization on the local regulation of neuronal transport. Nature Reviews
Neuroscience, 18(10), 585–597. http://doi.org/10.1038/nrn.2017.100
*Denotes equal contribution
Nirschl JJ, Janowczyk A, Peyster EG, Frank, R, Margulies, K, Feldman M, and
Madabhushi A. (2017). Deep Learning Tissue Segmentation in Cardiac
Histopathology Images. In S. K. Zhou, H. Greenspan, & D. Shen (Eds.), Deep
Learning for Medical Image Analysis. Cambridge, MA: Elsevier Academic Press.
1

Technology plays a pivotal role in cell biology and medicine, driving discovery and
deepening our understanding of physiology and disease. In early cell biology, advances
in microscopy and staining reactions were critical to observe and describe the cellular
organization of fixed tissues. Phase, polarization, fluorescence, and video-enhanced
microscopy enabled scientists to visualize and record processes in living cells. These
techniques were augmented by advances in image processing and computer-based
analyses, which improved image quality and allowed image quantification. For each
example, new technology supplied tools that were critical to extend our perception and in
the process provided new ways to think about, visualize, or interrogate biology.

Recent advances in fluorescent probes, optical microscopy, and automated imaging
platforms have once again revolutionized biomedical imaging, generating large, multidimensional image datasets on an unprecedented scale. Traditional, low-throughput
methods of image analysis are inadequate to handle the increased “volume, velocity,
and variety” that characterize the realm of “big data” (Laney 2001). Thus, biomedical
imaging requires a new set of tools, which includes advanced computer vision and
machine learning algorithms. A challenge for cell biology and medicine in the 21st
century will be incorporating new tools into existing paradigms and leveraging the
strengths of low and high-throughput approaches in new and creative ways.

2

The increased size of biomedical image datasets along with new developments in
computer vision and machine learning has brought new interest in the field of bioimage
informatics or computational image analysis. Bioimage informatics is the crossdisciplinary field of biology and bioinformatics concerned with the extraction of
quantitative information from biomedical images using computer vision, machine
learning, or applied mathematics and statistics (Meijering et al. 2016). It requires domain
expertise of the underlying biology as well as the ability to design and implement
creative computational solutions to address biological questions. One advantage of
computational image analysis is that it allows biologists to analyze the image data for
what matters, as opposed to what is convenient or traditional to measure. Fine-grained
analyses of cellular processes can be coupled to mathematical models of the underlying
molecular processes (Danuser 2011). They may also reveal phenotypes that were not
initially apparent to the human observer, sometimes referred to as “sub-visual features”
(Madabhushi and Lee 2016), which are features revealed through computational
analysis and are reproducibly associated with a biological phenomenon.

1.1.

Thesis aims and organization

In this thesis, I examine biological questions that are at the level of single molecules,
cells, and tissues. For each biological problem, I develop and apply computational
approaches that leverage recent advances in computer vision, machine learning, or
microscopy to gain new insight into the underlying biology. The following subsections
present an introduction to the significant contributions of each chapter. The remainder of
the chapter provides a focused review of the relevant topics covered in this dissertation.

3

1.1.1. Retrograde axonal transport
The axon terminal is the most distal subcellular region in the neuron, innervating targets
at distances up to 20,000-fold greater than the diameter of the soma. Cytoplasmic
dynein is the primary motor driving long-distance retrograde transport from the axon
terminal, and efficient retrograde transport initiation is critical to recycle cellular
components and transmit retrograde signals (Maday et al. 2014). Defects in the proteins
involved in retrograde transport initiation are sufficient to cause Perry syndrome, a fatal
neurodegenerative disease (Farrer et al. 2009; Lloyd et al. 2012; Moughamian and
Holzbaur 2012). Thus, understanding how this process is regulated is essential to
understand the disease mechanism as well as develop potential therapeutic strategies.

Chapter two presents a method for live-cell imaging and analysis of axonal transport.
Chapter three investigates the mechanisms that regulate retrograde axonal transport
initiation in neurons using a combination of approaches, including in vitro reconstitution
with Total Internal Reflection Fluorescence (TIRF) microscopy, single-particle tracking,
live-cell microscopy in primary neurons, super-resolution microscopy, and computational
image analysis. We show that at least two mechanisms regulate dynein retrograde
transport initiation in neurons: (1) cytoplasmic linker proteins, which are regulated by
phosphorylation, increase the capture radius around the microtubule, thus reducing the
time cargo spends in a diffusive search; (2) a spatial gradient of tyrosinated alpha-tubulin
enriched in the distal axon increases the local microtubule affinity of dynein-dynactin
associated cargo. Together, these mechanisms favor a multi-modal recruitment model
where interacting layers of regulation promote efficient, robust, and regulated transport.

4

1.1.2. Phenotypic profiling
Advances in automated microscopy have exponentially increased image data size and
complexity in biology. Large image datasets benefit from automated tools that leverage
computer vision and machine learning, including convolutional neural networks (CNNs).
However, there are few tools that allow biologists to leverage deep learning without
requiring significant computational and programming experience. To this end, we
developed the Cell DEep learning COmputational DEscriptoR (Cell DECODER) toolbox.
Cell DECODER is an open-source neural network toolbox, implemented in Python, built
on the Microsoft Cognitive Toolkit (CNTK) (Seide and Agarwal 2016). It is designed to
allow rapid exploration of large cellular microscopy datasets for 1) quality control, 2)
grouping images by phenotype, and 3) exploring relationships among image phenotypes
in different experimental conditions. The goal of exploratory image analysis with Cell
DECODER is to assist the identification of specific image phenotypes or features for indepth quantification and hypothesis testing.

In chapter four, we train deep residual networks on a large, diverse set of cellular
microscopy images from The Human Protein Atlas. We use the Cell DECODER toolbox
to apply neural networks as feature extractors on new images, without training. We show
that pre-trained networks encode robust “deep features” that cluster cellular structures
by type and differentiate drug compounds by the mechanism of action, even though they
were not trained for these tasks. Future applications include phenotypic profiling in
microscopy screens, where clustering genetic or small molecule treatments by image
phenotypes may reveal novel relationships between genetic or pharmacologic pathways.
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1.1.3. Digital pathology
Cardiac histopathology can be useful to evaluate and grade heart disease in particular
clinical conditions (Cooper et al. 2007). However, manual interpretation of cardiac
histopathology is associated with poor inter-observer agreement (Angelini et al. 2011).
Further, the lack of quantitative metrics in cardiac histopathology precludes the
development of predictive models in heart failure. This contrasts with other fields, such
as cancer, where advanced image analytics, including deep learning convolutional
neural networks (CNNs), have been shown to improve diagnosis and prognosis (Beck et
al. 2011; Bhargava and Madabhushi 2016; Esteva et al. 2017; Gulshan et al. 2016;
Litjens et al. 2016; Wang et al. 2017; Xu et al. 2016a; Yu et al. 2016).

One pathological feature of heart disease is the expansion of acellular stroma tissue,
known as fibrosis, which disrupts cardiac contraction. In chapter five, we present a
method for the automated segmentation of myocyte and stromal tissue using
convolutional neural networks (CNNs). In chapter six, we develop a CNN classifier to
detect clinical heart failure directly from H&E stained whole-slide images in a large
cohort of 209 patients. We show that the CNN gives a state-of-the-art performance, 99%
sensitivity, and 94% specificity, and outperforms conventional feature-engineering
approaches. Importantly, the CNN outperformed two expert pathologists by nearly 20%.
Our results suggest that deep learning analytics of cardiac histopathology can be used
to provide decision support, in the form of a second-reader, improving reproducibility in
cardiac histopathology. It may also be used to assist pathologists in developing models
to predict cardiovascular function or to detect and predict heart transplant rejection.

6

In the remainder of this chapter, we review background material for the thesis chapters.

1.2.

Microscopy

This section provides a historical introduction to the role of microscopy and imaging
technology in cell biology. We introduce the microscopy techniques used in this thesis –
light microscopy, live-cell imaging, Total Internal Reflection Fluorescence (TIRF)
microscopy, and super-resolution microscopy.

1.2.1. Historical introduction
The development of the first microscope allowed Robert Hooke to visualize and describe
biological specimens, including the “cells” of cork sections in his famous work,
Micrografia (Hooke 1665). Antoni van Leeuwenhoek, inspired by Hooke, used his handcrafted lenses and microscopes to describe “little animalcules,” which we now know to
be protozoa and bacteria (Sharp 1921). However, cells were not visible in most
biological tissue until improved microscope lenses and staining methods were developed
in the 19th century (Sharp 1921). The ability to stain and visualize cells in more biological
samples were critical for Schleiden and Schwann to formulate the “cell theory”; that cells
are the fundamental units that make up organisms (Sharp 1921).

Similarly, nervous tissue could not be adequately visualized until Camillo Golgi
developed the famous silver nitrate “black reaction,” staining neurons and their arbors in
their entirety (Golgi 1873; Pannese 1999). The Golgi stain was elegantly applied by
neuroanatomist Santiago Ramón y Cajal to describe the organization of the nervous
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system in great detail and formulate the neuron doctrine theory (Ramón y Cajal 1888;
1894), which provided the foundation for modern cellular neuroscience. Traditional light
microscopy and histological stains were essential to early cell biologists and
neuroanatomists, but these tools have limits. One critical drawback is that many of these
techniques require fixation and staining protocols that kill the sample, making it difficult
to study life in motion.

1.2.2. Live-cell imaging to probe dynamic processes
Most living biological samples are transparent in conventional light microscopes, which
is why histological stains were crucial in the early development of cell biology as a field.
Overcoming the limits of traditional light microscopy and staining would require either a
new microscope or a new visualization method. The first answer came in the 1940’s and
1950’s with the development of phase (Zernike 1942) and differential interference
contrast (Nomarski 1955; 1960) microscopy, along with the refinement and application of
polarization microscopy to cell biology, reviewed in Kam (1987). These tools allowed
stain-free imaging of processes in live cells, such as the mitotic spindle and
chromosome segregation during mitosis (Inoue 1953), before the development of
recombinant fluorescent proteins (discussed in section 1.2.4).
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1.2.3. Image processing in microscopy
Shinya Inoue, a pioneer in polarization microscopy, later went on to develop video
microscopy with image processing for enhanced contrast in live-cell imaging; the
technique was also independently developed by Allen and colleagues (Allen et al. 1981;
Inoue 1981). Video-enhanced microscopy improved sensitivity and led to the first direct
visualization of organelle motility in the squid axon (Allen et al. 1982). This was rapidly
followed by the discovery and in vitro reconstitution of the microtubule motor kinesin-1
(Vale et al. 1985a; Vale et al. 1985c) and cytoplasmic dynein (MAP1C) (Paschal and
Vallee 1987) using differential interference contrast, and video-enhanced microscopy.

1.2.4. Fluorescence microscopy
Fluorescence microscopy was a second answer for overcoming the limits of transmitted
light microscopy. The earliest comprehensive scientific characterization of the
phenomenon of fluorescence dates back to George Gabriel Stokes in 1852 (Stokes
1852), though it wasn’t widely used in biological research until the 1950’s when its utility
was demonstrated via the use of fluorescently conjugated antibodies (Coons et al. 1941;
Weller and Coons 1954). Over the next several decades, the improved fluorescent
microscopes, fluorescent labels, and dye-conjugates were critical to visualize subcellular
structures subcellular organelles by immunofluorescence (Kam 1987). However, robust
fluorescence imaging of proteins in live cells had to wait until fluorescent proteins, such
as the Aeqorea victoria green fluorescent protein (GFP), were discovered (Shimomura et
al. 1962) and cloned for use as recombinant proteins (Chalfie et al. 1994; Heim et al.
1994; Prasher et al. 1992).
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1.2.5. Single molecule and super-resolution microscopy
Fluorescence microscopy can provide excellent specificity for labeling biological
structures. However, visualizing single molecules in early biophysics and cell biology
was difficult because of poor sensitivity and high background, due to fluorescence
emission of out-of-focus molecules in solution. The phenomenon of total internal
reflection was applied in the 1980s to reduce background fluorescence and increase the
signal-to-noise ratio (SNR) in Total Internal Reflection Fluorescence (TIRF) microscopy
(Axelrod 1981; 2001). The principle involves positioning light sources at highly inclined
angles, larger than the critical angle, relative to the coverslip interface. This causes the
original light wave to be reflected entirely and creates an evanescent wave at the
coverslip-medium interface. The evanescent wave propagates with exponentially
decreasing intensity into the medium or biological sample. Fluorescence excitation is
limited to within ~150nm of the coverslip, thus reducing background, as shown in Figure
1.1, reprinted from Yildiz and Vale (2015). For a detailed review of TIRF microscopy, we
refer the reader to Axelrod (2001) or Yildiz and Vale (2015).

TIRF microscopy is useful for high SNR imaging of events near the coverslip such as
endocytosis in cells or in vitro reconstitution of single molecules. TIRF microscopy has
been instrumental to many advances in cell biology and biophysics including: visualizing
ATP turnover with single myosin (Funatsu et al. 1995), the stepping of myosin V (Yildiz
et al. 2003), single molecule kinesin motility (Vale et al. 1996; Yildiz et al. 2004), yeast
and mammalian dynein motility (Lippert et al. 2017; Reck-Peterson et al. 2006; Ross et
al. 2006), and multi-motor cargo transport (Hendricks et al. 2010; McIntosh et al. 2015).
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Figure 1.1 Schematic of Total Internal Reflection Fluorescence (TIRF) microscopy.
The angle of the incident light above the critical angle is totally internally reflected back
from the coverslip surface. The reflected beam generates an evanescent field that
decays exponentially into the sample. TIR illuminates molecules near (∼100 nm) the
glass surface. In live cell imaging, TIR only excites molecules in or near the cell
membrane and significantly reduces background fluorescence. Reprinted with
permission from Cold Spring Harbor Laboratory Press (Yildiz and Vale 2015),
copyright (2015).

Advances in single-molecule microscopy were complemented by new image processing
and single-molecule localization algorithms. The emitted fluorescence of a single
molecule is diffracted in space by the point spread function (PSF) to appear nearly
Gaussian in the lateral plane (Figure 1.2); though Bessel functions can give a more
accurate representation (Hopkins 1955; Small and Stahlheber 2014). Thus, two
molecules that are closer together than the diffraction due to the PSF cannot be resolved
and will appear as one object. This fundamental limit of resolution in microscopy, which
depends on the wavelength of light, is known as Abbe diffraction limit (Abbe 1873).
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Although the conventional resolution limit of fluorescence microscopy is ~250 nm, the
PSF can be approximated by a two dimensional Gaussian and the center can be
localized with a much higher precision, and the localization precision is proportional to
the inverse square root of the photons collected (Thompson et al. 2002). These
properties were elegantly applied in the Fluorescence Imaging with One Nanometer
Accuracy (FIONA) method, which enabled single-particle tracking with high accuracy
(Yildiz et al. 2003). Single-molecule localization algorithms were also crucial for the
development and application of single-molecule localization microscopy. The general
principle is that the PSF center of blinking fluorophores (Dickson et al. 1997) can be
localized with high precision, given the description above. The stochastically blinking
particles can be imaged over time and molecules in each frame can be precisely
localized in order to build a reconstruction of biological structures with resolution below
the Abbe diffraction limit (Betzig 1995; Betzig et al. 2006). For a detailed review of superresolution microscopy, see Schermelleh et al. (2010) or Turkowyd et al. (2016).
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Figure 1.2 Simulated Point Spread Function of an ideal point source.
A point light source will be diffracted by the PSF, which depends on the imaging system
and the wave properties, to produce an “Airy pattern” of concentric rings. The central
disk is referred to as the “Airy disc.” This PSF was generated in Icy (de Chaumont et al.
2012) and the intensity was transformed by the square root to visualize the pattern
better.
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1.3.

Image analysis in biomedical research

The development and application of video microscopy to biomedical images directly
paved the way for algorithms and computer-based image analysis. In this section, we
review the history of image analysis in biology and medicine, highlighting the role of
algorithms and computing in biomedical research.

1.3.1. Historical introduction
Although much attention has been given to the recent application of computer image
analysis algorithms to biomedical images, it would be mistaken to assume that image
analysis is new to biology or medicine. In fact, the field has a rich history dating back as
early as the 1950’s where video microscopy and image processing systems were being
developed to automatically count red blood cell number and size (Taylor 1954), detect
and classify chromosomes for karyotyping (Gilbert 1966; Ledley 1964), extract cellular
features (e.g. nuclear/cytoplasmic area, optical density etc.) to classify subtypes of white
blood cells (Prewitt and Mendelsohn 1966), and even detect lesions in mammograms
(Macy et al. 1969). Early applications in cell biology included counting or tracking cells
(Lewandowska et al. 1979), measuring shape changes (Verschueren and Van Larebeke
1984), and enhancing image contrast or acquisition sensitivity and speed (Allen et al.
1981; Inoue 1981). Later work developed systems that could track multiple cells in a
field, measure shape properties, and output up to 30 parameters (Soll et al. 1988), which
was remarkable given the computing power of the time.
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1.3.2. Feature extraction
Traditionally, the first step in developing a computer image analysis workflow, in any
discipline, is to measure relevant properties of an image in a process known as feature
extraction. Feature extraction refers to the process of 1) detecting relevant properties of
an image (e.g., edges or biological structures) and 2) assigning quantitative
measurements to the attribute (Bishop 2006; Gonzalez and Woods 2018). Feature
extraction is critical to obtain useful representations for computational analysis including
the segmentation of objects or measuring differences between groups.

Images contain multiple different types of information including intensity, the type and
number of objects in a field of view, as well as the spatial arrangement of intensity or
objects, among other examples. Thus, one can design many different features to
describe an image. The number of features used to describe an image is referred to as
the measured dimensionality of the image. The mean pixel intensity of an image is a
one-dimensional image description, though it is a very limited representation. An image
can also be described by the individual intensity of each pixel, so a 1000x1000 image
would have one million dimensions. This is not a useful representation either. Thus,
image features must be well-crafted in order to provide useful representations to
discriminate among experimental conditions and quantify image phenotypes.
Two important questions, though, are how do we know which features to measure and
how do we program a computer to measure these features? Historically, this required
engineers to work with domain experts such as biologists or pathologists. Domain
experts would highlight relevant parts of an image and the engineers would develop
transforms to detect and quantify these features. For example, to detect linear filaments,
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such as actin or microtubules, one may apply the Prewitt filter to compute the spatial
derivative of the intensity and highlight vertical or horizontal edges (Prewitt 1970).
Circular objects can be detected using the Gaussian or Laplace of Gaussian transforms,
and so on. Thus, advances in image processing allowed scientists to quantify image
features in biology and medicine. For a thorough text on digital image processing and
image feature extraction, we refer the reader to Gonzalez and Woods (2018).

1.3.3. High throughput microscopy and phenotypic profiling
The development of automated microscopy systems allowed image-based assays to
quantify phenotypes in large-scale RNAi, CRISPR, or pharmacology screens (Caie et al.
2010; Fuchs et al. 2010; McKinley and Cheeseman 2017; Moffat et al. 2006; Neumann
et al. 2010; Perlman et al. 2004). However, a small set of simple image features is
inadequate to describe complex phenotypes in a large dataset. The field responded by
engineering improved features and automated software to capture the rich information
contained in images including fluorescent protein expression and distribution, cellular
morphology, and responses at the population and single-cell level (Carpenter et al.
2006; Rajaram et al. 2012). The concept of describing phenotypes using a diverse set of
features is known as phenotypic profiling and is common in genetics and proteomics, but
image-based phenotypic profiling is relatively new in cell biology (Ljosa et al. 2013).
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At the same time, a similar process was happening in digital pathology. The advent of
whole-slide imaging (WSI) has increased the digitization of pathology slides, which is
generating large, information-rich datasets where modern computer vision and machine
learning methods thrive (Bhargava and Madabhushi 2016; Ghaznavi et al. 2013;
Madabhushi and Lee 2016). Traditional approaches for image analysis in digital
pathology have involved manually engineering image features to use in a machine
learning classifier (Bhargava and Madabhushi 2016). These features generally involve
pixel intensity statistics, texture descriptors, and image decompositions, as well as taskspecific features. Importantly, this can reveal sub-visual image features that were not
initially apparent, but reproducibly and quantitatively discriminate phenotypes. An
example of sub-visual image features that may be difficult to appreciate or quantify
without computational analysis includes the network pattern and arrangement of nuclei
or the local spatial variance in an image signal (e.g., texture), as shown in Figure 1.3
(Bhargava and Madabhushi 2016).

Despite the success of traditional feature extraction, there are limitations. First, the
process of identifying, engineering, and testing new features requires significant time
and technical expertise. Even if the process is successful, many features tend to be
domain-specific, meaning that they may not work in a different dataset or system.
Further, there may be relevant but yet unknown image features that we cannot measure.
Finally, it is often difficult to translate what humans see into machine vision. An expert
can readily appreciate the difference between a healthy and unhealthy cell, but this can
be difficult to express as an image transform or multi-parametric phenotypic profile.
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Figure 1.3 Feature extraction can reveal or enhance hidden structure in images.
A routine hematoxylin and eosin tissue image (left) can be converted into a histomorphometric representation comprising nuclear architecture (middle) and textural
measurements (right). Reprinted with permission from Annual Reviews (Bhargava and
Madabhushi 2016), copyright (2016).
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1.3.4. Learning algorithms
Machine learning refers to the process of applying mathematical, statistical, or
computational techniques to data in order to model or “learn” the underlying patterns
without explicit programming (Bishop 2006). The field has a long history, rooted in
classical statistical inference, but has gained attention recently due to the increased
amount of data available as well as advances in algorithms and computing resources.
Traditional machine learning involves feature extraction followed by the use of statistical
pattern recognition algorithms to discover structure in the data. For a text on machine
learning or applied statistics, we refer the reader to Bishop (2006) or Efron and Hastie
(2016).

For the reasons described in section 1.3.3, traditional feature extraction methods are
sometimes inefficient or unable to capture the necessary image information. A different
approach is known as representation learning, which includes neural networks and
“deep learning,” where an artificial system learns useful features or representations
directly from data. Neural networks have made significant advances in computer vision
and are becoming increasingly common in biomedical imaging (Bhargava and
Madabhushi 2016; LeCun et al. 2015; Peng et al. 2016). Deep learning has many
potential applications in biomedical imaging because it excels at tasks with large and
complex training data sets, such as high-throughput microscopy screens or WSI.
In addition, since deep learning workflows do not carry domain-specific information, a
deep learning pipeline can be rapidly applied to problems across different domains.
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Deep learning differs from conventional approaches in that features are not specified by
human experts, but are instead learned directly from the data. In general, deep neural
networks work by arranging nodes or artificial “neurons” in successive, convolutional,
max-pooling, and fully connected layers, reviewed in Bengio (2009); Schmidhuber
(2015). The connections between neurons are known as “weights” or parameters.
During training, the weights are iteratively adjusted to approximate complex functions
from data in a way that minimizes the error on the training set. The error, in supervised
learning, is typically defined as the difference between the machine prediction and a
human-defined label or true value, which is known as the ground truth. After training, the
neurons and connections among the neurons in the network contain hierarchical
features that map the input image into abstract feature vectors that capture complex and
nonlinear relationships in the data. For a comprehensive text on neural networks, we
refer the reader to Goodfellow et al. (2016).

20

1.4.

Axonal transport in the distal axon

In this final section, we provide a focused review of microtubules, dynein, dynactin, and
axon transport in the distal axon, which are the subject of investigation in chapters two
and three. We refer the reader to the following resources for a general review of: axonal
transport (Maday et al. 2014), axonal cargo sorting (Bentley and Banker 2016), axonal
transport in neurodegenerative disease (Millecamps and Julien 2013), the kinesin
superfamily (Hirokawa et al. 2009), microtubule plus-end binding proteins (+TIPS)
(Akhmanova and Steinmetz 2008; Galjart 2005), the neuronal cytoskeleton (Kapitein and
Hoogenraad 2015), or the local regulation of trafficking (Nirschl et al. 2017a).

1.4.1. Microtubules
Microtubules are biological polymers assembled from α and β tubulin, an obligate
heterodimer. The α-β tubulin heterodimer polymerize in a head-to-tail fashion to form
protofilaments, and approximately 13 protofilaments associate laterally to form a hollow
tube roughly 25 nm in diameter (Nogales 2000). The structural asymmetry of the α-β
tubulin heterodimer, as well as the mechanism of and rates of assembly at each end,
give microtubules an intrinsic polarity with the fast-growing, highly dynamic end
designated the microtubule plus-end and the opposing, slow-growing end designated the
microtubule minus-end. Microtubule motors can recognize this polarity and tend to move
in one direction along the microtubule track. Kinesin motors were the first to be identified
and move toward the microtubule plus-end (Vale et al. 1985b) whereas cytoplasmic
dynein moves toward the microtubule minus-end (Paschal and Vallee 1987).
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The intrinsic microtubule polarity and the directional preference of motors give rise to
polarized trafficking that depends on the cytoskeletal architecture. In neurons,
microtubules are organized radially in the soma; in the axon, microtubules are arranged
in a unipolar, tiled array with their plus-ends directed outwards (Baas et al. 1988). There
are many kinesin isoforms, and thus different kinesins can have overlapping functions or
specialize for a specific type of transport (Hirokawa et al. 2009). However, cytoplasmic
dynein is the only motor driving long-distance retrograde axonal transport, which makes
defects in dynein or retrograde transport prone to cause neurological disorders and
neurodegenerative diseases (Millecamps and Julien 2013; Perlson et al. 2010).
1.4.2. Dynein
There are two classes of dynein: axonemal dynein, which provides the force to beat cilia
and flagella, and cytoplasmic dynein, which is responsible for intracellular transport and
mitosis, among other cellular functions. Improved fixation reagents in electron
microscopy were critical for the early description of we now know as axonemal dynein.
Afzelius developed an osmium tetroxide fixative with improved contrast in electron
micrographs of sperm flagella, which revealed arms bridging the outer microtubule
doublets (Afzelius 1959). Afzelius hypothesized that the arms might play a role in the
motile properties of cilia, but it was not until cilia were isolated and characterized
biochemically (Gibbons 1963) and via electron microscopy that these arms were shown
to correlate with ATPase activity (Gibbons and Rowe 1965). Later work went on to show
that ATP promotes the weak binding state and microtubule release (Porter and Johnson
1983), and that axonemal dynein directly translocates microtubules in an ATPdependent manner (Brokaw 1989; Summers and Gibbons 1971).
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Cytoplasmic dynein was initially identified as a microtubule-associated protein (MAP1C),
enriched in brain tissue and potentially related to axonemal dynein, with microtubule
translocation and nucleotide-hydrolysis properties (Paschal et al. 1987). The direction of
microtubule translocation was found to be opposite of the anterograde motor kinesin,
and thus dynein was a likely candidate for retrograde organelle transport (Paschal and
Vallee 1987). Electron microscopy went on to confirm that cytoplasmic dynein was
structurally similar to axonemal dynein (Vallee et al. 1988) although the cytoplasmic
dynein heavy chain is encoded by a separate gene (Mikami et al. 1993; Zhang et al.
1993).

In vitro studies of cytoplasmic dynein showed robust microtubule translocation (Paschal
et al. 1987; Paschal and Vallee 1987). However, purified cytoplasmic dynein exhibited
little organelle motility without the addition of unknown activating factors in the cytosol
(Schnapp and Reese 1989; Schroer et al. 1989). These dynein activating factors would
later be identified as dynactin, discussed in section 1.4.3, which we now know is a multisubunit complex and required co-factor for motility and most essential functions of
cytoplasmic dynein.

Further studies revealed that cytoplasmic dynein complex is a large ~1.5 MDa complex
composed of two heavy chains and at least three classes of associated subunits
including intermediate chains, light intermediate chains, and light chains (reviewed in
Allan (2011)). In cells, it is the primary minus-end directed motor for organelle transport
(reviewed in Allan (2011)). Cytoplasmic dynein is unique compared to motors like kinesin
or myosin in that it takes a broad range of step sizes toward the minus-end (Mallik et al.
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2004; Toba et al. 2006), which can include reversing or sidestepping (Ross et al. 2006).
In contrast, kinesin-1 takes regular, processive forward steps of 8 nm with few
exceptions (Asbury et al. 2003; Yildiz et al. 2008; Yildiz et al. 2004). Dynein also requires
many adaptors to function. In addition to the dynactin complex, many other dynein
adaptors have been recently characterized including: BicD2, Spindly, and Hook family
proteins, among others (Hoogenraad et al. 2003; McKenney et al. 2014; Olenick et al.
2016; Redwine et al. 2017; Schlager et al. 2014; Splinter et al. 2012). Dynein adaptors
are reviewed in Hoogenraad and Akhmanova (2016); Kardon and Vale (2009).
1.4.3. Dynactin
The dynactin complex was identified as a set of soluble factors that co-purified with
dynein and stimulated dynein motility (Gill et al. 1991; Schroer and Sheetz 1991).
The largest subunit of the complex was a 150 kDa subunit with sequence homology to
the Drosophila Glued gene (Gill et al. 1991; Holzbaur et al. 1991; 1992) and was named
p150Glued as it is both the structural and functional mammalian homolog of Glued
(Holzbaur et al. 1991; 1992; Waterman-Storer and Holzbaur 1996).

Structural and biochemical analysis of the dynactin complex revealed a 37 nm filament
composed of the actin-related protein 1 (Arp1), named the Arp1 rod, and possibly trace
levels of β-actin (Schafer et al. 1994a). Early studies yielded conflicting evidence for
β-actin in the dynactin complex (Holleran et al. 1996; Schafer et al. 1994a), but recent
Cryo-EM structures conclusively show evidence for β-actin in the dynactin complex at an
8:1 stoichiometry of Arp1: β-actin (Urnavicius et al. 2015).
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The barbed end of the Arp1 rod is capped by a conventional actin capping protein, CapZ
(Schafer et al. 1994a; Schafer et al. 1994b) and the nearby shoulder element is
composed of the subunits p150Glued, p50, and p22/p24 (Echeverri et al. 1996; Eckley et
al. 1999; Karki et al. 1998). The stoichiometry of the p50 subunit is essential for the
integrity of the complex because overexpression disrupts the dynein-dynactin complex
and impairs dynein function (Burkhardt et al. 1997; Echeverri et al. 1996). However,
transgenic mice expressing low levels of p50-GFP can be used to label the endogenous
dynein-dynactin complex for in vitro reconstitution of dynein and organelle motility
(Hendricks et al. 2010; Nirschl et al. 2016; Ross et al. 2006). Finally, the pointed end of
the Arp1 rod is capped by Arp11, p25, p27, and p62; together the 11 subunits described
in the previous two paragraphs make up the ~1.2 MDa dynactin complex, reviewed in
Schroer (2004).

The p150Glued subunit has many domains, as shown in Figure 1.4, which confer critical
functions to the complex including: binding to microtubules and the Arp1 filament
(Waterman-Storer et al. 1995) and interacting with the dynein intermediate chain (Karki
and Holzbaur 1995; King et al. 2003; Vaughan and Vallee 1995). The N-terminal
Cytoskeletal Associated Protein-Glycine Rich (CAP-Gly) domain (Riehemann and Sorg
1993) allows binding to microtubules as well as microtubule plus-end binding proteins
(+TIPS), reviewed in Akhmanova and Steinmetz (2008). The interactions among
p150Glued, cytoplasmic linker protein 170 kDa (CLIP-170), and end-binding proteins 1 or
3 (EB1 or 3) during the process of retrograde transport initiation are discussed in
section 1.4.4.2.
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Figure 1.4 Schematic of the p150Glued subunit of the dynactin complex
A) Schematic of p150Glued (DCTN1) showing the point mutations in the CAP-Gly domain
associated with motor neuron disease HMN7B (Puls et al. 2003) in red or the genetic
parkinsonism known as Perry syndrome (Farrer et al. 2009; Wider and Wszolek 2008;
Wszolek and Konno 2016) in blue. B) Schematic showing the microtubule binding
domains, which include the CAP-Gly and basic (+) domains as well as the dynein
interacting regions in the first coiled-coil domain. The regions of DCTN1 that have been
mapped to interact with the adaptor proteins Sec23a, JIP1,3,4, and RLIP, SNX6, and
HAP1 are shown on the right with their putative interacting regions (Fu and Holzbaur
2014).
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There are multiple splice isoforms of p150Glued, which have different functions in vitro and
in cells (Tokito and Holzbaur 1998; Tokito et al. 1996). The full-length p150Glued isoform
is expressed all cells and contains two globular CAP-Gly domains at the N-terminus;
neurons also express a 135 kDa isoform, named p135, lacking most of the N-terminal
microtubule binding domains (Dixit et al. 2008; Tokito et al. 1996). Why neurons express
the p135 isoform in addition to full-length p150Glued is an intriguing question. One
hypothesis is that p135 and p150Glued may have unique, specialized functions in
neurons. Perhaps the absence of the CAP-Gly domain allows p135 to localize to regions
away from microtubule plus-ends or +TIPS and fulfill other cellular functions, but this has
not been tested. However, we do know that the tandem CAP-Gly and basic domains are
necessary to regulate microtubule dynamics in neurons, thus representing a unique
function for full-length p150Glued (Lazarus et al. 2013).

Dynactin was initially identified as an activator of dynein motility (Gill et al. 1991; Schroer
and Sheetz 1991). Later studies showed that antibodies to p150Glued that disrupt dyneindynactin interaction reduce organelle transport (Waterman-Storer et al. 1997). In vitro,
dynactin increases dynein run length and motor processivity while not affecting dynein
velocity (Kardon et al. 2009; King and Schroer 2000; Ross et al. 2006). The CAP-Gly
domain of p150Glued is not required for dynein motility in vitro (Kardon et al. 2009) or in
nonpolarized cells (Moore et al. 2009). However, the microtubule binding of purified
dynein-dynactin complexes and dynein-dynactin bound vesicles in vitro does depend on
the CAP-Gly domain, as antibodies specific to the p150Glued CAP-Gly domain reduce
microtubule binding (Hendricks et al. 2010; Ross et al. 2006).
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Human mutations in the p150Glued (DCTN1) subunit provided insight into the role of the
CAP-Gly domain in axonal transport. Figure 1.4 shows point mutations identified to
cause distal hereditary motor neuropathy 7B (HMN7B) (Puls et al. 2003) or the
autosomal dominant parkinsonism, Perry syndrome (Farrer et al. 2009; Wider and
Wszolek 2008; Wszolek and Konno 2016). Detailed cell biological studies in primary
mammalian neurons and in Drosophila showed that HMN7B mutations globally disrupt
mid and distal transport whereas Perry syndrome mutations cause a specific defect in
dynein-dynactin retrograde transport initiation from the distal axon (Lloyd et al. 2012;
Moughamian and Holzbaur 2012). Later work showed that EB1 and CLIP-170 are also
required for efficient retrograde transport initiation in the distal axon (Moughamian et al.
2013), as we discuss in section 1.4.4.2.

1.4.4. The distal axon
The axon terminal is the most distal subcellular region, innervating targets at distances
up to 20,000-fold greater than the diameter of the soma (Maday et al. 2014). The
extreme separation between the axon terminal and the soma defines the needs and
constraints of this region. Efficient anterograde and retrograde microtubule-based
transport are required to ensure a continuous supply of new cellular resources and
appropriate recycling or retrograde signaling. The microtubule cytoskeleton in this region
is sparse and highly dynamic, with mechanisms adapted for efficient transport delivery
and initiation Figure 1.5A. We focus our discussion below on constitutive transport in the
distal axon. However, the distal cytoskeleton and MAPs also have essential roles in
development and injury (Bearce et al. 2015; Bradke et al. 2012; Voelzmann et al. 2016)
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Figure 1.5 The cytoskeletal organization of the distal axon terminal.
a) The cytoskeleton of the distal axon terminal is characterized by a dense actin network
and sparse microtubule array. Although the morphology of a neuronal growth cone is
depicted here, these features are also found in mature axon terminals. The organization
of growth cones and such terminals contrasts with the dense, tiled array of more stable
microtubules found in the mid-axon. Anterograde cargoes are delivered by kinesin
motors, primarily belonging to the kinesin-1, kinesin-2 and kinesin-3 families. Actin and
myosin coordinate the delivery, retention, and release of presynaptic cargoes.
Retrograde cargo transport is driven by the dynein-dynactin complex. b) Multiple
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mechanisms regulate the loading of retrograde cargo onto microtubule plus ends. These
regulatory proteins include microtubule plus-end tracking proteins (+TIPs) such as endbinding protein 3 (EB3), cytoplasmic linker protein 170 (CLIP170), the dynactin complex
and lissencephaly-1 protein (LIS1; not shown). Initiation is tuned by the phosphorylation
(P) state of CLIP170, which assumes an open conformation when dephosphorylated and
then binds to the plus ends of microtubules in order to enhance the recruitment of the
dynein-dynactin complex (left panel). The local enrichment of tyrosinated microtubules
also enhances the recruitment of the dynein-dynactin complex to initiate retrograde
transport (right panel). PPase, phosphatase. Reprinted by permission from Macmillan
Publishers Ltd: Nature Reviews Neuroscience (Nirschl et al. 2017a), copyright (2017).
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1.4.4.1.

Anterograde trafficking and the delivery of distal cargo

The bulk of new axonal proteins and organelles is synthesized in the soma and
transported to the axon (Maday et al. 2014). As motors move cargo from the mid-axon to
the terminal, they encounter a sparse microtubule cytoskeleton that is also highly
dynamic. Recent work in C. elegans elegantly shows that in contrast to the dense,
stable, overlapping microtubules found along the axon shaft, microtubules are sparser in
the distal axon, with fewer overlaps between adjacent polymers and increased gaps
between microtubule ends (Yogev et al. 2016). Distal microtubules are also highly
dynamic, as demonstrated by the presence of increased EB3 dynamics and therefore
are enriched in tyrosinated α-tubulin (Moughamian et al. 2013; Nirschl et al. 2016).

Materials transported to the distal axon are usually distributed among multiple axonal
branches and terminals, with the distance-dependent distribution of resources
dependent on the cargo. For example, in vivo imaging of mitochondria in zebrafish
sensory neurons found that mitochondrial density decreased in a distance-dependent
manner along the axon (Plucinska et al. 2012). Furthermore, flux density decreased with
axon branching by a factor of two per axonal branch (Plucinska et al. 2012), consistent
with distributed delivery.

The mechanisms regulating the release of anterograde cargo from microtubules in the
axon terminal are not yet clear. The best studied of these mechanisms has been the
delivery of synaptic cargoes to distal presynaptic terminals, a subset of terminals among
the many en passant synapses along the axon shaft. The simplest model posits that
cargo dissociates from the ends of the microtubules once they reach the axon terminal;
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however, this explanation is not sufficient to account for selective cargo delivery to one
out of many terminals (Rizzoli 2014). Instead, the regulated disengagement or
inactivation of kinesins in the target terminal probably contributes to localized delivery. At
least four models for presynaptic cargo delivery have been proposed, although further
studies are required to establish the underlying mechanisms: kinesin dissociation via
RAB3 nucleotide exchange; phosphorylation-dependent release of motors from cargoes;
phosphorylation-dependent inhibition of retrograde transport, promoting distal
enrichment; and distal delivery followed by continuous anterograde–retrograde cycling
along synapses (Gibbs et al. 2015; Rizzoli 2014).

1.4.4.2.

Retrograde transport initiation

Many cargoes initiate retrograde transport in the axon terminal, including
autophagosomes, and neurotrophic-factor-associated signaling endosomes, (Maday et
al. 2014). For example, autophagosomes are preferentially generated in the axon
terminal (Maday and Holzbaur 2014; Neisch et al. 2017), and efficient retrograde
transport of these organelles from the axon terminal toward the soma is crucial for
autophagosome maturation and function (Fu et al. 2014). Rates of retrograde flux also
affect the long-distance signaling of neurotrophic factors from axon terminal to soma
(Wang et al. 2016b).
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One key barrier to the efficiency of retrograde transport is the sparse and dynamic
nature of microtubules at the axon terminal. Electron microscopy has consistently shown
a low and variable number of microtubules at terminals (Bodaleo and Gonzalez-Billault
2016; Yogev et al. 2016). More recent super-resolution studies also demonstrate a lower
density of more highly dynamic microtubules (Nirschl et al. 2016).

At least two primary mechanisms have been shown to contribute to the robust
attachment of retrograde cargos with microtubule tracks (Figure 1.5B). First, both dynein
and dynactin are distally enriched at the axon terminal. A direct interaction between
kinesin-1 and cytoplasmic dynein maintains a distal pool of dynein, driven by slow
axonal transport (Twelvetrees et al. 2016). Dynactin, as well as microtubule plus-end
tracking proteins (+TIPs) including EB3, cytoplasmic linker protein 170 (CLIP-170; also
known as CLIP1), and LIS1, are also enriched in the axon terminal, where they are
required for retrograde transport initiation (Moughamian and Holzbaur 2012;
Moughamian et al. 2013; Voelzmann et al. 2016). EB3 recruits +TIPs via interactions
with cytoskeleton-associated protein glycine-rich (CAP-Gly) domains, found in both
CLIP-170 and p150Glued, the largest subunit of the dynactin complex (Bieling et al. 2008;
Nirschl et al. 2016; Peris et al. 2006; Weisbrich et al. 2007). Constitutive retrograde
transport initiation in neurons requires both of these proteins, as well as EB3 or EB1 and
LIS1 (Lloyd et al. 2012; Moughamian and Holzbaur 2012; Moughamian et al. 2013).
Specifically, the CAP-Gly domain of p150Glued interacts with EB3 and CLIP-170
(Moughamian and Holzbaur 2012). EB3 binds to the growing end of dynamic
microtubules and can recruit CLIP-170, and dynein–dynactin-bound cargoes are
recruited to the microtubule via the EB3–CLIP-170 complex (Moughamian et al. 2013;
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Nirschl et al. 2016). This pathway is regulated by phosphorylation, as CLIP-170
assumes an autoinhibited, inactive conformation when it is phosphorylated in its third
serine-rich domain (Lee et al. 2010). Thus, local dephosphorylation of CLIP-170 may
allow temporal control of initiation. The dephosphorylated, active form of CLIP-170 forms
an extended 135 nm linker that effectively increases the search radius for cargo capture,
allowing efficient initiation despite the sparse microtubule cytoskeleton in the distal axon
(Nirschl et al. 2016).

If this were the sole mechanism of enhanced transport initiation, most retrograde
transport initiation would be confined to the distal 1–2 μm of dynamic microtubules. An
additional, non-exclusive pathway takes advantage of the spatial enrichment of
tyrosinated α-tubulin in the distal axon (Nirschl et al. 2016). The C-terminal EEY motif of
tyrosinated α-tubulin binds CAP-Gly-domain proteins such as p150Glued and CLIP-170
with high affinity (Bieling et al. 2008; Peris et al. 2006; Weisbrich et al. 2007). Thus,
dynactin can bind directly and robustly to the tyrosinated microtubule lattice (McKenney
et al. 2016; Nirschl et al. 2016). CLIP-170 also binds preferentially to tyrosinated
microtubules (Bieling et al. 2008; Nirschl et al. 2016), further enhancing the robust
association of the retrograde cargo with the microtubule. Together, these mechanisms
combine to provide robust and spatially specific regulation of transport initiation in the
distal axon terminal.
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1.4.4.3.

Actin and myosin in the axon terminal

The axon terminal is rich in a dynamic population of actin that is most often studied in
the context of the developing growth cone and the mature presynaptic terminal.
Interestingly, a recent study found that this population of distal actin is resistant to actin
depolymerization by cytochalasin D and latrunculin B, as all conditions showed dense Factin patches in approximately half of hippocampal neurites (Chia et al. 2016). Actin is
also concentrated in the presynaptic terminal of mature neurons, where it acts as a
scaffold to dock vesicles (Sankaranarayanan et al. 2003) and coordinates
neurotransmitter release and recycling (Cingolani and Goda 2008). Myosin II is
implicated in neurotransmitter release at presynaptic terminals, whereas myosin VI and
PDZ domain-containing protein GIPC1 may coordinate synaptic vesicle recycling and
endocytosis (Kneussel and Wagner 2013). Additional studies are required to elucidate
how actin and myosin regulate trafficking in the axon terminal as well as how actinbased transport interfaces with microtubule-based transport. The transition between
microtubule- and actin-based transport is likely to be critical for retrograde transport, as
discussed above, as actin depolymerization is required for the retrograde flux of
neurotrophic factor signaling endosomes (Harrington et al. 2011).
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2.

CHAPTER 2: Live-cell imaging of retrograde transport
initiation in primary neurons 2

2

This chapter is adapted from:
Nirschl, J. J., & Holzbaur, E. L. F. (2016). Live-cell imaging of retrograde
transport initiation in primary neurons. In K. K. Pfister (Ed.), The Neuronal
Cytoskeleton, Motor Proteins, and Organelle Trafficking in the Axon (pp. 269–
276).
36

2.1.

Abstract

Axonal transport is an essential function in neurons, as mutations in either motor
proteins or their adaptors cause neurodegeneration. While some mutations cause a
complete block in axonal transport, other mutations affect transport more subtly. This is
especially true of mutations identified in human patients, which impair but do not block
motor function in the cell. Dissecting the pathogenic mechanisms of these more subtle
mutations requires assays that can tease apart the distinct phases of axonal transport,
including transport initiation, sustained/ regulated motility, and cargo-specific sorting or
delivery. Here, we describe a live-cell photobleaching assay to assess retrograde flux
from the distal axon tip, a measure for distal transport initiation. We have previously
used this method to show that the CAP-Gly domain of DCTN1 is required for efficient
retrograde transport initiation in the distal axon, but it is not required to maintain
retrograde flux along the mid-axon. This approach has allowed us to examine the
effects of disease-causing mutations in the axonal transport machinery, and in
combination with other assays, will be useful in determining the mechanisms and
regulation of axonal transport in normal and diseased conditions.
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2.2.

Introduction

The development of video-enhanced microscopy (Allen et al. 1981; Inoue 1981) allowed
the first direct visualization of organelle motility in squid axons (Allen et al. 1982) and
extruded squid axoplasm (Brady et al. 1982). This was followed by the discovery of the
microtubule motors kinesin-1 (Vale et al. 1985a) and cytoplasmic dynein (Paschal and
Vallee 1987), which were later identified as the motors driving anterograde (Hirokawa et
al. 1991) and retrograde (Hirokawa et al. 1990) transport, respectively. Since then, livecell imaging and neuron culture have continued to play a critical role in our
understanding of axonal transport. Here, we will focus on cytoplasmic dynein and the
dynactin complex, which form the primary motor complex responsible for long-distance
retrograde axonal transport.

Cellular studies examining the mechanisms of dynein-mediated retrograde transport
have been complemented by genetic approaches, which have identified mutations in
dynein/ dynactin and other adaptors or cytoskeleton associated proteins in a number of
neurodevelopmental and neurodegenerative diseases, reviewed in (Maday et al. 2014;
Perlson et al. 2010). Approaches to study the effects of these mutations at the cellular
level have involved overexpressing wild type or mutant protein and visualizing the axonal
transport of fluorescently labeled proteins/ vesicles. These approaches have been
successful in identifying mutations that cause gross disruption of axonal transport.
However, since dynein and many other cytoskeletal proteins have essential functions in
all cells (e.g. the essential role of dynein/ dynactin in mitosis), mutations that cause
complete loss of function are embryonic lethal. Thus, mutations that persist into
adulthood and cause late-onset neurodegenerative diseases likely cause subtle defects
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or target specific phases of axonal transport, such as transport initiation, sustained/
regulated motility, or cargo-specific sorting or delivery.

Here, we describe an assay to measure retrograde flux from the distal axon. Using this
assay, we confirm that the N-terminal Cytoskeletal-associated Protein Glycine-rich
(CAP-Gly) domain of dynactin is required for retrograde transport initiation, but is not
required for mid-axonal transport maintenance (Lloyd et al. 2012; Moughamian and
Holzbaur 2012). This assay, and the development of additional novel assays that are
sensitive to distinct phases of axonal transport will be useful in determining the
pathogenic mechanisms of subtle, novel mutations in motor proteins, adaptors, or their
associated cytoskeletal components.

2.3.

Methods

2.3.1. Primary neuron culture
Imaging organelle and vesicle dynamics in primary neuron cultures is a well-established
method to probe the molecular mechanisms of axonal transport. We use mouse dorsal
root ganglion sensory neurons as a robust system to examine the effects of mutations in
motor proteins or their adaptors on axonal transport. Results from DRG neurons have
been corroborated in other neuronal subtypes using the photobleaching approach. Here
we focus on the photobleaching assay and analysis of transport initiation. For more
information on neuron isolation, enrichment, and culture please refer to any of the recent
protocols on the topic (Kaech and Banker 2006; Malin et al. 2007; Skaper 2012).
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2.3.2. Live-cell imaging
2.3.2.1.
•
•
•
•
•
•
•
•

Materials

Neurons transfected with fluorescently-tagged proteins of interest, cultured in glassbottomed dishes.
Glass bottomed dish for live-cell imaging. We use 35mm Fluorodish (FD35-100) or
Mat-Tek (P35G-1.5-20-C) glass bottomed dishes.
Inverted microscope.
Spinning disk confocal equipped with a photobleaching module.
Controller software: Volocity (PerkinElmer), MetaMorph (Molecular Devices), or
µManager.
Hibernate A low fluorescence medium (BrainBits)
B27 Supplement (Gibco 17504-44)
GlutaMAX supplement (Invitrogen 35050061)

2.3.2.2.
•

•

General considerations for photobleaching assays

It is important to calibrate the photobleaching module prior to each imaging
session, especially if multiple users are using the same microscope or if the
photobleaching module has not been used recently. To calibrate the system, take
a uniformly fluorescent test slide or sample and select a region of interest (ROI)
using your integrated microscope manager software. Bleach the test slide/
sample and compare the area of photobleaching with your ROI. If the system is
calibrated, the ROI and bleached region should completely overlap with minimal
bleaching outside your ROI. If not, re-calibrate the photobleaching module
according to your system’s User Manual.
Prior to starting the experiment, perform test experiments to determine:
o the minimal laser power and photobleaching cycles required to bleach a
region of axon.
o the frame rate required to capture the dynamics of your labeled protein.
o the image acquisition settings (exposure, gain, sensitivity, laser power)
and duration of time-lapse imaging.
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2.3.2.3.
•

•

•
•
•

•

•
•

Setup of photobleaching and image acquisition

In your microscope manager software, set up a new image acquisition protocol in
the photobleaching module. Set the desired number of photobleaching cycles,
laser power, and frame rate (frames per second or fps). When using LAMP-1RFP, a marker of late endosomes/ lysosomes, we use 25 photobleaching cycles
at 100% laser power and a frame rate of 3fps post-bleaching.
Set the camera to acquire time-lapse series pre-bleach and another series postbleach. For LAMP-1-RFP vesicles, which exhibit rapid, bidirectional transport, we
use at least 5- 10 seconds pre-bleach and 120 seconds post-bleach. These
settings will depend on the fluorescently labeled protein.
Next, prepare your transfected neurons for imaging. Gently remove the neuron
culture media and replace with 37°C, low fluorescence imaging media preequilibrated in CO2 (Hibernate A + 2% B27 supplement + 2mM Glutamax).
Transfer the live-cell dish onto the stage and get the coverslip into focus.
Next, find the cell body or axon of a healthy, low expressing neuron. Manually set
the contrast to a window where the relative level of fluorescent protein
expression is easily visualized. Avoid cells that appear saturated due to very high
expression of fluorescent protein.
Trace the axon to the distal axon terminal, adjusting the Z focus to follow the
axon as it moves over/ under non-transfected neurons. After identifying the distal
axon, capture a static image. Next, use the “measure” tool to trace 10 µm
proximal to the distal axon tip and draw an ROI to photobleach. When we image
at 100X, we draw an ROI beginning 10 µm proximal to the distal axon and
extending retrograde 40 µm toward the cell body. We find that photobleaching is
much faster with small, thin, rectangular ROIs than with freehand ROIs.
Acquire images using the protocol described above.
In the same neuron, move at least 100 -150 µm proximal from the distal axon tip
and acquire a time-lapse movie from the mid-axon. We recommend imaging
paired distal and mid-axons to compare distal transport initiation with mid-axonal
retrograde flux within the same neuron. Record the neuron and the orientation of
the axons (anterograde/ retrograde).
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Figure 2.1 Schematic overview of the approach used in the photobleaching assay.
(A) Primary neuron culture. (B) Live cell photobleaching assay in paired distal and midaxon segments. Red circles represent fluorescently labeled LAMP-1-RFP vesicles. (C)
Kymograph analysis: representative kymographs from the distal axon of wild type DRG
neurons shows the tracks of vesicles that recently initiated retrograde transport from the
axon tip. The arrowhead and dotted line in the schematic indicate the pre-defined
distance threshold for analyzing retrograde flux. Only retrograde-moving vesicles were
traced.
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2.4.

Data Analysis

We use manual kymograph analysis to measure retrograde flux in this assay. A
kymograph is a 1 dimensional projection of the fluorescent intensity along the long axis
of the axon over time. The X-axis is the distance along the axon and the Y-axis is the
time elapsed. The primary output of this analysis is the vesicles per minute that have
moved retrograde into the bleached region a specified distance (retrograde flux). In the
distal axon, just before the axon tip or growth cone, this provides a measure of the
number of vesicles starting transport and moving retrograde.

2.4.1. Materials
•
•

ImageJ (NIH) or other image processing software (e.g. Volocity, MetaMorph)
Open source kymograph analysis tools:
o Icy (http://icy.bioimageanalysis.org/)
o KYMOMAKER (http://www.pharm.hokudai.ac.jp/shinkei/Kymomaker.html)
o KymographDirect (https://www.nat.vu.nl/~erwinp/downloads.html)

2.4.1.1.
•

•
•
•

Kymograph analysis of retrograde flux

Draw a 1 pixel wide segmented line along the axon beginning with the distal
region of the bleached ROI and extending proximally toward the soma. Save the
ROI line selection or take an RGB reference image indicating where the line was
drawn.
Generate a kymograph with time displayed on the Y-axis. In ImageJ, use the
‘MultipleKymograph’ plugin.
Determine the point at which you will measure retrograde flux. In our analysis, we
make a line ~50 pixels (3-4 microns with a 100x objective) retrograde from the
distal end of the ROI.
Trace the cargo trajectories using automated kymograph tracing tools such as
Icy (de Chaumont et al. 2012), KYMOMAKER (Chiba et al. 2014), or
KymographDirect (Mangeol et al. 2016) or manual tracing. Kymographs with low
signal to noise ratios or high cargo density may require manual tracing. Then,
count the total number of vesicles crossing this distance threshold vertical line.
This represents the Retrograde Flux (vesicles·min-1) in an axonal region. In the
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•

2.5.

distal axon, this measurement represents the number of vesicles initiating from
the distal axon.
Repeat the process for the mid-axon and compare whether there is selective
disruption of distal retrograde flux vs. mid axonal flux.

Conclusions

Here we describe a photobleaching assay to analyze retrograde flux in the distal axon,
as a measure of retrograde transport initiation. We have previously used this approach
to show that the CAP-Gly domain of dynactin is required for efficient retrograde transport
initiation from the distal axon (Moughamian and Holzbaur 2012; Moughamian et al.
2013). This assay may be applied to study the role of dynein, dynactin, or other
microtubule plus-end binding in retrograde transport initiation and to investigate how
mutations in these proteins disrupt axonal transport and contribute to human
neurodegenerative diseases.
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3.

CHAPTER 3: Alpha-tubulin tyrosination and CLIP-170 phosphorylation
regulate the initiation of dynein-driven transport in neurons 3
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3.1. Abstract

Motor-cargo recruitment to microtubules is often the rate-limiting step of intracellular
transport, and defects in this recruitment can cause neurodegenerative disease. Here,
we use in vitro reconstitution assays with single molecule resolution, live-cell transport
assays in primary neurons, computational image analysis and computer simulations to
investigate the factors regulating retrograde transport initiation in the distal axon. We find
that phosphorylation of the cytoskeletal-organelle linker protein CLIP-170 and posttranslational modifications of the microtubule track combine to precisely control the
initiation of retrograde transport. Computer simulations of organelle dynamics in the
distal axon indicate that while CLIP-170 primarily regulates the time to microtubule
encounter, the tyrosination state of the microtubule lattice regulates the likelihood of
binding. These mechanisms interact to control transport initiation in the axon in a
manner sensitive to the specialized cytoskeletal architecture of the neuron.
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3.2.

Introduction

Microtubule-based transport by molecular motors is essential in most eukaryotic cells.
One of the first steps in transport is to recruit motor-cargo complexes to microtubules.
This process can be regulated at multiple levels, including the motor, motor adaptors,
microtubule associated proteins (MAPs), or the microtubule track itself. How the cell
integrates these multiple layers of regulation to allow precise spatial and temporal
control of transport initiation is not yet understood.

The specialized morphology of neurons renders these cells particularly dependent on
the precise regulation of transport initiation. Due to the uniform plus-end out orientation
of microtubules in the axon, the dynein-dynactin complex is the primary motor driving
retrograde transport from the distal axon toward the cell soma. Efficient loading of
dynein-dynactin-bound cargos is crucial for neuronal survival, as mutations in dynein or
dynactin cause neurodegeneration in mice and humans (Maday et al. 2014). More
specifically, mutations in the highly conserved cytoskeleton-associated protein glycinerich (CAP-Gly) domain of the p150Glued subunit of dynactin cause a significant reduction
of retrograde transport initiation in neurons in vitro and in vivo (Lloyd et al. 2012;
Moughamian and Holzbaur 2012). In humans, mutations in the CAP-Gly domain of
dynactin are sufficient to cause a lethal form of parkinsonism known as Perry syndrome
(Farrer et al. 2009).

The mechanisms controlling the initiation of retrograde transport involve plus-end
binding proteins or +TIPs (Akhmanova and Steinmetz 2008) including CLIP-170,
p150Glued, and end binding proteins EB1 or EB3, collectively referred to as EBs
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(Moughamian and Holzbaur 2012; Moughamian et al. 2013). Dynein is thought to be
dynamically recruited to the microtubule plus end via hierarchical interactions of EBs,
CLIP-170, and p150Glued (Ayloo et al. 2014; Bieling et al. 2008; Dixit et al. 2009;
Duellberg et al. 2014; Lomakin et al. 2009; Moughamian et al. 2013; Watson and
Stephens 2006) (Figure 3.1A). Although many of the molecular players in this pathway
are known, how this recruitment pathway is regulated in neurons is not understood.
CLIP-170 may serve as one crucial regulatory point, as this protein can link p150Glued to
EBs, and CLIP-170 binding interactions are regulated by phosphorylation (Lee et al.
2010; Rickard and Kreis 1991). CLIP-170, the first identified +TIP, was initially
characterized as a cytoplasmic linker between endosomes and microtubules (Pierre et
al. 1992; Rickard and Kreis 1996). CLIP-170 can assume a folded, autoinhibited
conformation when phosphorylated in the third serine-rich domain, or an open
conformation when dephosphorylated (Lansbergen et al. 2004; Lee et al. 2010). These
observations led to the hypothesis that CLIP-170 phosphorylation may provide a way to
dynamically regulate recruitment of vesicular cargo to microtubules; however, direct
evidence for this model in neurons is lacking.

Post-translational modifications of the microtubule track are another potential
mechanism to regulate the recruitment of microtubule motors (Wehenkel and Janke
2014; Yu et al. 2015). In neurons, there is a spatial gradient of tubulin modifications
along both axons and dendrites (Janke and Kneussel 2010). Intriguingly, the retrograde
transport initiation zone in the distal axon defined by live cell imaging (Moughamian and
Holzbaur 2012) coincides with a region enriched for tyrosinated (Tyr) α-tubulin (Brown et
al. 1993; Robson and Burgoyne 1989). Most α-tubulins are initially synthesized with a C48

terminal EEY motif, but the terminal tyrosine of this motif can be cleaved by a tyrosine
carboxypeptidase following assembly of tubulin dimers into the microtubule lattice
(Kumar and Flavin 1981). The cleavage of the terminal tyrosine to form detyrosinated αtubulin (Detyr) can only be reversed following disassembly of the microtubule, as the
enzyme tubulin tyrosine ligase (TTL) acts on soluble Detyr tubulin dimers (Ersfeld et al.
1993; Prota et al. 2013). Both CLIP-170 and p150Glued are sensitive to the C-terminal
tyrosine motif of Tyr-α-tubulin (Bieling et al. 2008; Peris et al. 2006), suggesting that this
modification may play a role in spatially defining retrograde transport initiation in the
distal axon, although this hypothesis has not been tested.
Here, we address the regulation of transport initiation using both in vitro reconstitution of
organelle binding to microtubules and live cell assays in primary neurons. We find that
the phosphodeficient, open conformation of CLIP-170 effectively promotes transport
initiation in vitro and in neurons. We also find that isolated neuronal vesicles, in complex
with motors/ adaptors, show a robust preference for Tyr-microtubules over Detyrmicrotubules. These mechanisms interact, as CLIP-170 phosphorylation levels further
modulate motor-cargo recruitment to Tyr-microtubules. Together, our observations fit a
multi-modal recruitment model, where both the microtubule modification status and
CLIP-170 phosphorylation specifically tune the kinetics of transport initiation to the
requirements of the cell. Computer simulations of organelle dynamics in the distal axon
indicate that CLIP-170 primarily regulates the time to microtubule encounter, while the
tyrosination state of tubulin regulates the likelihood of binding. Together, these
mechanisms provide spatiotemporal specificity, with spatial regulation controlled by the
distal gradient of Tyr-microtubules and temporal regulation via control of the
phosphorylation state of CLIP-170.
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3.3.

Results

3.3.1. CLIP-170 comets serve as docking sites for p150Glued vesicles in cells
Conformational changes in CLIP-170 regulate its association with microtubules and the
accessibility of the C-terminus for binding to other +TIPs (Lansbergen et al. 2004).
Phosphomimetic mutations in the third serine rich domain of CLIP-170 promote a closed,
autoinhibited conformation while phosphodeficient mutations promote an open
conformation (Lee et al. 2010). We generated phosphomimetic (CLIP-E) and
phosphodeficient (CLIP-A) constructs by mutating 5 key serine residues to Ala or Glu,
respectively (Figure 3.1B), and confirmed previous observations (Lee et al. 2010), using
confocal microscopy to show that CLIP-A decorates microtubule plus end as comets that
are significantly longer than CLIP-E comets (APPENDIX I, Figure S1A, B). The Cterminal Zinc knuckle and EEY motif of CLIP-170 are exposed in phosphodeficient CLIPA; these motifs can recruit dynactin through a direct interaction with the p150Glued subunit
(Duellberg et al. 2014; Galjart 2005). Co-expression of CLIP-A with myc-tagged
p150Glued induces the pronounced localization of p150Glued-positive puncta to CLIP-170
comets (Figure 3.1C, D). The resulting linear punctate arrays are reminiscent of vesicles
binding to microtubules (Gill et al. 1991; Vaughan et al. 1999). As in vitro studies have
shown that the CAP-Gly domain of p150Glued binds directly to CLIP-170 (Weisbrich et al.
2007), we tested whether the localization of p150Glued puncta to CLIP-170 comets was
dependent on this interaction by comparing the localization of wild type p150Glued to that
of a G71R point mutation in the CAP-Gly domain. This mutation is causative for the
lethal neurodegenerative disease known as Perry syndrome (Farrer et al. 2009), and
acts as a loss-of-function mutation for the CAP-Gly domain (Moughamian and Holzbaur
2012). As shown in Figure 3.1C, D, the recruitment of myc-tagged p150Glued-positive
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puncta to CLIP-A comets observed in cells expressing wild type p150Glued was abolished
in cells expressing similar levels (APPENDIX I, Figure S1C) of the G71R point mutation.
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Figure 3.1 CLIP-170 comets serve as docking sites for p150Glued vesicles in cells.
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(A) Deconvolved max projection STED image of microtubules in the neuronal growth
cone with the cell border outlined in white (left). Schematic of the recruitment of dyneindynactin organelles in the neuronal growth cone (right). (B) Schematic of p150Glued
(above) showing the CAP-Gly, basic (+), and coiled-coil domains. Schematic of CLIP170 with relevant CAP-Gly, Ser rich, coiled-coil, and Zinc knuckle (Zn) domains. The
phosphorylation sites (S-309, -311, -313, -319, -320) and phosphomutant constructs are
shown below. (C) Confocal slices of COS-7 cells co-transfected with HT-CLIP-A and
either full-length myc-p150Glued WT or G71R (above). Upsampled images of individual
comets show punctate p150Glued associated with CLIP-A comets (below). The dashed
white lines denote where line profiles were performed in D. (D) Line intensity profiles
along upsampled images in C. (E) 3D-STORM super-resolution was used to image
microtubules in fixed COS-7 cells (Movie S1). Shown are cropped microtubule plus ends
from the two different conditions. CLIP-A (magenta) fully decorates the plus end as
comet like structures and discrete p150Glued clusters associate with the CLIP-A comet
(tubulin is unlabeled in these images). This shows that these p150Glued puncta form
discrete punctate structures (white arrowhead) on CLIP-A comets; the morphology of
these punctae are consistent with a vesicular population. In addition, there is a separate
population of point-localized individual p150Glued molecules (gray arrowhead). (F)
Histogram of the maximum equatorial diameter for of ellipses manually fit around
clusters of p150Glued WT puncta in STORM images (n = 133 puncta total from 2 cells, N=
1).
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To better visualize the population of p150Glued-positive puncta in cells, we used direct
Stochastic Optical Reconstruction Microscopy (dSTORM) super-resolution microscopy.
This approach more clearly revealed discrete clusters of localized p150Glued associated
with CLIP-A comets (Figure 3.1E, S1D, Movie S1). Using dSTORM, we measured the
size distribution of p150Glued-positive puncta, and found a mean diameter of 103±2nm
(Figure 3.1F); parallel analysis on STED-acquired images resulted in an average
diameter of 106±3nm. These measurements are very similar to the 90nm diameter
determined for isolated dynactin-positive neuronal vesicles as measured by EM
(Hendricks et al 2010). Thus, a population of p150Glued-positive vesicles dock at CLIP170 comets in cells; this docking requires an intact CAP-Gly domain.

3.3.2. Reconstitution of CLIP-170 dependent organelle recruitment in vitro
To study the regulation of organelle recruitment by CLIP-170 phosphorylation at the
single molecule level, we moved to an in vitro system using neuronal vesicles isolated
from the brains of p50-EGFP transgenic mice (Hendricks et al. 2010; Ross et al. 2006)
visualized with single molecule total internal fluorescence (TIRF) microscopy. Vesicles
co-purify with an endogenous complement of dynein, dynactin, and kinesins (APPENDIX
I, Figure S2), are positive for markers of late-endosomes/ lysosomes (Rab7/ LAMP-1)
but not early endosomes (Rab5), and exhibit dynein-dependent motility in vitro
(Hendricks et al. 2010). To mimic recruitment of organelles to the GTP-like microtubule
lattice at the plus end, we used Guanosine-5'-[(α,β)-methyleno]triphosphate (GMPCPP)
stabilized microtubules (Alushin et al. 2014) that specifically recruit +TIPs including EB1
and CLIP-170 (Dixit et al. 2009; Lopez and Valentine 2016; Zanic et al. 2009), and
provide a stable landing platform more tractable for automated analysis of landing rates
55

than dynamic microtubules. To this, we added purified recombinant unlabeled EB1 and
high speed supernatant (HSS) from COS-7 cells transfected with either HaloTag (HT)
CLIP-A or CLIP-E, or HSS from mock-transfected cells (Mock-HSS)(Figure 3.2A). As
endogenous CLIP-170 is not enriched on our vesicle population (Figure 3.2B), it likely
functions as a cytosolic accessory factor. To ensure equal levels of HT-CLIP in the
assay, we measured the absorbance of the TMR-labeled protein (APPENDIX I, Figure
S3A, B); HT-CLIP levels were further confirmed by Western blotting (APPENDIX I,
Figure S3C).

To analyze landing rates of vesicles loading onto microtubules, we applied unbiased,
whole-field multi-particle tracking using uTrack software (Jaqaman et al. 2008) to track
particles, map their starting coordinates to microtubule masks, and measure landing
rates and dwell times (APPENDIX I, Figure S3F). Representative kymographs of p50GFP-vesicles show processive, bidirectional, or confined motility, defined by mean
squared displacement (Figure 3.2C). p50-GFP-vesicles with EB1 in the absence of
exogenous CLIP-170 show a low, basal rate of microtubule landing (Figure 3.2D). In the
presence of EB1+CLIP-A, vesicles show a 2-fold enhancement of the landing rate, an
effect not seen in any other condition (Figure 3.2E). Importantly, however, dwell times
were not significantly different among conditions, suggesting that the increased
recruitment induced by CLIP-A does not affect the characteristic dwell time of the motorcargo complex (Figure 3.2F).
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Figure 3.2 Reconstitution of CLIP-170 dependent organelle recruitment in vitro.
(A) Schematic of in vitro reconstitution assay with p50-GFP-vesicles, EB1, and CLIP-A
or CLIP-E in COS-7 cell extract HSS. (B) Western blot of fractions from neuronal vesicle
isolation from mouse brain shows p150Glued and DIC are enriched in the vesicle fraction.
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Most of the CLIP-170 is retained in the low speed pellet and only a faint band for
endogenous CLIP-170 is found in the vesicle fraction. Cytosolic marker GAPDH is not
enriched in the vesicle fraction. (C) Representative kymographs of p50-GFP-vesicles on
GMPCPP microtubules show that they exhibit processive, bidirectional, and confined
motility, as defined by mean squared displacement analysis of particle trajectories. (D)
Representative kymographs of p50-GFP-vesicles on single GMPCPP microtubules from
each of the three conditions (100nM EB1 + Mock-HSS or CLIP-A or CLIP-E in motility
assay buffer). The estimated final concentration of TMR-labeled HT-CLIP in this assay
was ~100nM. EB1 + Mock-HSS and EB1 + CLIP-E show a basal landing rate, whereas
there is an increase in organelle recruitment with CLIP-A. At least three different
preparations of cell lysates were used. (E) Quantification of the landing rates in each of
the experimental conditions shows a significant increase in organelle recruitment only
with EB + CLIP-A (n >= 22 movies per condition with each movie with > 500 events per
movie; N >= 3 independent vesicle isolations; Kruskal-Wallis (KW) one-way ANOVA with
Tukey post-tests) (F) Empirical cumulative distribution function (CDF) for microtubule
dwell times of all non-fixed particles. The stair plot starts at 0.1s as this is the minimum
observable dwell time. Double exponential fit obtained via Maximum Likelihood
Estimation (MLE) with 100 bootstrapped fits to obtain 95% CI. The dwell time
distributions for Mock-HSS, CLIP-A, CLIP-E were compared in pairs using a two sample
Kolmogorov-Smirnov (KS) test with a Bonferroni correction (p > 0.20 for all comparisons;
n > 1500 particles per condition; N >= 3).
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3.3.3. CLIP-170 phosphorylation state modulates retrograde transport initiation in
neurons
Next, we used live-cell imaging of primary dorsal root ganglion (DRG) sensory neurons
to test whether the phosphorylation state of CLIP-170 regulates retrograde transport in
the distal axon (Moughamian and Holzbaur 2012). We depleted endogenous CLIP-170
using siRNA, and expressed siRNA-resistant WT or phosphomutant forms of CLIP-170.
To visualize retrograde transport we also expressed LAMP-1-RFP. To unambiguously
measure retrograde transport initiation, we photobleached a 40µm region of axon 10µm
proximal to the distal growth cone tip, then measured the flux of LAMP-1-RFP organelles
moving in the retrograde direction from the growth cone into the bleached region (Figure
3.3A). CLIP-170 knockdown reduces distal initiation (Figure 3.3B). As previously noted,
the effect of CLIP-170 knockdown on distal initiation is specific, as it does not
significantly alter retrograde flux along the mid-axon (Moughamian et al. 2013).
Quantitative analysis of OregonGreen-labeled CLIP rescue constructs demonstrated that
all expressed to similar levels (APPENDIX I, Figure S4), but strikingly, only expression of
either CLIP-WT or CLIP-A was capable of rescuing transport initiation to normal levels
following CLIP-170 knockdown. In contrast, CLIP-E only partially rescued the deficit
caused by loss of endogenous CLIP-170 expression (Figure 3.3B, C; Table S1).
Importantly, the number of vesicles in the growth cone was comparable across all
conditions, indicating that the decreased flux observed in the knockdown and CLIP-E
rescue experiments was not due to depletion of the distal vesicle pool, nor do we see a
deficit in anterograde transport (Figure 3.3D). Thus, consistent with our in vitro results,
the phosphorylation state of CLIP-170 modulates retrograde transport initiation in
neurons.
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Figure 3.3 CLIP-170 phosphorylation state modulates retrograde transport
initiation in neurons.
(A) Schematic of live-cell assay for retrograde transport initiation in neurons. (B)
Representative kymographs for each condition with a schematic tracing of the analyzed
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vesicles to the right. The dashed red line indicates 3.5µm from the distal end of the
bleaching ROI and is the site for flux analysis. (C) Quantification of retrograde flux for all
conditions. CLIP-170 knockdown reduces the efficiency of retrograde flux and this is
rescued by CLIP-WT or CLIP-A, but CLIP-E shows incomplete rescue (n= 18-36
neurons total, N > 3 experiments; KW ANOVA with Tukey post-tests). A complete list of
the pairwise post-tests is shown in Table S1. (D) Quantification of the number of LAMP1-RFP vesicles in the growth cone at the start of the movie shows a comparable
distribution of vesicles indicating that the reduced retrograde flux in the siRNA or siRNA
+ CLIP-E is not due to a reduced distal vesicle pool.
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3.3.4. The distal axon is rich in tyrosinated α-tubulin
The retrograde transport initiation zone observed in our live-cell experiments is
coincident with the region of the distal axon thought to be enriched for tyrosinated αtubulin (Brown et al. 1993; Robson and Burgoyne 1989). We used super-resolution
imaging to more precisely map the tyrosination state of α-tubulin along the axon.
Stimulated Emission Depletion (STED) imaging of the distal axon of cultured DRG
neurons shows a profound enrichment of Tyr-tubulin over Detyr-tubulin distally (Figure
3.4A,B). We measured the Tyr/Detyr gradient, which stretches ~20μm from the axon tip
and then decreases moving proximally toward the cell body (Figure 3.4C). This gradient
correlates spatially with the distal loading zone observed in live cell assays, and in
conjunction with previous observations that p150Glued puncta preferentially localize to
tyrosinated microtubules in nonpolarized cells (Peris et al. 2006; Vaughan et al. 1999)
led us to test the contribution of Tyr-microtubules to organelle recruitment.

63

Figure 3.4 The distal axon is rich in tyrosinated α-tubulin.
(A) STED super-resolution images of the distal axon shows an enrichment of tyrosinated
α tubulin (white arrowhead distal axon; gray arrowhead ~30µm proximal to the distal
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axon tip) (B) Detyrosinated α tubulin is enriched in the proximal axon, relative to
tyrosinated α tubulin. The white arrowhead shows the first axonal branch point after
exiting the cell body. The cell body was identified by morphology, but is not shown in
these images. (C) Bootstrapped mean and 95% CI for line intensity profiles of Tyr/ Detyr
in the distal axon (n = 4 neurons per condition, 10 line profiles per neuron; N = 2). The
blue line indicates a ratio of 1. The images for Tyr or Detyr staining represent paired
images where the Tyr distal axon in A is from the same neuron as the Tyr cell body
staining in B with the same true for Detyr. Representative paired images were chosen
from >4 images per condition, per experiment of similar quality.
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3.3.5. Tyrosinated α-tubulin promotes robust organelle recruitment in vitro
We directly compared the recruitment of organelles to Tyr- and Detyr-microtubules using
an in vitro reconstitution assay (Figure 3.5A). Tubulin purified from HeLa cells is primarily
tyrosinated; brief treatment with Carboxypeptidase A (CPA) produces a population highly
enriched in Detyr tubulin (Figure 3.5B) (Barisic et al. 2015; Kreitzer et al. 1999).
Microtubules were polymerized from either Tyr- or Detyr-tubulin and GMPCPP, and
differentially labeled with AF-647- and TRITC-conjugated tubulin at a low ratio (5%);
there was no significant difference in length between Tyr/ Detyr-microtubules
(APPENDIX I, Figure S5A). Labeled Tyr- and Detyr-microtubules were flowed into the
same chamber, allowing the simultaneous measurement of landing rates.

Kymographs of interactions of p50-GFP-vesicles with Detyr-microtubules show a low
basal landing rate (Figure 3.5C), similar to landing rates observed with microtubules
polymerized from bovine brain tubulin (Figure 3.2E). In contrast, we observed a more
than 4-fold increase in the landing of p50-GFP vesicles onto Tyr-microtubules (Figure
3.5D Movie S2). The choice of fluorescent label did not affect our observations, as the
reversing the labels on Tyr-/ Detyr-microtubules did not affect the results (APPENDIX I,
Figure S5 B-D, Movie S3). Importantly, we found that despite the marked differences in
landing rates, dwell times for vesicles bound to either Tyr- or Detyr-microtubules were
very similar. Thus, the mechanisms that promote recruitment to the microtubule are
distinct from the processes that determine the sustained engagement of the motor-cargo
complex.

66

Figure 3.5 Tyrosinated α-tubulin promotes robust organelle recruitment in vitro.
(A) Schematic of the p50-GFP-vesicle recruitment assay using GMPCPP stabilized Tyr-/
Detyr-microtubules labeled separately with either 5% AF-647 or TRITC. (B) Western of
Tyr/ Detyr tubulin purified from HeLa cells shows a homogenous population of fully
tyrosinated or fully detyrosinated tubulin, compared to brain tubulin. (C) Representative
kymographs of p50-GFP-vesicle landing on Detyr versus Tyr microtubules. (D)
Quantification of landing rate shows a robust and significant increase in landing rate on
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Tyr microtubules (n = 70 movies per condition, each movie with > 500 events; N = 3
independent vesicle isolations; Wilcoxon Rank-Sum test p < 1x10-10). (e) Empirical CDF
for microtubule dwell times of all non-fixed particles with double exponential fit and 95%
CI for fit parameters. The dwell time distributions for vesicles on Tyr or Detyr
microtubules were compared using a two sample KS test (p = 0.07; n > 1x104 particles
per condition, N = 3).
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3.3.6. CLIP-170 phosphorylation regulates recruitment to Tyr-microtubules
CLIP-170, with two tandem CAP-Gly domains per monomer (four per dimer complex), is
also sensitive to Tyr-tubulin, and preferential recruitment of CLIP-170 to Tyrmicrotubules has been shown in cells and in vitro (Bieling et al. 2008; Peris et al. 2006).
However, it is not known how phosphorylation affects the binding of CLIP-170 to Tyrtubulin. Using single molecule TIRF microscopy, we measured the landing rates on Tyr-/
Detyr-microtubules for TMR-HT-labeled CLIP-WT, CLIP-A, and CLIP-E expressed in cell
lysates. Constitutively active kinesin-1 motor domain fused to a TMR-HT (CA-Kinesin1[560]) was used as a control; we saw robust localization to both Tyr- and Detyr
microtubules.
Maximum intensity projection images over time show colocalization of CLIP-WT and
CLIP-A with Tyr-microtubules, but little binding to Detyr-microtubules (Figure 3.6A).
CLIP-E was recruited poorly to either Tyr- or Detyr-microtubules. Quantification of
landing rates confirms that CLIP-WT and CLIP-A show a significant preference for Tyrmicrotubules (Figure 3.6B, Table S2). Although CLIP-E retains a significant preference
for Tyr, its landing rate is significantly reduced relative to CLIP-WT or CLIP-A
(APPENDIX I, Table S2). The landing rates for CA-Kinesin-1[560] were similar on both
Tyr- or Detyr-microtubules, confirming that sensitivity to Tyr- microtubules is not a
general feature of microtubule binding proteins in this assay.
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Figure 3.6 CLIP-170 phosphorylation regulates recruitment to Tyr-microtubules.
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(A) Image of max intensity projection over time shows selective localization of CLIP-WT
and CLIP-A to Tyr microtubules. CLIP-E shows reduced localization to Tyr microtubules.
(B) Quantification of landing rate on Tyr- or Detyr- microtubules shows a significantly
increased landing rate of CLIP-WT and CLIP-A on Tyr-microtubules. CLIP-E retains a
significant preference for Tyr-microtubules, but landing is significantly reduced compared
to CLIP-WT or CLIP-A (a table of all pairwise post-tests is found in APPENDIX I, Table
S2). Single molecule landing rates for CA-Kinesin-1[560] in cell extracts show no
differences between Tyr-/ Detyr-microtubules (n > 24 movies per condition, each movie
with > 500 events; N = 3 independent cell lysate preparations; KW ANOVA with Tukey
post-tests). The estimated final concentration of TMR-labeled HT-CLIP in this assay was
~0.5nM for HT-CLIP constructs or 2.5nM for CA-Kinesin-1[560]. (C) Image panel for
ensemble recruitment assay using 100nM purified proteins. Faint GFP-p150[1-210] signal
is present on Detyr microtubules and is likely mediated by the low affinity basic
microtubule binding domain. (D) Quantification of the median normalized GFP
fluorescent intensity per microtubule. The gray rectangle indicates the 95% CI for the
median normalized GFP intensity for areas with no microtubules in each condition (n >
100 microtubules per condition; N = 3; KW ANOVA with Tukey post-tests). No
exogenous EB1 was added in the experiments shown in Figure 3.6A–D.
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3.3.7. p150Glued CAP-Gly is a major factor on vesicles for sensing Tyr-α-tubulin
To further define the domains involved in recruitment, we tested the specificity of purified
recombinant constructs of CLIP-170 and p150Glued (APPENDIX I, Figure S6) for binding
to Tyr- and Detyr-microtubules, in comparison to the motor domain of kinesin-1. We find
that the N-terminal H2 fragment of CLIP-170 and the N-terminus of p150Glued [1-210] are
both robustly sensitive to the tyrosination state of the microtubules (Figure 3.6C,D),
consistent with previous results (Bieling et al. 2008; Peris et al. 2006). Importantly, we
find that the ability of p150Glued to sense tubulin tyrosination requires only the CAP-Gly
domain, as deletion of the low microtubule affinity basic domain does not reduce the
preference for Tyr-microtubules, while deletion of the CAP-Gly completely abolishes
microtubule binding (Figure 3.6C). Of the potential CAP-Gly proteins sensitive to tubulin
tyrosination that we tested, only p150Glued is selectively enriched our vesicle fraction
(Figure 3.2B). In previous work, we have shown that the CAP-Gly domain of p150Glued is
the major determinant mediating the initial interaction of neuronal vesicles with the
microtubule, as vesicle binding is effectively blocked by pre-incubation with a
monoclonal antibody specific for this domain but not by antibodies to dynein or kinesin
motors (Hendricks et al. 2010). Thus, we conclude that the CAP-Gly domain of p150Glued
is likely the major determinant regulating the specificity of neuronal vesicles for
tyrosinated microtubules.

3.3.8. Simulation of vesicle diffusion and microtubule capture in the distal axon
Our experimental data indicate that both the phosphorylation state of CLIP-170 and the
tyrosination state of the microtubule contribute to effective cargo capture. To rigorously
test our model, we performed Monte-Carlo simulation of vesicle diffusion and
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microtubule capture using experimentally derived parameters. In the simulation, vesicles
initiate at random positions in the growth cone and undergo 2D diffusion until they reach
the microtubule, upon which capture occurs at a pre-specified probability. We model the
open conformation of CLIP-170 as an extended ~135-nm rod (Scheel et al. 1999) that
can increase the effective microtubule search radius when bound to the lattice. We
simulated two extremes, one where CLIP-170 does not decorate the microtubule as a
model for CLIP-E, and a second scenario assuming full microtubule decoration as model
for CLIP-A, simulated by dilating the microtubule mask by a disk structuring element of
radius 135nm. The tyrosination state of microtubules is incorporated into the model by
altering the normalized binding probability, with binding probabilities of 1 and 0.25 for
Tyr- and Detyr-microtubules respectively, values empirically determined from vesicle
landing rates on Tyr- or Detyr-microtubules (Figure 3.5D). To model the diffusion
constant of vesicles in the cytoplasm we used an empirically determined diffusion
constant, D, of 0.006µm2/sec (Zajac et al. 2013). However, we also performed parallel
simulations over a broad range of diffusion constants. For each condition, 1000 vesicles
were randomly seeded within the growth cones of four different simulation spaces traced
from experimentally captured STED images. Vesicles were allowed to diffuse for a
maximum of 20 minutes simulated time and the position of each vesicle was determined
every 100ms (pseudocode shown in APPENDIX I, Figure S7 A). All simulations for a
given condition were repeated five independent times for a total of 5000 simulated
vesicles per neuron (2x104 per condition).

CLIP-A decoration reduces the effective distance to the microtubule compared to CLIPE, thus increasing the microtubule search radius. At a binding probability of 1 (Tyr), this
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dramatically reduced the effective time for microtubule capture of randomly seeded
vesicles undergoing 2D diffusion (Figure 3.7B). The effect of CLIP-A in reducing the
median time to microtubule capture holds over three orders of magnitude of diffusion
constants, from 0.001 – 1.0µm2/sec (Figure 3.7C, Figure S7 B). Strikingly, we found a
2.4 fold increase in the number of vesicles that never encounter a microtubule over the
20 min course of the simulation in our models of CLIP-E as compared to CLIP-A
(APPENDIX I, Figure S7 C). To our surprise, our modeling revealed that decreasing the
binding probability to 0.25 to mimic binding to Detyr-microtubules had only a modest
effect on the median time to microtubule capture (Figure 3.7B). We also repeated our
simulation limiting CLIP-A decoration to the terminal ~2 microns of the microtubule (D =
0.006µm2/sec). Again, we saw that CLIP-A significantly reduced the median capture
time, in this case by an average of 5.0s (95% CI 4.8 - 5.1) as compared to CLIP-E.
Finally, to test the overall utility of our model, we calculated the predicted rate of
retrograde flux from our simulation. The flux rate observed in our simulation is not too far
from our measured rates of flux in primary neurons, further supporting the predictive
power of our modeling (Figure 3.7D).

Thus, both our experimental observations and our simulations are consistent with a
multi-modal recruitment model, where CLIP-170 phosphorylation and the tyrosination
state of microtubules regulate transport initiation via interacting pathways. The primary
role of CLIP-170 is to extend the microtubule search radius, reducing diffusion times in a
region of the cell characterized by sparse microtubules, while gradient of Tyrmicrotubules provides spatial specificity by promoting efficient organelle recruitment.
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Figure 3.7 Simulation of vesicle diffusion and microtubule capture in the distal
axon.
(A) STED image Tyr-microtubules in the neuronal growth cone with the cell border
outlined in white (left) and a schematicgrowth cone (right). (B) Median (with
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bootstrapped 95% CI of the median) for the effective time to microtubule capture in
computer simulations with CLIP-E or CLIP-A, and either Tyr or Detyr binding
probabilities (D = 0.006um2/sec). (C) Simulated retrograde flux for four different traced
neuronal growth cones used in the simulation. In some neurons, CLIP-A decoration
increases the simulated retrograde flux. (d) Median time to microtubule capture using
Tyr binding probabilities and a range of diffusion coefficients (also see Figure S7). (e)
Working model for the regulation of transport initiation in neurons. A gradient of
tyrosinated α-tubulin is enriched in the distal axon provides spatial regulation and
promotes efficient binding in a region where many cargos originate. CLIP-170 is highly
phosphorylated and not microtubule associated in the growth cone at baseline. Transient
or local dephosphorylation may provide temporal regulation and is required for efficient
transport initiation in neurons.
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3.4.

Discussion

3.4.1. Multi-modal regulation of transport initiation.
The initial recruitment of motor-cargo complexes to microtubules may be the rate-limiting
step of intracellular transport, and this process is likely to be regulated for efficient,
coordinated organelle motility in the cell. Here, we show that CLIP-170 phosphorylation
regulates organelle transport initiation in vitro and in neurons in a mechanism dependent
on the canonical plus end tracking EB proteins. In addition, we find regulation at the level
of the microtubule track, as enrichment of tyrosinated α-tubulin in the microtubule lattice
also promotes robust organelle recruitment.

Together, these results favor a multi-modal recruitment model where interacting layers of
regulation promote efficient, robust, and regulated transport. Multi-modal recruitment
advances the “search-capture” model for recruitment of dynein-dependent cargo
(Vaughan 2005) in at least two important ways. First, the observation that Tyrmicrotubules preferentially recruit motor-cargo can account for cargo landing anywhere
along the Tyr microtubule lattice, which extends the potential landing zone up to 20µm
from the axon tip, a much more extensive zone than the ~1µm EB- comet tails at
dynamic microtubule plus ends. Thus, spatial regulation of microtubule post-translational
modifications may account for regional differences in transport at the cellular scale.

Second, layered regulatory interactions allow tuning of transport initiation that may be
responsive to the specialized cytoskeletal architecture of differentiated cell types. For
example, cells with sparse microtubules or slow rates of vesicle diffusion may exhibit
distance-limited transport and rely on CLIP-170-dependent extension of the microtubule
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search radius to decrease diffusion distance. In contrast, cells with dense microtubule
networks may exhibit capture-limited transport, relying on a spatially defined enrichment
of tyrosinated tubulin to increase the binding efficiency of cargo within the microtubule
search radius.

In the specific case of retrograde transport initiation in the neuron, high levels of Tyrtubulin in the distal axon (Brown et al. 1993; Robson and Burgoyne 1989) coincide with
the region where many essential cargo and signaling factors initiate transport. Although
we modeled LAMP1-positive vesicles here, all other cargoes we have examined require
this mechanism for retrograde transport initiation, including Rab5-positive endosomes,
TrkA/TrkB signaling endosomes, and mitochondria (Moughamian et al. 2013). CLIP-170
contributes by extending the microtubule search radius in the growth cone, where
microtubule density is low. This mechanism can be tightly regulated in time, as the
phosphorylation state of CLIP-170 modulates auto-inhibition and thus allows for
temporal tuning of the CLIP-170 dependent recruitment pathway. In combination, these
pathways give robust spatial and temporal control of transport initiation based on cellular
needs.

3.4.2. CLIP-170 and retrograde transport initiation.
We propose that the distal pool of CLIP-170 is highly phosphorylated and thus
preferentially assumes the closed conformation. The transient or local dephosphorylation
of CLIP-170 would relieve autoinhibition and favor the open conformation that promotes
efficient transport initiation. Recent large-scale phosphoproteomic studies in mammalian
tissue indicate that CLIP-170 in brain is highly phosphorylated (Huttlin et al. 2010; Liao
78

et al. 2012), and therefore autoinhibited. The predominance of auto-inhibited CLIP-170 is
consistent with recent immunofluorescent staining in the Drosophila and mammalian
neuronal growth cones, where much of either D-CLIP-190 or CLIP-170 was found to be
soluble or associated with F-actin patches (Beaven et al. 2015). Here, we show that
dephosphorylation of CLIP-170 is likely to be an important and highly regulated step in
the initiation of transport in the distal axon. However, CLIP-170 may do more than bind
microtubules in the distal axon. For example, CLIP-170 interacts with the formin mDia1
(Lewkowicz et al. 2008), and may facilitate crosstalk between actin and microtubules.
With respect to axonal transport, the enrichment of CLIP-170 in actin-rich regions of the
growth cone suggests there may be a pathway to promote efficient translocation of actincoated endosomes to microtubules for transport initiation.

3.4.3. Regulation of transport by post-translational modifications.
In the proposed model, post-translational modifications of microtubules and +TIPs work
together to regulate transport initiation. Post-translational modifications of microtubules
have received much attention recently, with a growing catalogue of elements
contributing to the ‘tubulin code’ (Wehenkel and Janke 2014; Yu et al. 2015). Here, we
find a dramatic difference in the recruitment of organelles depending on the tyrosination
state of α-tubulin. At the molecular level, CAP-Gly proteins such as p150Glued and CLIP170 are highly sensitive to this modification, shown in (Bieling et al. 2008; Peris et al.
2006) and this report, while Kinesin-1 recruitment is insensitive to the tubulin tyrosination
state in our assays, further demonstrating the specificity of the tubulin code. Additional
support for a key role for α-tubulin detyrosination in regulating retrograde axonal
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transport comes from (Song et al. 2015),who found that tubulin tyrosine ligase (TTL) is
important for injury signaling after neuronal damage.

3.4.4. Why do cells need multiple recruitment mechanisms?
Although cells have evolved multiple mechanisms to promote robust transport initiation,
it may not be immediately evident why the microtubule binding domains of motor
proteins alone are not sufficient. Many kinesins are autoinhibited when not bound to
microtubules, and thus it is not surprising that kinesin-dependent microtubule recruitment
may require additional factors (Hirokawa et al. 2009). While cytosolic dynein is not
known to be autoinhibited, recent structural work suggests potential autoinhibitory states
(Torisawa et al. 2014). But even if dynein were not structurally autoinhibited, dynein's
microtubule binding interactions are governed by nucleotide concentration, and the high
cellular ATP levels ( ~1mM) (Rangaraju et al. 2014), favor the weak binding state of
dynein (Porter and Johnson 1983). These predictions agree with both biochemical and
immunostaining observations that a significant fraction of dynein is cytosolic (Gill et al.
1991; Vaughan et al. 1999). Thus, motor-dependent recruitment alone may not be
sufficient to explain the rapid and robust recruitment of motor-cargo complexes to
microtubules in cells (Zajac et al. 2013).

3.4.5. Recruitment mechanisms promote landing and then let go.
Both CLIP-A-dependent recruitment and Tyr-tubulin-dependent recruitment lead to an
increased landing rate, without significant changes in the distribution of dwell times
(Figure 3.2 and Figure 3.5). This raises an interesting biophysical question as to how the
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apparent on-rate for cargo recruitment to the microtubule is increased while the off-rate
or dwell time is unchanged. In the traditional theory of diffusion-controlled reactions the
reaction rate is governed by collision frequency and the on-rates do not change while the
off-rates determine the duration of binding. However, this does not fit the observed data.
One explanation may be that recruitment mechanisms change the spatial factor for the
reaction by introducing multiple extended, flexible proteins such as p150Glued or CLIP170 to increase the number and types of spatial conformations available for motormediated attachment. Importantly, the in vitro dwell time data agree with evidence from
axonal transport studies in neurons, where the CAP-Gly domain of p150Glued is important
for transport initiation in the distal axon, but it is not required to maintain sustained midaxonal retrograde transport (Moughamian and Holzbaur 2012; Moughamian et al. 2013).
This suggests that, although the p150Glued CAP-Gly must be accessible for microtubule
recruitment, there is a mechanism to disengage the CAP-Gly domain so that it does not
act as a brake to prevent sustained dynein motility (Ayloo et al. 2014). Recent structural
work has shown that a subset of purified dynactin complexes have the N-terminus of
p150Glued folded back on itself, suggesting a structural conformation where the CAP-Gly
domain is stably disengaged from the microtubule; however the flexibility of this region
made it difficult to visualize the CAP-Gly domain directly (Chowdhury et al. 2015;
Urnavicius et al. 2015). The mechanism of disengagement and whether it occurs due to
forces from dynein motility or requires additional protein adaptors remains to be
determined.
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3.4.6. Distinct loading mechanisms in the distal versus mid-axon.
We have previously shown that p150Glued, CLIP-170, and EB1 are required for efficient
distal transport initiation, but knockdown does not significantly affect mid-axonal
transport (Moughamian and Holzbaur 2012; Moughamian et al. 2013). Lis1, however, is
a +TIP required for both distal and mid-axonal transport initiation (Moughamian et al.
2013). When Lis-1 binds to dynein it induces a stable complex strongly bound to
microtubules (Huang et al. 2012; Toropova et al. 2014). In the mid-axon, where teams of
dynein mediate processive retrograde transport (Chowdary et al. 2015), individual motor
detachment may be followed by Lis1 recruitment, leading to the formation of a stable
motor-cargo-microtubule complex until transport can resume. Lis1 then likely detaches
from the motile dynein complexes, as observed in fungi (Egan et al. 2012; Lenz et al.
2006). However, the requirement of CLIP-170 for distal transport initiation in our assays
indicates that mechanisms for Lis1-dependent initiation in fungi are insufficient to explain
transport initiation in neurons.
3.4.7. Inefficient transport initiation leads to neurodegeneration
The importance of retrograde transport initiation in neurons is highlighted by the fact that
mutations in p150Glued that selectively disrupt transport initiation cause human
neurodegeneration (Farrer et al. 2009; Lloyd et al. 2012; Moughamian and Holzbaur
2012). Patients with mutations in the CAP-Gly domain develop Perry syndrome, a lateonset rapidly progressive and fatal Parkinsonism (Wider and Wszolek 2008). In addition,
patients with nonsense mutations in CLIP-170 develop intellectual disability, seizures, as
well as other complications (Larti et al. 2015). So what makes neurons especially
vulnerable to reduced efficiency of transport initiation? First, a number of essential
cargos initiate transport from the distal axon, including signaling endosomes carrying
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neurotrophic factors and autophagosomes (Cosker et al. 2008; Maday et al. 2012).
There is also a lower density of microtubules in the distal axon relative to the axon shaft,
increasing the distance required for diffusion to microtubules. Further, decreased
microtubule stability is associated with neurodegenerative diseases (Cartelli et al. 2012;
Esteves et al. 2010), and tubulin tyrosine ligase expression may decrease with age
(Gabius et al. 1983); these changes are predicted to further decrease binding efficiency.
Importantly, the mechanisms regulating transport initiation described here suggest
potential therapeutic approaches. Modulating either α-tubulin tyrosination or CLIP-170
activation may boost transport initiation and thus mitigate transport defects. However,
“more is better” is not the simple motto for retrograde transport initiation, as the disease,
cellular context, and specific cargo being transported make all the difference (Perlson et
al. 2010).
3.5.

Methods

Animal work
All animal protocols were approved by the University of Pennsylvania IACUC.
Protein biochemistry
Tyrosinated tubulin was purified from Hela S3 cells (ATCC, CCL-2.2) as described
(Barisic et al. 2015). Carboxypeptidase A (CPA, Sigma C9268, app 6U/mg of tubulin)
was added to the soluble tubulin to produce detyrosinated tubulin and the tyrosination
status of the tubulin was verified by Western blot (Figure 3.5B). See the Supplemental
Experimental Procedures for additional information.
In vitro reconstitution of microtubule recruitment
Double-cycled GMPCPP microtubules were polymerized according to (Gell et al. 2010)
using with 5% labeled tubulin (AlexaFluor-488,-647, or TRITC; Cytoskeleton) and 95%
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unlabeled tubulin (bovine brain or HeLa tubulin). Cell lysates from COS-7 cells (ATCC,
CRL-1651) were prepared as follows: cells expressed recombinant HaloTag constructs
for ~22hours, labeled with TMR-Halo ligand (Promega), and then lysed in 40mM
HEPES, 120mM NaCl, 0.1% Triton X-100 supplemented with protease inhibitors (2mM
phenylmethylsulfonyl fluoride, 53µM p-Tosyl arginine methyl ester, 210µM leupeptin,
1.5µM pepstatin-A). Lysates were clarified by centrifugation at 17K xg and again at 352K
xg to obtain high speed supernatant (HSS). The relative concentration of TMR-labeled
protein in cell extracts was determined by measuring the absorbance of TMR at 555nm
in reference to a standard curve of TMR at known concentrations. EGTA and EDTA
were excluded from all buffers to maintain the integrity of the CLIP-170 Zn knuckle.
Motility assays were performed in flow chambers made from silanized (PlusOne Silane,
GE) #1.5 coverslips (Warner) attached to glass slides using adhesive tape and vacuum
grease. Typical chamber volumes were ~15µl, incubation times were 5 minutes, and
chambers were washed with 3-4 chamber volumes between incubations. Following
incubation with monoclonal anti-β-tubulin (Sigma T5201) diluted 1:200 in Motility Assay
Buffer (MAB, 10mM PIPES, 50mM K-Acetate, 4mM MgCl2, pH 7.0) and blocking with
5% pluronic F-127; labeled GMPCPP-stabilized microtubules were introduced;
chambers were pre-incubated with MAB supplemented with (0.3mg/ml BSA, 0.3mg/ml
casein, 1mM ATP, 15mg/ml D-Glucose, 10mM DTT); this buffer with supplements also
served as the ‘assay buffer’ for all in vitro assays except Figure 6C-D where purified CAKinesin-1 was supplemented with 1mM AMP-PNP and no ATP was added to purified
proteins. Vesicles diluted in assay buffer were added as noted with or without cell extract
and unlabeled EB1, followed by an oxygen scavenging system (0.5mg/ml glucose
oxidase, 470 U/ml catalase, and 15mg/ml glucose). All assays with labeled Tyr or Detyr
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microtubules included an approximately equal number of repeats with the fluorescent
label for Tyr or Detyr reversed (Figure S5 B-D).
Vesicles were isolated from B6.SJL.Tg-(Thy1.2-p50-EGFP) mice (Ross et al. 2006), as
described (Hendricks et al. 2014). For more information, see APPENDIX I.

Cell culture and live-cell imaging
Dorsal root ganglia were dissected from adult wild type mice, isolated, transfected using
Amaxa Nucleofector SCN program 6 (Lonza), and cultured for 4 days in vitro (DIV)
(Moughamian and Holzbaur 2012; Perlson et al. 2009). Live-cell photobleaching and
imaging of distal retrograde transport initiation was performed according to (Nirschl and
Holzbaur 2016). For more information, see APPENDIX I.
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All CLIP-170 knockdown and rescue neurons used for live-cell imaging experiments met
the following criteria: low expression of recombinant HT-CLIP-170 protein; axonal
processes extending > 500µm from the cell body; normal axonal contours and
morphology with no swellings, bulbs, or membrane blebbing; normal mid-axonal LAMP1-RFP transport (as shown in (Moughamian et al. 2013)).

COS7 cells were cultured in DMEM media, supplemented with 10% fetal bovine serum
and 1% L-glutamine. Cells at ~80% confluence were transfected using FuGENE6
(Roche).
For immunofluorescence, Cos7 cells were fixed in 4% PFA and neurons were fixed with
4% PFA/ sucrose for 10 min. Cells were permeabilized with 0.2% Triton-X100 in PBS
for 15 min, blocked, and incubated with primary antibodies overnight at 4C, then
secondary antibody for 1hour at RT. Samples were mounted in Mowiol-488
(Calbiochem).

Image processing and analysis
Particle tracking of TIRF images was performed in MATLAB R2015a (Natick,
Massachusetts) using the open-source uTrack package (v.2.1.3) from the Danuser lab
(Jaqaman et al. 2008). An initial parameter sweep was conducted to find the optimal
uTrack parameters for detecting local maxima, multi-Gaussian fitting, track linking, and
gap closing (Figure S4). For more information, see APPENDIX I.

Distal flux image analysis: Kymographs of LAMP-1-RFP transport initiation were
prepared using the Kymograph Clear 1.0 ImageJ plugin (Mangeol et al. 2016). Using the
86

mask of the bleached region, a line was automatically generated 50 pixels (~3.5µm)
retrograde to the distal end of the bleached region for retrograde flux analysis. A vesicle
counted in the flux measurement if it started distal to the bleached region and moved
retrograde 3.5µm through the site of flux measurement, regardless of later directional
reversals. The number of vesicles crossing the flux line was manually counted for every
neuron, with the analyst blinded to experimental condition.
Movies 2-4 were processed with the ImageJ (NIH) background subtraction plugin (rolling
ball, 20pixel radius) for improved visualization. However, all TIRF particle tracking and
analysis was performed on raw, unprocessed data. Individual line scans in Figure 3.4
were drawn along the β-tubulin image, Tyr- or Detyr- intensity along this line was
normalized to β-tubulin intensity for each image, and the normalized Tyr/Detyr ratio was
smoothed with a sliding window mean filter prior to calculating the bootstrapped mean
and 95% CI intensity values. MT images in Figure 3.6 were background subtracted using
the method above for visual clarity. The GFP intensity images (Figure 3.6C) for
measuring fluorescent intensity were filtered with a Gaussian kernel to reduce the
contribution of high frequency noise. Where specified, images were deconvolved using
Huygens Professional.

Simulation of vesicle diffusion and microtubule capture in the distal axon
Computer simulations were performed as described in the results section. Pseudocode
for the simulation of vesicle diffusion and microtubule capture is shown in Figure S7A.
For more information, see APPENDIX I.

Statistics
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Statistical tests and distribution fitting were performed in MATLAB R2015a, as noted in
the legends. Box and whisker plots show the median (red bar) and interquartile range
(IQR, blue box) with whiskers extending to the most extreme inliers. Statistical outliers,
defined as data greater than median +/- 1.5*IQR, were included in all analysis, but are
not shown in boxplots to avoid compression of the majority of data. Statistical
abbreviations: n = number of observations per condition, per experiment; N = number of
independent experiments. For more information, see APPENDIX I.
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CHAPTER 4: Cell DECODER: A Neural Network Toolbox for
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4.1.

Abstract

Advances in microscopy have increased image dataset size and complexity in biology.
Large image datasets benefit from automated processing tools that leverage machine
learning, including convolutional neural networks (CNNs) or “deep learning”. However,
there are few tools that allow biologist to leverage CNNs in their research. We develop
the Cell DECODER toolbox, a CNN-based pipeline for unsupervised feature extraction
and phenotypic profiling. We train a 50-layer deep residual network on a large and
diverse dataset from The Human Protein Atlas. We use this trained neural network to
extract “deep features” for unsupervised phenotypic profiling on a different task. We
show that networks trained on one dataset encode robust image phenotypes that are
sufficient to cluster subcellular structures by type and separate drug compounds by the
mechanism of action on a different task, without additional training, supporting the
strength and flexibility of this approach. This approach can be used for quality control,
grouping images by phenotype, and exploring relationships among image phenotypes to
discover relationships between experimental conditions or genetic and pharmacologic
pathways in image-based assays.
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4.2.

Introduction

While imaging is a foundation of cell biology, recent advances in fluorescent probes and
microscopy technology have made image datasets larger and more complex than ever
before. The rapid exploration and visualization of large, high-dimensional datasets is
critical for identifying phenotypes and designing specific, testable, and quantitative
image analysis pipelines. This is especially true for high-throughput microscopy screens
where there can be tens of thousands of images and specific, testable image
phenotypes may not be known before the screen. Thus, there is a need for
computational image analysis tools that are fast and capture a diverse and robust set of
image phenotypes.

There are many excellent tools for directed image analysis approaches including
segmentation and traditional feature extraction pipelines (Carpenter et al. 2006; Rajaram
et al. 2012; Sommer and Gerlich 2013; Sommer et al. 2011). This approach is the
method of choice when specific image features are known and easy to specify in terms
in a set of discrete image processing steps. However, these traditional approaches can
require complex segmentation schemes and parameter optimization in addition to long
computational runtimes. Traditional feature extraction is also limited in that it may not
fully represent the complexity or diversity of image phenotypes due to previously
unrecognized image features. Finally, although many human experts can easily
appreciate and recognize complex phenotypes in cells, such as the difference between
two cell lines, these concepts can be difficult to express as an image transform or even
multi-parametric phenotypic profile. Thus, there is a need for computational image
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analysis tools that can extract complex image features in order to allow for the full
exploration and characterization of phenotypes in image based assays.
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Deep convolutional neural networks (CNNs) are powerful representation learning
algorithms that have shown remarkable success in image classification and object tasks
in basic, commercial, and medical research applications (LeCun et al. 2015; Litjens et al.
2016; Peng et al. 2016). These algorithms can learn abstract image phenotypes that are
difficult to manually engineer using traditional approaches. In addition, the application of
trained networks can be remarkably fast on both CPUs and graphical processing units
(GPUs) due to optimized linear algebra libraries available on most modern computers.

We have developed the Cell DEep learning and COmputational DEscriptoR
(DECODER) toolbox, a set of high-level Python modules, trained neural networks, and
Jupyter notebook tutorials for deep feature extraction and unsupervised phenotypic
profiling. A schematic overview of this pipeline is illustrated in Figure 4.1. We use stateof-the-art deep residual networks (He et al. 2015) and train on a large and diverse set of
fluorescent micrographs curated from The Human Protein Atlas (Thul et al. 2017; Uhlen
et al. 2010). We use this dataset to train networks with robust hidden-layer
representations or “deep features” for feature extraction and unsupervised phenotypic
profiling. See the materials and methods for implementation details.
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Figure 4.1 Schematic overview of Cell DECODER pipeline.
(A) High throughput microscopy screens can generate many thousands of images,
which make manual exploration impractical. Image Credit: The Human Protein Atlas. (B)
Pre-trained CNNs can be used to extract “deep features” that preserve image
phenotypes. (C) The deep features (1024 dimensional vector) can be reduced to fewer
dimensions for visual exploration using dimensionality reduction approaches such as tdistributed Stochastic Neighbor Embedding (SNE) (van der Maaten and Hinton 2008).
The network is agnostic to the true label (drug, gene knockout), but the label can be
used to color the data after the fact to look for batch effects or experimental conditions
that share similar image phenotypes. Each point corresponds to one image.
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4.3.

Results and discussion

The first step is to train a state-of-the-art deep residual network on a large, diverse set of
fluorescent micrographs of >600,000 cells from 22 cell lines, curated from The Human
Protein Atlas (Thul et al. 2017; Uhlen et al. 2010). During training, the network will learn
hierarchical image features in order to correctly predict cell type from an RGB image of
DNA, endoplasmic reticulum, and microtubules. These hidden-layer representations or
“deep features” then basis for our unsupervised phenotypic profiling.

We trained our networks to predict a cell line from 22 different human cell lines using
images of cells stained for DNA, ER, and microtubules (97% accuracy). After training,
we remove the final classification layer, which predicts cell type, to leave a 1024
dimensional vector as the output. This vector representing a high-dimensional image
phenotype, which can be visualized with dimensionality reduction techniques such as
tSNE (van der Maaten and Hinton 2008). When the 1024 dimensional vector is reduced
using tSNE the held-out test images of cell lines from The Human Protein Atlas organize
into different clusters (Figure 4.1C). The clusters are colored based on the true cell type
and similar colors (cell lines) cluster together. However, the network was trained for the
task of classifying cell line from an image, so this clustering is expected. The real test is
whether these deep features contain useful representations to explore image
phenotypes from different datasets and tasks.

Our first external test uses grayscale DAPI images of binucleate and mononucleate cells
from the IICBU 2008 benchmark suite (Shamir et al. 2008). The goal is to use
unsupervised phenotypic profiling to determine whether “deep features” from a network
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trained to predict cell type can be used to separate binucleate and mononucleate cells
without having been trained for this task. In addition, we can assess whether our
approach will generalize to different datasets since these images were acquired using a
different form of microscopy (widefield), at a different magnification, and a different color
depth (grayscale) than The Human Protein Atlas training set (confocal, 100x, RGB). We
extracted features using the pre-trained network, with the network agnostic to the true
label (binucleate vs mononucleate), and applied color labels after the fact. Movie S 5
shows the 3D scatterplot with a separation of the classes.
Our second external test moved to a multi-class scenario that included grayscale images
of ten different subcellular structures from the HeLa structures dataset (Boland and
Murphy 2001; Murphy et al. 2000). This dataset differs from the training set in that
images represent maximum intensity projections of Z-stacks instead of single confocal
slices. Interestingly, phenotypic profiling reveals clusters that recapitulate subcellular
structures as well as semantic relationships between subcellular clusters, as seen in
Movie S 6. For example, actin and microtubules, which are both linear filamentous
structures, are closer in the tSNE embedding than vesicular structures such as
endosomes and lysosomes. The nucleus/ nucleolus and cis/trans Golgi are close in the
embedded space. Finally, we apply our unsupervised profiling approach to the published
image-based drug screen BBBC021v1 (Caie et al. 2010), available from the Broad
Bioimage Benchmark Collection (Ljosa et al. 2013).This high-content screen applied
small molecules to MCF-7 cells for 24 hours, after which cells were fixed and labeled for
DNA, F-actin, and α-tubulin for imaging as described (Caie et al. 2010). We find that
cytoskeletal drugs with opposing mechanisms of action separate from each other, and
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from the negative control condition (DMSO) both in 2D scatterplots as well as when
comparing their tSNE feature vectors using the cosine distance (Figure 4.2).
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Figure 4.2 Phenotypic profiling of small molecules in BBBC021
(A) Phenotypic profiling of DMSO versus the F-actin stabilizing drug jasplakinolide and
the depolymerizing drug latrunculin B, shown as a 2D scatterplot of tSNE embedded
features (top). We compare the cosine distance (1- cosine similarity) between the 2D
tSNE feature vector for each image and the mean DMSO vector, scaled 0-1. A value of
0 represents perfect agreement whereas a value of 1 represents diametrically opposed
vectors. Each point corresponds to one image. Due to the large number of DMSO
images, we sampled a random N subset of DMSO points to match the N of the treatment
group in each panel. The tSNE embeddings in A, B, and C are performed independently,
and since it is stochastic, the tSNE scales are different for each embedding. Thus, the
scale of the tSNE components and relative position of individual points will be different in
each panel. (B) Phenotypic profiling of microtubule destabilizing (nocodazole) and
stabilizing (taxol) compounds. (C) Phenotypic profiling of the protein synthesis inhibitors
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Anisomycin and the proteasome inhibitor MG-132. The two compounds appear to fall
along a continuum of the same phenotypic space and their feature vectors differ from the
DMSO control.
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Thus, we have shown that training a large CNN on fluorescence microscopy images
produces robust hidden-layer representations or “deep features” that can be applied to
new datasets with different cell types, bit depths, and fluorescent labels while retaining
useful semantic information about biological image phenotypes. All of these results were
obtained without any training on the new datasets. This type of unsupervised image
phenotype exploration can reveal novel relationships among genetic or pharmacologic
pathways that may have similar image phenotypes. It can also be used for quality
control. For example, coloring the data in the scatterplot by the variables such as the
experiment date could reveal batch effects, where the data is clustered by technical
variation rather than biological variation.

A supplemental resource of this work includes multiple pre-trained neural networks and
Jupyter notebook tutorials for network training, transfer learning, and phenotypic
profiling. We have multiple networks trained on a large set of biological images including:
22 cell lines from the Human Protein Atlas, 18 subcellular organelles and structures from
The Human Protein Atlas, and mixed biological samples and microscopy types (yeast, E.
coli, mammalian cell lines, confocal, widefield, etc.). These networks trained on large
datasets can be fine-tuned on smaller datasets, which will make getting started in deep
learning accessible to more biologists. However, we note that this toolbox is not meant
to replace popular high-level deep learning application programming interfaces (APIs)
meant for developers, such as NVIDIA DIGITS or Keras, which provide extensive tools
and support for training custom neural networks. Rather, Cell DECODER is aimed at cell
biologists who wish to apply deep learning models pre-trained on biological datasets for
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phenotypic profiling of their own image datasets with minimal additional training or
customization.
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4.4.

Materials and Methods

Training datasets
Individual grayscale fluorescence microscopy images from The Cell Atlas of The Human
Protein Atlas v16 were downloaded on January 2017. The original images were acquired
at 100x magnification (2048 x2048 pixels), as described on The Human Protein Atlas
website and associated metadata. We modified the original images by applying a lowpass Gaussian filter to reduce jpeg compression artifacts, down-sampling to 655x655
(250nm per pixel) using the least-squares image resizing ImageJ plugin from EPFL, and
making RGB images from the individual down-sampled grayscale images.

The images were allocated into a training and held-out test dataset. We used ten-fold
cross-validation to split the training dataset into ten folds to monitor training progress and
tune neural network hyperparameters. However, a single fold was randomly chosen for
phenotypic profiling. Future work will average multiple networks to form an ensemble
phenotypic profile, which may improve performance.

We used a principled approach to data augmentation in order to increase the diversity of
images presented to the network. Fluorescence microscopy images of cells in culture
retain their cell identity regardless of random cropping, image flipping, mirroring, rotation,
or subtle intensity/ contrast adjustments. Since there were multiple cells within each
image, we augmented the dataset on-the-fly during training by taking a randomly
cropped 224x224 pixel field of view within each 655x655 down-sampled image. We also
used random rotation, horizontal/ -vertical flipping, and contrast/-saturation adjustment
(Krizhevsky et al. 2012).
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Evaluation datasets
The IICBU binucleate dataset used in Movie S 5 was originally described in Shamir et al.
(2008). HeLa images of subcellular structures used in Movie S 6 were originally
described in Boland and Murphy (2001). The image-based drug screen BBBC021v1 was
originally described in (Caie et al. 2010), and made available from the Broad Bioimage
Benchmark Collection (Ljosa et al. 2013).

Implementation
We implemented Cell DECODER in Python 3.5 using the Microsoft Cognitive Toolkit
CNTK (Seide and Agarwal 2016). We adapted the ResNet 50 architecture from (He et
al. 2015) by reducing the number of parameters in each layer by half and adding a
dropout layer with a probability of 0.5 at the final pooling layer (pool 5). We trained for
150 epochs using momentum stochastic gradient descent and on-the-fly data
augmentation including randomly applied: rotation, horizontal flipping,
brightness/intensity/ saturation jitter (Krizhevsky et al. 2012), and scale jitter applied via
randomly cropping images to the range (0.4, 0.875) of the original 655x655 input image
before rescaling to 224x224. The network architecture and learning parameters will be
uploaded with the source code. Training was performed on Windows 10 PC with two
Intel Xenon E5-2623 processors, 96GB RAM, and a NVIDIA Titan-X Pascal GPU.
Training lasted approximately 22 hours (10ms per image). The MATLAB package for
tSNE from Laurens van der Maaten was used for dimensionality reduction of the deep
features.
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We used the cosine distance to compare the similarity of the 2D tSNE feature vectors in
Figure 4.2 because the tSNE embedding produces a nonlinear manifold and Euclidean
distance isn’t an accurate representation of true distance or similarity in high dimensional
space (van der Maaten and Hinton 2008).
Code and data availability
The Cell DECODER source code and the data that support these results will be
uploaded to https://github.com/jnirschl/ within 6 months of publication. Microscopy
images from The Human Protein Atlas are Copyright of The Human Protein Atlas and
used under the CC BY-NC-ND 4.0 License. The images must be obtained from The
Human Protein Atlas, as the NoDerivatives clause limits the distribution of modified
images. The IICBU 2008 binucleate dataset can be obtained from Goldberg lab at the
NIH (https://ome.grc.nia.nih.gov/iicbu2008/) The HeLa structures dataset can be
obtained at the Murphy lab (http://murphylab.web.cmu.edu/data/2Dhela_images.html).
The BBBC021v1 dataset is available from the Broad Bioimage Benchmark Collection
https://data.broadinstitute.org/bbbc/BBBC021/.
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5.1.

Abstract

Cardiac biopsies are obtained for the diagnosis of acute heart failure as well as postheart-transplant rejection. On histology, both are characterized by an expansion of the
cellular and acellular stromal tissue as well as morphologic changes within myocytes,
among other features. There is growing evidence, from a number of diseases, that
computer-extracted features of tissue and nuclear architecture are not only useful for
diagnostics, but can also predict disease recurrence, progression, and patient outcome.
Automated tools to segment myocytes and stroma with high fidelity are a critical first
step toward developing predictive models to improve diagnosis, prognosis, and
reproducibility in cardiac pathology. Whole-slide imaging in digital pathology is producing
large, rich data sets for machine learning algorithms that learn features representations
directly from data, such as deep neural networks or “deep learning”. Deep learning has
achieved state of the art performance in computer vision and is becoming ubiquitous
within the realm of digital pathology. Here, we present a deep learning framework for
myocyte and stroma segmentation in H&E stained cardiac tissue using a data set of 103
patients with clinical heart failure or non-heart failure controls. We provide a tutorial for
how to use the AlexNet architecture, implemented in Caffe, to train a pixel-level classifier
for segmentation. We compare the performance of our deep learning approach to a
random forest classifier with 333 intensity and texture features and test on 20 held-out
patient images with expert ground-truth annotation of tissue boundaries. We find our
deep learning segmentation outperforms random forests in terms of mean (a) AUC (0.95
vs 0.80), (b) F-score (0.96 vs 0.91), (c) TPR (0.96 vs 0.92), (d) TNR (0.94 vs 0.67), and
(e) modified Hausdorff distance on the segmentation perimeter pixels (51 vs 122).
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5.2.

Introduction

The advent of whole-slide imaging (WSI) has increased the digitization of pathology
slides, which is generating large, information-rich data sets where modern computer
vision and machine learning methods thrive (Bhargava and Madabhushi 2016; Ghaznavi
et al. 2013; Madabhushi and Lee 2016). Traditional approaches for image analysis in
digital pathology have involved manually engineering image features to use in a machine
learning classifier (Bhargava and Madabhushi 2016). These features generally involve
pixel intensity statistics, texture descriptors, and image decompositions, as well as taskspecific features. However, representation learning methods, such as deep convolutional
neural networks or “deep learning”, have made significant advances in computer vision
and are becoming increasingly common in medical image analysis (Bhargava and
Madabhushi 2016; LeCun et al. 2015). Deep learning has many potential applications to
digital pathology because it excels at tasks with large and complex training data sets,
such as WSI. In addition, since deep learning models do not carry domain or tissuespecific information, a general workflow can be rapidly applied to problems across
different domains. In this chapter, we provide a brief introduction to digital pathology,
deep learning, and cardiac histopathology. We then present a workflow for segmentation
of myocytes versus stroma in cardiac histopathology images. The long-term motivation
for developing this segmentation workflow is to allow the exploration of whether
computer-extracted histomorphometric features of tissue architecture from cardiac
biopsy images are predictive of cardiac failure and/or rejection in the context of heart
transplant patients.
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Manual pathological examination takes advantage of the human visual system, which
excels at automatically and efficiently partitioning an image into distinct components.
The pathologist uses domain knowledge to provide biological context to the image and
interpret structures into their appropriate tissue or cellular subtypes. This is followed by
the identification of image features that can be used to label tissue as normal or
abnormal. The final diagnosis is made through a combination of diagnostic criteria,
histopathological image features, and prior experience. Computational analysis of digital
pathology slides takes a similar process; image segmentation generally precedes the
extraction of tissue-specific and disease-relevant features, which are ultimately used for
diagnosis.

Image segmentation in digital pathology involves the partitioning the image into
histologic primitives, or the biologically-relevant tissue, cellular, or sub-cellular structures
(e.g. stromal tissue, nuclei, etc.) (Cireşan et al. 2013; Wang et al. 2014; Xu et al. 2016a;
Xu et al. 2016b). This allows the extraction and quantification of tissue or cell-specific
features that can be used for diagnosis or prognosis (Basavanhally et al. 2011; Beck et
al. 2011; Doyle et al. 2012; Lewis et al. 2014; Litjens et al. 2016; Madabhushi et al.
2011). The process of applying computerized image analysis to quantify histologic
features is known as quantitative histomorphometry. One important reason to segment
histologic primitives prior to quantitative histomorphometry is to account for features that
may have different predictive power depending on their context within the tissue. For
example, normal cardiac tissue has stroma but it is limited to perivascular regions.
However, when stroma is embedded between myocytes it is abnormal and can
represent disease or fibrosis, as shown in Figure 5.1. Although segmentation is an
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important step in digital pathology, manual segmentation is neither efficient nor routinely
incorporated into clinical practice. Thus, developing automated algorithms for robust
tissue segmentation is an important prerequisite for quantitative histomorphometry and
predictive modeling.

Representation learning methods, such as deep convolutional neural networks or “deep
learning”, have made significant advances in computer vision and are becoming
increasingly common in medical image analysis (Bengio et al. 2013; Bhargava and
Madabhushi 2016; LeCun et al. 2015). Deep learning has many potential applications to
digital pathology because it excels at tasks with large and complex training data sets,
such as WSI. In addition, since deep learning models do not carry domain or tissue
specific information, a general workflow can be applied to multiple cases. Deep learning
differs from conventional approaches in that important features are not specified and
designed a priori, but are rather learned directly from the data. A representation learning
approach to image segmentation in digital pathology reduces the time spent
engineering features and ensures that the biological diversity and technical variance of
the data set is captured.

In general, deep neural networks work by arranging nodes or artificial “neurons” in
successive, convolutional, max-pooling, and fully connected layers as described
elsewhere (Bengio 2009; Schmidhuber 2015). Parameters that specify neuron weighting
are iteratively adjusted during training to approximate functions from data in a way that
minimizes a loss function, which is typically correlated with the task at hand (e.g. class
separation). The net result is the extraction of hierarchical features that map the input
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image into abstract feature vectors that capture complex and nonlinear relationships in
the data. Deep learning has recently been successfully applied to a number of digital
pathology problems including localizing invasive ductal carcinoma (Cruz-Roa et al.
2014), mitosis detection (Cireşan et al. 2013; Wang et al. 2014), colon gland
segmentation (Kainz et al. 2015), epithelial and stromal segmentation (Xu et al. 2016a),
and histopathological diagnostic support (Litjens et al. 2016). In this work, we explore the
use of a deep learning framework for tissue segmentation in cardiac histopathology.

The two most prominent tissue classes in cardiac tissue are the myocytes, responsible
for heart contraction, and the stroma, consisting of cellular and acellular support tissue.
The stromal tissue is generally minimal in normal heart tissue. However, in the context of
heart failure or cardiac rejection there is an expansion of the stromal tissue (see Figure
5.1).
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Figure 5.1 Example of normal and abnormal cardiac tissue.
(A) Cardiac biopsy from a patient without heart failure shows stroma limited to
perivascular regions as well as regular, dense arrays of cardiomyocytes. (B) A biopsy
from a patient with clinical heart failure shows an expansion of stromal tissue that
disrupts the cardiomyocyte arrays. In addition, myocytes and their nuclei can be
enlarged relative to normal tissue. Segmentation of myocytes and stroma is a first step
toward quantifying these tissue abnormalities. Images are 2000 µm x 2000 µm at 5x
magnification. Reprinted with permission from Elsevier Academic Press (Nirschl et al.
2017b), copyright (2017).
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Cardiac biopsy is performed in the setting of new-onset heart failure, or for posttransplant rejection surveillance in adult heart transplant recipients (Cooper et al. 2007;
Costanzo et al. 2010). Histopathological examination of these cases shows an
expansion of the cellular and acellular stromal tissue, fibrosis, and morphological
changes within myocytes, among other features. Manual review of biopsies is time
consuming and intra- and inter-observer variability is high, even using revised diagnostic
guidelines (Angelini et al. 2011).

In cardiac biopsies, some features based on diagnostic criteria and domain knowledge
include the percent tissue area that is stroma (fibrosis), lymphocyte presence and
number in each tissue compartment, as well as morphological features of myocytes and
their nuclei. Together, these features may allow automatic and quantitative prediction of
the risk of heart failure or cardiac rejection, which would significantly improve efficiency,
reliability, and quality of care for the treatment of heart failure and heart transplant
patients.

In the remainder of this chapter, we focus on developing a deep learning framework for
myocyte and stroma segmentation in cardiac histopathology images. Section 5.3
describes the design and implementation of two models for tissue segmentation, a deep
learning approach or a random forest classifier with handcrafted features. We present
our results for these experiments in Section 5.4. The first set of experiments compares
the segmentation performance of a deep learning model to a traditional featureengineered approach and supervised machine learning classifier. The second highlights
the sensitivity of deep learning to the fidelity of the training annotations as well as patch
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representation within the training set. We conclude in Section 5.5 with potential
downstream applications of myocyte and stroma segmentation in heart failure and
rejection.
5.3.

Experimental Design and Implementation

5.3.1. Data set description
The data set includes 103 whole-slide images of H&E stained, full-thickness cardiac
biopsies obtained at the time of death for non-heart-failure controls (52 patients) or heart
transplant for patients with end-stage heart failure (51 patients). Images were scanned at
20x magnification using an Aperio ScanScope slide scanner and down- sampled to 5x
magnification for image processing and analysis. An equal number of patients from each
disease class (10 failing or non-failing) were randomly allocated to a held-out validation
set and the remaining patients were used for training, such that 83 patient WSI were
used for training models and 20 patients were kept as a held-out validation cohort.

5.3.2. Manual ground truth annotations
For each patient in the training data, at least 1x 104 µm2 tissue area of the WSI, per
class, was manually annotated as myocyte or stroma. Training patches were selected
from these annotated regions with hypersampling of regions at the interface between
two tissue classes (myocyte or stroma), which we refer to as edge-hypersampling. See
Figure 5.2 for example training annotations used for patch selection.
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Figure 5.2 Ground truth for myocytes or stroma.
(A) Original images. (B) Binary ground truth mask for myocytes (top) or stroma (bottom)
for pixel-level training annotations. White pixels indicate class membership. (C) Overlay
image of binary mask in B on original image in A. Images are 500 µm x 500 µm at 5 x
magnification. Reprinted with permission from Elsevier Academic Press (Nirschl et al.
2017b), copyright (2017).
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Manual ground truth annotations from the 20 patients in the held-out validation set were
used to assess segmentation performance. These validation annotations were
performed on one ROI of 500 µmx 500 µm 5x magnification image for each patient. In
each ROI, the entire field was annotated, in detail, to allow a pixel-level comparison of
the manual and automated segmentation methods. Example ground truth validation
annotations are shown in Section 5.4.
5.3.3. Implementation
There are a number of excellent and well-maintained platforms for implementing deep
learning. Apart from language, speed, and ease of implementation, an actively
maintained package with a strong development community is important. We provide an
abbreviated list of platforms in Table 5.1. In this tutorial, we use the open-source
framework Caffe (Jia et al. 2014). We direct the reader to (Jia et al. 2014) and the Caffe
online documentation for additional information.

Table 5.1 Abbreviated list of deep learning software packages
Reprinted with permission from Elsevier Academic Press (Nirschl et al. 2017b), copyright
(2017).
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5.3.3.1.

Network architecture

Many software platforms have existing networks that can be modified for new specific
uses cases. In this example, we use a modified version of the AlexNet architecture
(Krizhevsky and Hinton 2010; Krizhevsky et al. 2012), which was used in the 32 x 32
CIFAR-10 challenge (Krizhevsky 2009).
5.3.3.2.

Building a training database

The CIFAR-10 network requires training patches to be 32 x 32 pixels. The first step,
then, then, is to determine the appropriate magnification for training patches. In general,
we recommend the highest magnification that allows the histologic primitive of interest to
fit within the patch window, while still containing contextual information outside of the
histologic primitive. The patch should also have enough resolution and context for an
expert to correctly classify the center pixel of image. For cardiac histopathology, we
downsample the 20x magnification WSI to 5x apparent magnification, which allows a
typical myocyte in cross-section to occupy approximately 50% of the patch window.
Example training patches are shown in Figure 5.3.
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Figure 5.3 Example training patches.
Example 32 × 32 training patches used for both the deep learning and RF approach,
where the center pixel of the patch determines the class label. (A) Myocyte training
patches. (B) Stroma training patches. Each patch is 64 µm x 64 µm at 5x magnification.
Reprinted with permission from Elsevier Academic Press (Nirschl et al. 2017b), copyright
(2017).
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As mentioned previously, deep learning identifies discriminative features directly from
training data. Thus, the next important consideration is the choice and representation of
training patches. We find that training is more efficient when the transition zones, or the
interfaces between one or more classes, are over-represented in the data set, as we
later show in Experiment 2. To this end, we hypersample patches from the edges of the
annotated training masks such that edge patches are over-represented in the training
data set based on their distance to the mask edge.
5.3.3.3.

Training a deep learning model

We train the deep learning classifier using 5 x 103 patches per patient, and augment the
training set by rotating each patch by 90, 180, or 270 degrees for 1.66 x 106 patches per
class and a total of 3.32 x 106 training patches. These patches were split into three
training and testing-folds at the patient level with balanced myocyte and stroma patches.
Each fold was trained for 6 x 105 iterations on a Tesla K20c GPU with CUDA 7.0 using
the cuDNN setting, the AdaGrad solver (Duchi et al. 2011) built into Caffe, and a fixed
batch size. The network parameters for the AlexNet architecture are shown in
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Table 5.2 Deep learning hyperparameters
Reprinted with permission from Elsevier Academic Press (Nirschl et al. 2017b), copyright
(2017).
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5.3.4. Training a model using engineered features
We compare our deep learning approach to a traditional segmentation workflow using
engineered features and a Random Forest classifier. Random forests were chosen as a
classifier because they are among the top performing supervised machine learning
algorithms (Caruana et al. 2008; Caruana and Niculescu-Mizil 2006), they perform well
on biomedical image data sets (Parmar et al. 2015), and require fewer adjustments to
obtain stable results.
The Random Forest classifier for myocyte and stroma segmentation was trained
using 1000 trees and 333 engineered-features based on intensity and texture.
Table 5.3 lists the features used here. The intensity features capture the differences in
H&E staining between myocytes and stroma by considering intensity magnitude,
variation, and higher-order moments. Texture features such as Co-occurrence of Local
Anisotropic Gradient Orientations (CoLlAGe) features (Prasanna et al. 2014), Gabor
features (Gabor 1946), and Haralick features (Haralick et al. 1973), among other texture
features (Laws 1980), were designed to detect the edges of class boundaries as well as
the heterogeneity and disorder of the stroma relative to myocytes. These features were
computed for each 32 x 32 patch of the grayscale converted RGB image as well as the
color-deconvolved hematoxylin or eosin grayscale image (Ruifrok et al. 2003). The
feature vector and label for the center pixel patch was used for training. All of the training
patches were used to construct a single RF model.
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Category
Intensity

Length
13 x 3 images

Texture

98 x 3 images

Features
Energy, entropy, min, max, standard deviation, variance,
mean, median, median absolute deviation, range, root
mean squared, skewness, and kurtosis of patch intensity
13 Haralick texture features, 25 Laws texture features, 1
Local Binary Pattern, 21 XY gradient features, 6 Gabor
features, 26 CoLlAGe features, 6CORF features

Table 5.3 Description of features used for the Random Forest stroma classifier
Intensity features were calculated on a 32 x 32 sliding window with the center pixel
assigned the computed value for each patch. The three grayscale images of each patch
that were used include a grayscale conversion of the RGB image and a colordeconvolved hematoxylin or eosin grayscale image. Reprinted with permission from
Elsevier Academic Press (Nirschl et al. 2017b), copyright (2017).
5.3.5. Experiments
5.3.5.1.

Experiment 1: Comparison of Deep Learning and Random Forest

Segmentation
Experiment 1 compares the segmentation performance of deep learning model to a
random forest model using engineered features in cardiac histopathology images. Each
approach was trained using the same set of image patches and the output from each
model is an image where each pixel is assigned a probability of class membership,
between 0 and 1. Thresholding the probability output at 0.5 should maximally separate
the classes, which is why a fixed threshold of 0.5 was used to create binary masks.
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5.3.5.2.

Experiment 2: Evaluating the Sensitivity of Deep Learning to Training Data

Routine tissue annotation in digital pathology is generally performed at intermediate
magnifications and produces masks that lack delineation of precise, pixel-level tissue
boundaries. While this approach can rapidly annotate large regions of the WSI, it may
have consequences for the data that ultimately go into the network. Since deep learning
techniques learn models from the data presented, it is important to consider the training
annotation method as well as the best procedure for sampling patches from within these
annotations. Figure 5.4 shows an example of coarse annotations (A) versus fine
annotations with pixel-level boundaries shown in (B).

124

Figure 5.4 Coarse versus fine training annotations.
This figure shows two different approaches for generating training annotations for deep
learning. (A) Coarse annotations maximize the tissue area that is annotated, but may
lack precise class boundaries. (B) Fine training annotations capture less tissue area and
may require more effort, but generate delineate class boundaries with pixel-level
precision. Experiment 2 shows the effect of training annotation and patch representation
on the deep learning output. Myocytes are annotated in the top row and stromal tissue in
the bottom row. Images are 500 µm x 500 µm. Reprinted with permission from Elsevier
Academic Press (Nirschl et al. 2017b), copyright (2017).
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Uniform random sampling of patches from training annotations assumes that all patches
provide equally valuable information for classification. This is not true in general, though,
as WSI often contain large regions of tissue that are qualitatively very different and
easily classified using simple approaches. However, the transition zones between tissue
classes are more challenging, and we can direct the deep learning network to learn
these boundaries better by modifying the patch representation within the training data.
We modify patch representation by hypersampling patches near the edge of the training
annotation, or edge-hypersampling, an approach also used in (Janowczyk et al. 2016).
In this experiment we compare uniform and edge-hypersampling approaches for both
coarse and fine, pixel-level training annotations.

5.3.6. Testing and performance evaluation
The fully annotated ROIs from the held-out patients were used to assess segmentation
performance for both sets of experiments. We evaluate the segmentation performance
for each experiment using multiple criteria including: the Area Under the Curve (AUC),
F1 score, True Positive Rate (TPR), True Negative Rate (TNR), Positive Predictive
Value (PPV), Modified Hausdorff Distance (MHD) (Dubuisson and Jain 1994; Powers
2011).

5.4.

Results and Discussion

5.4.1. Experiment 1: Comparison of deep learning and random forest segmentation
An overlay of the probability output on the original image for each classifier is shown in
Figure 5.5. Table 5.4 shows the quantitative evaluation of each classifier on 20 held- out
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patients using the performance metrics listed in the previous section (AUC, F1 score,
TPR, TNR, PPV, MHD). Qualitatively, the deep learning model produces much more
confident predictions of class membership, as noted by the green or magenta intensity of
the probability outputs. It is also clear that both the deep learning and random forest
models perform well on regions far from the interface with the opposing class, as
expected. Since large regions of the image are easier to classify both models achieve a
high F1 score and TPR. However, only the deep learning model is able to achieve both a
high TPR (sensitivity) and TNR (specificity).

What is also evident from Figure 5.5 is that deep learning more accurately delineates the
class boundaries. This is quantified in Table 5.4 using the MHD, which is a robust
measurement for matching objects based on their edge points (Dubuisson and Jain
1994). The MHD shows that deep learning more accurately delineates tissue boundaries
compared to the random forest model. Finally, related to the previous point, deep
learning excels at detecting fine features such as small myocytes embedded in stromal
tissue. These are often assigned low probabilities in the random forest model, which are
lost with thresholding. Together, these data suggest that deep learning should be used
when precise delineation of tissue boundaries are desired. However, in the next
experiment we examine the sensitivity of deep learning and highlight an important
caveat with deep learning models.
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Table 5.4 Mean ± SD segmentation performance on validation set for Experiment
1.
Reprinted with permission from Elsevier Academic Press (Nirschl et al. 2017b), copyright
(2017).

Figure 5.5 Qualitative comparison of segmentation performance.
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(A) The original H&E image and ground truth annotation. (B) Random forest probability
output overlaid on the original image and binarized segmentation mask. (C) Deep
learning probability output overlaid on the original image. The green or magenta channel
intensity in the probability output probability of the pixel belonging to the myocyte or
stroma class, respectively. White pixels in the binary masks represent the myocyte
class. Images are 500 µm x 500 µm. Reprinted with permission from Elsevier Academic
Press (Nirschl et al. 2017b), copyright (2017).
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5.4.2. Experiment 2: Evaluating the sensitivity of deep learning to training data

Figure 5.6 Effect of training annotations fidelity on DL performance.
(A) Original image (top) and ground truth annotation. (B) DL network trained with uniform
random patch sampling from coarse masks. (C) Network trained with edgehypersampling of patches from coarse masks. (D) Network with uniform random patch
sampling of fine training masks. (E) Network trained with edge-hypersampling of fine
training masks. Probability outputs overlaid on the original images (top row) and binary
masks (bottom). Images are 500 µm x 500 µm. Reprinted with permission from Elsevier
Academic Press (Nirschl et al. 2017b), copyright (2017).
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Figure 5.6 shows the effect of coarse versus fine training annotations and edge
hypersampling on deep learning segmentation. The first result is that coarse annotations
produce coarse results. While it is not entirely surprising, the visual results are striking.
Edge hypersampling can partially compensate for coarse annotations, but the best
results are obtained after re-annotation with precise pixel-level boundaries. The effect of
edge-hypersampling is less clear in the specific case of fine myocyte and stroma
annotations. This is likely due to the fact that a majority of the annotations are already at
the tissue interface and already considered “edges”. The addition of edge-hypersampling
to fine annotations has little effect, but importantly does not harm performance (Table
5.5).

Table 5.5 Mean ± SD segmentation performance on validation set for Experiment 2
Although, we manually annotate myocytes and stroma, due to their irregular boundaries,
different histologic primitives may benefit from less time-consuming approaches. For
example, reliable nuclei annotations can be obtained using an approach similar to
Janowczyk et al. (Janowczyk et al. 2016). In this case, high fidelity “edge” annotations
for the non-nuclei class were generated by dilating the nuclei mask and then subtracting
the original mask. In any case, it is important for digital pathology users to match the
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granularity of their training annotations with the quality of the desired output. Reprinted
with permission from Elsevier Academic Press (Nirschl et al. 2017b), copyright (2017).
5.5.

Concluding remarks

In this chapter we described the use of deep learning for the specific case of segmenting
myocytes and stroma in cardiac histopathology images. We developed two models to
segment myocytes and stroma, a deep learning approach and the use of a random
forest classifier in conjunction with handcrafted features. A deep learning approach was
used because this method has shown excellent performance in computer vision tasks
and it excels with large data sets.

We evaluated the performance of our two models using a held-out data set of 20 patient
images with expert annotated tissue boundaries, where deep learning was superior in all
metrics. Most notably, deep learning segmentation had both a high sensitivity and
specificity as well as more accurate tissue boundaries, compared to a random forest
model. In addition, our results suggested that deep learning is highly sensitive to the
fidelity of the training annotations and that edge-hypersampling can improve
segmentation performance.

In summary, our deep learning framework required no feature engineering and showed
improved segmentation performance compared to a classifier trained using handcrafted
features. This will enable the identification and quantification of tissue-specific features
predictive of heart failure or cardiac transplant rejection. Future work using these
segmentation results will allow the development of features predictive of cardiac
disease, and may eventually lead to pipelines for image-based predictors of outcome
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based off cardiac histopathology. This has the potential to improve cardiac biopsy
screening, provide real-time feedback for clinicians, and serve as an objective second
reader for pathologists.
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6.

CHAPTER 6: A deep-learning classifier identifies patients with clinical
heart failure using whole-slide images of H&E tissue 6
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6.1.

Abstract

Over 26 million people worldwide suffer from heart failure annually. When the cause of
heart failure cannot be identified, endomyocardial biopsy (EMB) represents the goldstandard for the evaluation of disease. However, manual EMB interpretation has high
inter-rater variability. Deep convolutional neural networks (CNNs) have been
successfully applied to detect cancer, diabetic retinopathy, and dermatologic lesions
from images. In this study, we develop a CNN classifier to detect clinical heart failure
from H&E stained whole-slide images from a total of 209 patients, 104 patients were
used for training and the remaining 105 patients for independent testing. The CNN was
able to identify patients with heart failure or severe pathology with a 99% sensitivity and
94% specificity on the test set, outperforming conventional feature-engineering
approaches. Importantly, the CNN outperformed two expert pathologists by nearly 20%.
Our results suggest that deep learning analytics of EMB can be used to predict cardiac
outcome.
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6.2.

Introduction

Cardiovascular diseases are the leading cause of death globally and the leading cause
of hospital admissions in the United States and Europe (Kochanek et al. 2011). More
than 26 million people worldwide suffer from heart failure annually and about half of
these patients die within five years (Ambrosy et al. 2014; Mozaffarian et al. 2016). Heart
failure is a serious, progressive clinical syndrome where impaired ventricular function
results in inadequate systemic perfusion. The diagnosis of heart failure usually relies on
clinical history, physical exam, basic lab tests, and imaging (Hunt et al. 2009). However,
when the cause of heart failure is unidentified, endomyocardial biopsy (EMB) represents
the gold standard for the evaluation and grading of heart disease (Cooper et al. 2007).
The primary concern with the manual interpretation of EMB is the relatively high interrater variability (Angelini et al. 2011) and limited clinical indications (Cooper et al. 2007;
Stewart et al. 2005). Automated analysis and grading of cardiac histopathology can
serve as an objective second read to reduce variability.

With the advent of digital pathology, a number of groups have been applying computer
vision and machine learning to these datasets to improve disease characterization and
detection (Bhargava and Madabhushi 2016; Ghaznavi et al. 2013; Gurcan et al. 2009;
Madabhushi and Lee 2016). Recent work has shown that sub-visual image features
extracted from digitized tumor histopathology via computer vision and machine learning
algorithms can improve diagnosis and prognosis in a variety of cancers (Basavanhally et
al. 2011; Beck et al. 2011; Cruz-Roa et al. 2017; Doyle et al. 2012; Lee et al. 2014;
Lewis et al. 2014; Litjens et al. 2016; Madabhushi et al. 2011; Romo-Bucheli et al. 2016;
Yu et al. 2016). In contrast, image analysis on cardiac histopathology has received little
137

attention, although quantification of adipose tissue and fibrosis have been proposed in a
few preliminary studies (Gho et al. 2014).

Recently, many approaches for image analysis have applied deep convolutional neural
networks (CNNs) or “deep learning” instead of engineered image features. Deep
learning is an example of representation learning, a class of machine learning
approaches where discriminative features are not pre-specified but rather learned
directly from raw data (LeCun et al. 2015). In a CNN, there are many artificial neurons or
nodes arranged in a hierarchical network of successive convolutional, max-pooling, and
fully-connected layers. The hierarchical structure allows the model to approximate
complex functions and learn non-linear feature combinations that maximally discriminate
among the classes. Once a CNN model is trained on a sufficiently large data set, it
should be able to generalize to unseen examples from the population. For a more
detailed description of neural networks and their structure, we refer readers to Bengio et
al. 2013 and Schmidhuber 2015 (Bengio et al. 2013; Schmidhuber 2015).

Deep learning has already been successfully applied to detect cancer in biopsies (Wang
et al. 2016a; Wang et al. 2014), diabetic retinopathy (Gulshan et al. 2016), and
dermatologic lesions (Esteva et al. 2017). There are many other potential applications to
digital pathology because deep learning excels at tasks with large and complex training
data sets, such as whole slide images (WSI). In this study, we develop a CNN to detect
clinical heart failure from cardiac tissue. We show that the CNN detects heart failure with
high accuracy using only cardiac histopathology, outperforming conventional featureengineering approaches and two expert pathologists. We also show that these
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algorithms are highly sensitive to tissue-level pathology, as our algorithms promote a reexamination of clinically normal patients who were subsequently found to have severe
tissue pathology.

6.3.

Results

6.3.1. Dataset description and image analysis pipeline.
The dataset consisted of left ventricular tissue from 209 patients, collected at the
University of Pennsylvania between 2008 and 2013. There were two cohorts of patients:
those with end-stage heart failure (Failing or Fal; N = 94) and a comparison group
without heart failure (Non-failing or NF; N = 115). The failing cohort tissue was collected
from patients with clinically diagnosed ischemic cardiomyopathy (ICM; N = 51) or
idiopathic dilated cardiomyopathy (NICM; N = 43) who received heart transplants or leftventricular assist devices during the collection period and consented to the study. The
patients in the non-failing cohort were organ donors without a history of heart failure, but
where the heart tissue was ultimately not used for transplant. All patients with tissue
sectioned, stained, and scanned during the collection phase were included for analysis.
We randomly split the patients into two datasets: 104 patients were designated for
training, and a separate cohort of 105 patients was held out as an independent test set.
Patient demographics for the training and held-out test dataset are shown in Table 6.1.
The training dataset was further split, at the patient level, into three-folds for crossvalidation to assess training and validate algorithm parameters. For each patients’ whole
slide image (WSI), down sampled to 5x magnification, we extracted eleven nonoverlapping images or regions of interest (ROI 2500µm2) at random from within the
Otsu-thresholded (Otsu 1979) and manually refined tissue border.
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Table 6.1 Patient demographics for the heart failure data set.
Where applicable, data are shown as mean ± SD. The two sub-classes of heart failure
are ischemic cardiomyopathy (ICM) and non-ischemic cardiomyopathy (NICM).

140

The training images were used to build two independent models to classify patients with
or without heart failure from cardiac histopathology. The primary classifier used a CNN
with a modified AlexNet (Krizhevsky et al. 2012) architecture to transform the image
pixels into the probability that the image came from a patient with heart failure. We
compared our CNN to a traditional feature-engineering approach using WND-CHARM
(Orlov et al. 2008), a generalized image pattern recognition system coupled to a random
decision forest classifier (RF). WND-CHARM computed 4059 features for each image.
The top 20 features (Table S3) were selected using the minimum Redundancy Maximum
Relevance method (Peng et al. 2005) on the training set, and these top features were
input to an RF classifier (Breiman 2001).

For each image, both classifiers calculated the probability of whether that image came
from a patient with heart failure. Images with probabilities greater than 50% were
considered as a prediction of the “failing” class at the image-level. The image-level
predictions were grouped by patient and the fraction of images predicted as ‘failing’ for
each patient gave the patient-level probabilities. Figure 6.1 shows a summary of the
digital pathology workflow and Figure S8 shows representative images of cardiac
histopathology.
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Figure 6.1 Schematic overview of digital pathology workflow to detect heart
failure.
(a) Patients were divided into a training and test dataset. WSI were scanned and regions
of interest (ROI) were extracted for image analysis. All ROIs from the same patient were
given the same label, which was determined by whether the patient had clinical or
pathological evidence of heart disease. (b) Three-fold cross validation was used to train
heart failure classifiers using a deep learning model or engineered features in WNDCHARM + a random decision forest classifier. (c) Trained models were evaluated at the
image and patient-level on a held-out test dataset.
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6.3.2. CNNs identify heart failure patients from histopathology with high accuracy
We evaluated the performance of the CNN on the training set using three-fold cross
validation. In addition, we applied each of the trained models to the held-out test dataset
as an independent test for model generalization. Table 6.2 shows the classification
accuracy for detection of clinical heart failure at the image and patient-level for both the
training cross-validation and held-out test datasets. The CNN performs very well,
detecting heart failure from histopathology at both the image and patient-level with
accuracy exceeding 93% on both the training and test datasets.
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Table 6.2 Image and patient-level performance evaluation for predicting clinical
heart failure from H&E stained whole-slide images for validation folds of the
training data set.
The results are presented as the Mean ± SD of three models. Each model was trained
on ~ 770 images from ~70 patients. The validation models were evaluated on the
validation fold of ~35 patients. The models were then tested on a held-out data set of
105 patients. The patient-level diagnosis is the majority vote over all the images from a
single patient. Statistical comparisons between RF and DL models were determined by
an unpaired two-sample t-test with an N of three folds. Statistical comparisons between
DL and the pathologists used a one-sample t-test compared with the maximum value
from either pathologist, with all p values ≤0.01. AUC: Area Under the Curve for the
receiver operator characteristic.
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Next, we compared the classification accuracy of the CNN to the WND-CHRM + RF
model (Table 6.2). Although the WND-CHRM + RF model was able to identify heart
failure patients, the accuracy and sensitivity was significantly lower than the CNN model
at both the image and patient-level on the held-out test set (p < 0.05, unpaired twosample t-test). Thus, the learned features in the CNN result in a classifier that is more
discriminative than a feature-engineering approach, which is capable of accurately
detecting heart failure from cardiac histopathology.

To address the question of how these algorithms compare to human-level performance,
we had two pathologists independently review the 105 patients in the held-out test set.
The pathologists were blinded to the patients’ clinical history, and they were only shown
the same 11 images per patient that were used in evaluating the algorithms. For each
patient, they gave a binary prediction of whether the set of images were from a patient
with clinical heart failure or not. The pathologists both had an individual accuracy of 75%
at the patient-level (Table 6.2) with a Cohen’s kappa inter-rater agreement of 0.40. The
CNN significantly outperformed pathologists in all metrics with a 20% differential in terms
of sensitivity and specificity (p < 0.05, one-sample t-test compared to the best human
performance for each evaluation metric).
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6.3.3. Review of correct and incorrectly classified images
Representative images that were correctly classified by both algorithms are shown in
Figure 6.2A. These images are exemplars for the well-described histological findings in
normal tissue and heart failure, described in Figure S8. Images uniquely misclassified by
the CNN are shown in Figure 6.2B. A qualitative review of these images by expert
pathologists showed that a few contain minor tissue processing artifacts. However, many
images have some features of both normal and abnormal myocardium such as large
regions of healthy, densely packed myocytes or fibrosis and enlarged myocyte nuclei,
respectively. This could make these images challenging for both computers and humans
to classify when only given a single image.

Review of the errors unique to the WND-CHARM + RF model reveals some obvious
errors, such as classifying an image from a heart failure patient with extensive fibrosis as
“Non-Failing” (Figure 6.2C, False Negative second row). There were also many
examples in which the WND-CHRM + RF model made errors on images containing
minor tissue-processing artifacts, such as small areas of white space between bundles
of intact, normal myocardium (Figure 6.2A, False Positive top row).
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Figure 6.2 Review of classified images and unsupervised clustering of patients.
Representative images from ROIs that were: correctly classified by both algorithms (a);
errors unique to the Random Decision Forest (b); and errors unique to Deep Learning
(c). The ground truth is shown in white text in the upper left corner of the image whereas
the algorithm prediction is shown in the upper right and color coded with green = correct
and yellow = incorrect. (d) ROIs from two patients without clinical heart failure that were
classified with clinically “Failing” patients by both algorithms. These patients were later
found to have evidence of tissue-level pathology by two independent pathologists. (e)
Consensus clustering using WND-CHARM feature vector reveals evidence for three
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clusters in the data. The consensus clustering dendrogram and class results are shown
above the clustergram. Some patients form a small third cluster between the two larger
groups, marked by an arrowhead, which was found to contain a patient with tissue
pathology but no clinical heart disease.
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While reviewing the errors, we identified several non-failing patients incorrectly predicted
as “failing” with a very high probability by the CNN and WND-CHRM + RF at both the
image and patient-level. The high likelihood of class membership assigned by both
models prompted a detailed re-examination of these cases. Two expert pathologists,
blinded to the patients’ clinical history, reviewed the tissue pathology and labeled their
findings as mild-moderate pathology or severe tissue pathology. The consensus
agreement of the pathologists was that two patients exhibited severe tissue-level
pathology (Figure 6.2B) while the other cases had mild to moderate pathology or tissueprocessing artifacts. Thus, at least in a couple cases, our algorithm detected severe
tissue pathology in patients without pre-existing heart failure.

6.3.4. Non-failing patients with severe pathology cluster with heart failure patients
To determine whether the misclassified patients reproducibly clustered with the incorrect
class, we used unsupervised clustering. Consensus clustering is an unsupervised
clustering and resampling technique that provides a visual and quantitative measure of
the number and stability of discrete classes in a dataset (Monti et al. 2003). It involves
subsampling a data set, hierarchical clustering using a distance metric, and computing
the proportion of times items occupy the same cluster with repeated sub-sampling. Since
both the CNN and WND-CHRM misclassified these patients, and the CNN hidden layer
activations are difficult to interpret, we used the image-level WND-CHARM feature
vectors for consensus clustering.

We assessed 𝑘𝑘 ∈ {1, … ,10} clusters and the maximum for the consensus cumulative
distribution function was at three clusters. Adding more clusters did not significantly
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increase the consensus values. The consensus matrix for 𝑘𝑘 = 3 is shown in Figure

6.2C. Although many patients cluster with patients that have similar heart function, a

small subset of patients fall into a third, smaller cluster in-between the failing and normal
clusters. Misclassified patients without heart failure, but who had severe tissue
pathology, either fell into this third cluster or had a majority of their images in the failing
cluster.

The reproducible unsupervised clustering of these patients with the failing or
intermediate cluster supports our original findings for a high likelihood of class
membership in the failing class. This prompted the designation of a new ground truth
label based on both the clinical history and histopathological findings. The two nonfailing patients described above were reassigned to an “abnormal or heart failure” class
due to their severe pathology and reproducible clustering away from other non-failing
samples. The remaining failing and non-failing patients did not change after review and
were assigned to the “abnormal or heart failure” or “within normal limits” classes,
respectively.

6.3.5. CNNs accurately detect tissue pathology in heart failure patients
Table 6.3 and Table 6.4 show the evaluation metrics for classification based on the new
ground truth labels at the image and patient-level for both the cross-validation and heldout test datasets, respectively. The CNN showed superior accuracy with a test set
accuracy of 96.2 ± 1% compared to the 91.7± 1% accuracy using WND-CHARM + RF.
The CNN also outperformed WND-CHRM + RF in nearly all other metrics on the held-
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out test set most notably, a higher accuracy, sensitivity, and area under the curve (AUC)
for the Receiver Operator Characteristic (ROC) curve (all p < 0.01, unpaired t-test).

Table 6.3 Patient-level performance evaluation for predicting clinical heart failure
or severe tissue pathology from H&E stained whole-slide images for validation
folds of the training data set.
The results are presented as the Mean ± SD of three models. Each model was trained
on ~770 images from ~70 patients. These models were evaluated on the validation fold
of ~35 patients. The patient-level diagnosis is the majority vote over all the images from
a single patient. Statistics were determined by an unpaired two-sample t-test with an N
of three folds.
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Table 6.4 Patient-level performance evaluation for predicting clinical heart failure
or severe tissue pathology from H&E stained whole-slide images for the held-out
test set.
The results are presented as the Mean ± SD of three models. Each model was trained
on ~770 images from ~70 patients. These models were evaluated on the held-out test
set of 105 patients. The patient-level diagnosis is the majority vote over all the images
from a single patient. Statistics were determined by an unpaired two-sample t-test with
an N of three folds.
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Figure 6.3 shows the corresponding ROC curves for the classifiers trained using labels
based on clinical history and tissue pathology. We compared the image-level ROC
curves between the CNN and WND-CHRM + RF using a two-sample KolmogorovSmirnov test to show that the CNN significantly outperforms the feature-engineering
approach. However, the difference between ROC curves at the patient-level results was
not statistically significant. Although both algorithms are reasonably efficient at detecting
tissue pathology, the CNN gives higher sensitivity, specificity, and positive predictive
value.

153

Figure 6.3 Receiver Operator Characteristic (ROC) curve for detection of clinical
heart failure or severe tissue pathology.
(a) ROC curve for image-level detection on the training dataset (DL vs. RF, p < 0.0001,
two-sample Kolmogorov-Smirnov (KS) test). (b) ROC curve for patient-level detection on
the training dataset (DL vs. RF, ns, KS test). (c) ROC curve for image-level detection on
the held-out test dataset (DL vs. RF, p < 0.0001, KS test). (d) ROC curve for patientlevel detection on the held-out test dataset (DL vs. RF, ns, KS test).
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6.4.

Discussion

In this study, we developed a CNN classifier to detect clinical heart failure from cardiac
histopathology. Previous studies that have applied deep learning to digital pathology
have used CNNs to generate pixel-level cancer likelihood maps (Cruz-Roa et al. 2017;
Litjens et al. 2016) or segment relevant biological structures (e.g. glands, mitoses,
nuclei, etc.) that are used as features for subsequent classification (Cruz-Roa et al.
2014; Wang et al. 2016a). However, our CNN directly transforms an image into a
probability of a patient-level diagnosis, which is similar to recent approaches that have
applied CNNs to diagnose referable diabetic retinopathy and skin cancer (Esteva et al.
2017; Gulshan et al. 2016).

This direct diagnosis approach can work well but has the disadvantage that the features
used by the CNN for classification aren’t immediately transparent or interpretable. A few
methods have been proposed to visualize intermediate features in CNNs (Nguyen et al.
2015), but what these intermediate features represent and how they are combined to
make a diagnosis will require interpretation by pathologists. However, a benefit of
representation learning approaches is that they may reveal novel image features,
learned by the CNN, that are relevant to myocardial disease. The performance
difference between the CNN and WND-CHRM + RF pipeline likely reflects the
contribution of the features learned by the CNN, which are not present in the set of
engineered features.
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The highly accurate and reproducible performance by the CNN shows that cardiac
histopathology contains robust image features sufficient for classification and diagnosis.
However, a somewhat surprising finding of this study was that the CNN outperformed
pathologists at detecting clinical heart failure by a significant margin, up to 20% in terms
of sensitivity and specificity. Unlike cancer, where the definitive diagnosis is based on
tissue pathology and genetic or molecular markers, heart failure is a clinical syndrome.
In the clinical setting, pathologists are not called upon to determine whether a patient is
in heart failure given a cardiac biopsy. Rather, when no cause of heart failure can be
identified, pathologists interpret the tissue to identify potential etiologies (e.g. viral
myocarditis, amyloidosis, etc.). However, it is interesting to note that the Cohen’s kappa
inter-rater agreement of 0.40 in our task is similar to the value of 0.39 reported for
Fleiss’s kappa inter-rater agreement for grading heart rejection using the ISHLT 2005
guidelines (Angelini et al. 2011). Together, these data suggest that deep learning can be
used in conjunction with digitized pathology images of endomyocardial biopsies to
predict cardiac failure. This is particularly relevant in light of the recent FDA approval of
whole imaging systems for primary diagnosis using digital slides (Caccomo 2017).

A review of the misclassified non-failing patients where the CNN gave a high likelihood
of heart failure led to the discovery of severe tissue pathology in two patients.
Unsupervised clustering reproducibly grouped these patients away from the non-failing
class and into the failing class or a third, intermediate cluster. Thus, the CNN identified
tissue pathology in patients without pre-existing heart failure, suggesting these patients
may represent cases of occult cardiomyopathy. An important area of research moving
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forward is whether CNNs or other models can use EMBs to predict the future onset of
heart failure or the rate of decline in patients with mild or moderate heart failure.
Our study did have its limitations. We assessed our classifier on the extremes of heart
disease: patients with severe heart failure requiring advanced therapies (e.g. cardiac
transplant or mechanical circulatory devices) versus patients without a history of clinical
heart failure. One may argue that comparing extremes exaggerates classifier
performance. However, the identification of tissue pathology in a small subset of patients
without a definitive clinical diagnosis suggests these algorithms are very sensitive to
pathological features of myocardial disease. Future research will need to evaluate the
ability of CNNs to detect pre-clinical disease.

In summary, we develop a CNN classifier to detect heart failure and show that cardiac
histopathology is sufficient to identify patients with clinical heart failure accurately. We
also find that these algorithms are sensitive to detect tissue pathology, and may aid in
the detection of disease prior to definitive clinical diagnosis. These data lend support for
the incorporation of computer-assisted diagnostic workflows in cardiology and adds to
the burgeoning literature that digital pathology adds diagnostic and prognostic utility.
Future work will focus on predictive modeling in heart failure and post-transplant
surveillance for rejection, etiologic discrimination of cardiomyopathy etiologies, and risk
stratification studies which correlate digital histopathology with disease progression,
survival and treatment responses.
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6.5.

Materials and Methods

Human tissue research
Human heart tissue was procured from two separate groups of subjects: heart transplant
or LVAD recipients with severe heart failure (Fal), and brain dead, organ donors with no
history of heart failure (non-failing, NF). No organs or tissue were procured from
prisoners. Prospective informed consent for research use of heart tissue was obtained
from all transplant or LVAD recipients and next-of-kin in the case of organ donors. All
patient data and images were de-identified, and all protocols were performed in
accordance with relevant guidelines for research involving tissue from human subjects.
Tissue used in this study was collected and processed at the Cardiovascular Research
Institute and the Department of Pathology and Laboratory Medicine at the University of
Pennsylvania between 2008 and 2013. All patients were from the same institutional
cohort. All study procedures were approved or waived by the University of Pennsylvania
Institutional Review Board.

Dataset collection and histological processing
Both failing and non-failing hearts received in situ cold cardioplegia in the operating
room and were immediately placed on wet ice in 4°C Krebs-Henseleit buffer. Within 4
hours of cardiectomy, transmural biopsies from the left ventricular free wall were fixed in
4% paraformaldehyde and later processed, embedded in paraffin, sectioned and stained
with hematoxylin and eosin (H&E) for morphologic analysis. Whole-slide images were
acquired at 20x magnification using an Aperio ScanScope slide scanner. Images were
down-sampled to 5x magnification for image analysis, a magnification sufficient for
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expert assessment of gross tissue pathology. The allocation to the training and held-out
test cohort was random and performed prior to image analysis.
Image analysis and machine learning

All image processing and analysis were performed in in MATLAB R2016a, Python, or
Caffe (Jia et al. 2014).The CNN uses a modified version of the AlexNet architecture
(Krizhevsky 2009; Krizhevsky and Hinton 2010; Krizhevsky et al. 2012). The network
accepts 64x 64 pixel RGB image patches (128µm2) with a label corresponding to the
cohort to which the patient belongs (failing or non-failing). The CNN classifier was
trained using 100 patches per ROI, per patient, and the training set was augmented
rotating each patch by 90 degrees. The output of the CNN is a pixel-level probability of
whether ROIs belong to the failing class. The pixels in a single image were averaged to
obtain the image-level probability. Each fold of the three-fold cross validation was trained
using NVIDIA DIGITS for 30 epochs on a Titan X GPU with CUDA7.5 and cuDNN
optimized by Stochastic Gradient Descent built into Caffe and a fixed batch size of 64.

The comparative approach used WND-CHARM (Orlov et al. 2008) to extract 4059
engineered features from each ROI, including color, pixel statistics, polynomial
decompositions, and texture features among others. This rich feature set has shown to
perform as well or better as other feature extraction algorithms on a diverse range of
biomedical image (Orlov et al. 2008). The top 20 features were selected using the
minimal Redundancy Maximal Relevance algorithm (Peng et al. 2005). Alternative
feature selection methods, such as the Wilcoxon Rank-Sum test and the Fischer score,
did not show improved performance. These features were used to train a 1000 tree
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Breiman-style random decision forest (Breiman 2001) using the TreeBagger function in
MATLAB. The output of the random decision forest was an image-level probability of
whether an ROI belongs to the failing class.

Evaluation metrics
The performance of the heart failure classifiers was evaluated using traditional metrics
derived from a confusion matrix including accuracy, sensitivity, specificity, and the
positive predictive value (Powers 2011). The area under the ROC curve was computed
over the three-fold cross-validated models.

The human-level detection of heart failure was performed independently by two
pathologists experienced in cardiac histopathology. In order to train the pathologists for
the task, they were given access to the 104 patients in the training dataset, grouped by
patient, with their images and ground truth labels. To evaluate their performance on the
test set, each pathologist was blinded to all patient information in the test set. For each
patient in the test set, they were asked to provide a binary prediction of whether the set
of images were from a patient with clinical heart failure or not. The pathologists were
given unlimited time to complete the task. The inter-rater agreement was measured
using Cohen’s kappa statistic (Cohen 1960).

Code and data availability
WND-CHARM is open-source and hosted at https://github.com/wnd-charm/wnd-charm.
The deep learning procedure used here follows the method described in Janowczyk and
Madabhushi 2016 (Janowczyk and Madabhushi 2016); a deep learning tutorial with
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source code is hosted at http://www.andrewjanowczyk.com/deep-learning. The data that
support the findings of this study will be made publicly available through the Image Data
Resource (Williams et al. 2017) within six months of publication.
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Statistics
Statistical tests were performed in MATLAB R2016a. An unpaired, two-sample t-test was
used to compare two sample means. A one sample t-test was used to compare the CNN
to the best human performance value for each evaluation metric. A two-sample
Kolmogorov-Smirnov test was used to compare two distributions. Unsupervised
clustering was performed using the package consensusClusterPlus in R (Wilkerson and
Hayes 2010).
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7.

7

CHAPTER 7: Discussion 7

This chapter contains sections that were adapted from:
Nirschl JJ*, Ghiretti AE*, & Holzbaur ELF. (2017). The impact of cytoskeletal
organization on the local regulation of neuronal transport. Nature Reviews
Neuroscience, 18(10), 585–597. http://doi.org/10.1038/nrn.2017.100
*Denotes equal contribution
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This thesis has interrogated biological questions at the level of single-molecules, cells,
and tissues using recent advances in computer vision, machine learning, and
microscopy. We used state of the art microscopy and single-particle tracking algorithms
to delineate the mechanisms regulating dynein-dynactin loading in a minimal in vitro
system as well as in primary neurons. We developed a Python toolbox and trained
neural networks in order to extract high-level image features from microscopic images in
biological screens. Finally, we developed CNNs to segment histologic structures and
detect clinical heart failure from whole-slide images of cardiac histopathology.

7.1.

Axon transport

7.1.1. Processes regulating retrograde axonal transport
In chapter three, we provide evidence for multiple mechanisms regulating retrograde
transport initiation in neurons. First, there is a spatial gradient of microtubule posttranslational modifications that enhance the affinity of the dynein-dynactin complex, as
well as other cytoplasmic organelle linker proteins, for microtubules. Second,
phosphorylation of CLIP-170 in the third serine-rich domain regulates whether CLIP-170
is active and able to facilitate the transport initiation process. Third, CLIP-170 may act to
increase the effective search radius of the microtubule, linking the microtubule with
cargo up to 135nm away, in order to allow efficient cargo capture in the sparse
microtubule cytoskeleton of the distal axon. Thus, multiple mechanisms converge on the
transport initiation machinery to provide a robust and highly modular system of
regulation for a process that is essential to molecular recycling and retrograde signaling.
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Even these mechanisms only describe a fraction of the processes that could regulate
retrograde transport. In this work, we considered the regulation of CLIP-170 by
phosphorylation, but p150Glued (DCTN1) is also subject to phosphorylation at serine
residues that may play a role in intracellular trafficking (Farshori and Holzbaur 1997).
Two known examples of the phosphoregulation of p150Glued include phosphorylation at
Ser-19 by PKA to regulate microtubule binding in non-polarized cells (Vaughan et al.
2002) and at Ser-179 by Polo-like kinase 1 during mitosis (Li et al. 2010). However, the
role of p150Glued phosphorylation in axonal transport has not been examined.

A natural question is whether there is any evidence of p150Glued phosphorylation in the
nervous system. Since, there are no formal studies on this subject, information was
mined through public phosphor-proteomic databases to address this challenge. Table
7.1 shows brain-specific phosphorylation sites in p150Glued. The sites mentioned in the
paragraph above are also identified but are not brain-specific (Huttlin et al. 2010).
Peptide ID

Position

Residue Gene

EDGADTTpSPETPDSS 105

Ser

DCTN1

ADTTSPEpTPDSSASK

Thr

DCTN1

108

Table 7.1 Brain-specific phosphorylation sites in p150Glued.

Predicted
Kinases
CK1, CDC2,
CDK2, CDKL5,
MOK
MOK, CDKL5,
CDC2, CDK5,
NEK kinases,
PLK1

Ascore
(x1000)
18.9
14.9

Table of brain-specific phosphorylation sites compiled from a mouse tissue atlas of
protein phosphorylation (Huttlin et al. 2010) and cultured primary neurons (Liao et al.
2012). The phosphorylated residue is the amino acid immediately following p. The
Ascore is the probability of the correct phosphorylation site localization in the peptide
fragment based on the MS/MS spectra (Beausoleil et al. 2006).
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This table provides several avenues for future research. An obvious first step involves
developing phosphor-specific antibodies to recognize these sites and directly assessing
endogenous phosphorylation in vivo and in primary neurons using immunofluorescence
or Western blotting. One benefit of the immunofluorescence approach is that it would
allow visualization of neuronal morphology to address both the absence/ presence of the
phosphor-protein as well as potential domain-specific localization.

If the endogenous phosphorylation results are promising, a candidate approach would
be an efficient way to address the potential kinases involved. The P-Ser 105 peptide
sequence is a predicted site for Casein Kinase 1. This site is not only ranked highly by
prediction engines but a related kinase family member, Casein Kinase 2, can bind to and
phosphorylate cytoplasmic dynein (Karki et al. 1997). Since dynein and dynactin are in a
complex, one possible mechanism of regulating transport is that a Casein Kinase family
member could act on both components simultaneously to coordinate motility or motoradaptor assembly. A straightforward biochemical test would involve 32-P labeling of
purified, recombinant N-terminal fragments of p150Glued and Casein Kinase 1 or 2.

At least three other kinases deserve mention here. CDK5 and CDKL5 are both predicted
kinases for sites 105 and 108. CDK5 is known to play a role in the cellular stress
response and also has a role in regulating axonal transport via phosphorylating Ndel1,
which regulates dynein via the Lis1/ Ndel1 complex (Klinman and Holzbaur 2015;
Pandey and Smith 2011). Much less is known about CDKL5 in intracellular trafficking,
but it does interact with cytoskeletal proteins, and mutations in CDKL5 are linked to
defects in neuronal architecture as well as the neurodevelopmental disorder Rhett
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syndrome (Kilstrup-Nielsen et al. 2012). Finally, the NEK kinase family member, NEK1,
has been implicated in amyotrophic lateral sclerosis (ALS) (Kenna et al. 2016), a fatal
motor neuron degenerative disease. Mutations in DCTN1 are also linked to motor
neuron disease (Puls et al. 2003) and ALS (Munch et al. 2004), though previous ALSassociated DCTN1 mutations did not show robust phenotypes in cells (Dixit et al. 2008).

Assessing the regulation of transport via p150Glued phosphorylation represents an
exciting future direction; not only because of the bioinformatics results above, but also in
vitro experimental work in neurons. In neurons, the CAP-Gly domain of p150Glued is not
required for efficient mid-axonal retrograde transport (Moughamian and Holzbaur 2012).
In vitro, the CAP-Gly domain of p150Glued can act as a brake to reduce processive
dynein-driven transport (Ayloo et al. 2014). Perhaps there is a phosphorylationdependent switch that reduces p150Glued microtubule affinity after transport initiation?
Another possibility is that motility or motor adaptors cause a structural rearrangement of
the dynactin complex which disengages the p150Glued CAP-Gly domain. Recent
structural work may support this idea because the structure from a subset of dynactin
particles show the Coiled-Coil domain of p150Glued can fold back to a position where the
CAP-Gly domain is likely inaccessible to the microtubule (Urnavicius et al. 2015).
Finally, the future directions listed above may not only provide insight into the regulation
of transport but also disease processes in neurodegeneration. A recent study applied
amyloid-β aggregates, a pathological hallmark of Alzheimer’s disease, to cultured
neurons and reported that amyloid-β treatment reduced DCTN1 phosphorylation levels
(Henriques et al. 2016). However, the raw phosphorylation peptides not reported, so we
cannot confirm which of the phosphorylation sites in DCTN1 were affected.
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Up to this point, we have considered the regulation of retrograde transport by the
microtubule cytoskeleton and a subset of microtubule-associated proteins, but we know
the distal axon is enriched with actin and actin-binding proteins (Cingolani and Goda
2008). Investigating the role of actin in retrograde transport initiation will be an exciting
line of research. The neurotrophic factor literature has started to shed light on the role of
actin in retrograde transport. Harrington et al. (2011) show that actin depolymerization is
required for Quantum-dot labeled NGF to reach the soma after uptake in the distal axon.
However, the precise mechanisms involved in actin depolymerization, such as where
and when it is required, as well as how organelles transition from actin to microtubulebased transport are unclear.

A direct follow-up to the neuronal work in chapter 3 could use cultured neurons in
microfluidic chambers and apply actin stabilizing (e.g., jasplakinolide) or destabilizing
(e.g., latrunculin B, cytochalasin D) compounds selectively to the mid or distal axon.
Live-cell imaging of retrograde flux in these conditions would provide insight into when
and where actin dynamics are required for efficient, processive transport. However,
disrupting actin dynamics in neurons may prove challenging. Actin in dendritic spines is
known to be resistant to the depolymerization compound cytochalasin D, suggesting a
population of stable, depolymerization resistant F-actin in neurons (Allison et al. 1998).
Further, a recent study found evidence for continued neurite outgrowth and intact F-actin
in the distal axon in neurons treated with latrunculin B or cytochalasin D for 24 hours at
all tested concentrations of (1-10µM) (Chia et al. 2016).
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This presents a challenge for experimental work, but raises a separate set of intriguing
questions regarding the neuronal cytoskeleton such as: What confers resistance to Factin depolymerization in the axon terminal and dendritic spines? How do stable actin
filaments develop in the neuron and does it occur via time-dependent maturation or
specific targeting of a subset of actin filaments by post-translational modifications and
actin-binding proteins or both? And what role, if any, does this stable population of Factin in the distal axon have to do with maintaining the distal enrichment of dynein or
dynactin (Moughamian and Holzbaur 2012; Twelvetrees et al. 2016). With respect to the
final question, it is clear that kinesin-driven slow anterograde transport of dynein, and
likely dynactin, are essential to transport dynein distally (Twelvetrees et al. 2016).
Intuitively, the dynein and dynactin must be sequestered or inactivated until needed to
preserve the gradient; however, this needs to be tested.

Returning the question of the retrograde transport, cytoplasmic linker proteins (CLIPS
and CLASPS) may be critical bridges for more than just dynein-dynactin loading. For
example, in addition to binding to DCTN1 and microtubules, CLIP-170 can also bind to
actin binding proteins such as mDia1 (Lewkowicz et al. 2008). In the distal axon, CLIP170 localizes to F-actin patches in the growth cone (Beaven et al. 2015). The finding that
CLIP-170 is phosphorylated in brain tissue suggests (Huttlin et al. 2010) that inactive
CLIP-170 may localize to actin in the distal axon until required for transport. However,
we know that CLIP-170 has roles outside of axonal transport, including regulating actin
and microtubule dynamics as well as axon formation and outgrowth (Bearce et al. 2015;
Galjart 2005; Neukirchen and Bradke 2011). A thorough understanding of CLIP-170 in
the distal axon will require integrating its many functions into a coherent framework.
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The actin-CLIP-170 interaction may also be relevant to our in vitro studies of CLIP-170
and dynein-dynactin transport initiation. Surprisingly, CLIP-170 and mDia1 were recently
shown to promote ultra-fast actin polymerization from growing microtubule plus-ends in
vitro (Henty-Ridilla et al. 2016). This suggests a possible mechanism for organelle
capture by CLIP-170 ‘riding’ on polymerizing actin. Our in vitro reconstitution assay
would be an excellent system to test this hypothesis. However, reconstituting actin and
microtubule dynamics with purified CLIP-170 and a functional dynein-dynactin complex
is a very technically challenging project. Another mechanism through which CLIP-170mediated actin polymerization could be relevant for transport initiation is via generating
actin-microtubule intersections. Recent work has shown that actin-microtubule
intersections can facilitate the initiation or termination of cargo driven by multiple motors
(McIntosh et al. 2015) and this could provide yet another layer of regulation.

7.1.2. Translating molecular insights into therapeutic strategies
In the process of dissecting the mechanisms that regulate retrograde transport initiation,
we can learn information relevant to potential therapeutic strategies. The fatal
neurodegenerative disease Perry syndrome is caused by point mutations in the p150Glued
subunit of dynactin (Farrer et al. 2009). The primary phenotype in cultured mammalian
neurons and Drosophila in vivo is a specific reduction in retrograde transport initiation
from the distal axon (Lloyd et al. 2012; Moughamian and Holzbaur 2012). Our results
suggest that therapies which improve the efficiency of loading dynein-dynactin cargo
onto microtubule, such as modulating CLIP-170 dependent recruitment, may mitigate
defects transport initiation. However, the transport initiation process is complicated and
developing therapies may not be straightforward.
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For example, over-expression of active, de-phosphorylated CLIP-170 (CLIP-A) can
rescue the siRNA knockdown of CLIP-170, but it did not produce noticeably increased
rates of lysosomal transport initiation compared to wild-type (Figure 3.3). Perhaps
lysosomes are not the best cargo for testing therapeutic strategies for transport initiation.
Other cargoes, such as autophagosomes or neurotrophic factor signaling endosomes
may be more appropriate since they represent organelles enriched in the distal axon that
depend on retrograde transport to reach the soma and fulfill their cellular function.
Alternatively, there may be a ceiling to rates of transport initiation due to the density of
cargo, microtubules, and motors in the distal axon; or that CLIP-170 is not the ratedetermining step in transport initiation. There are no therapies to modulate axonal
transport, but continued basic research, such as the work described here, will help focus
the lines of investigation to critical proteins and pathways.
7.1.3. Local regulation of transport in other neuronal compartments
Retrograde transport initiation in the distal axon is just one example of the local
regulation of transport in a single neuronal compartment. However, the mature neuron is
composed of many subdomains, each with a distinctive cytoskeletal organization. This
local structure creates unique transport challenges and requirements within each region.
The dynamic interplay between the local cytoskeleton, motors, and gradients of
regulatory elements within each subdomain makes it clear that neuronal trafficking must
be understood in a subcellular context. Although each subdomain faces different
challenges and needs, local regulation is achieved using a core set of cytoskeletal and
molecular tools. We are only beginning to discover how these tools are differentially
employed and executed to allow the precise navigation of the neuronal cytoskeletal
architecture, and many critical questions lie ahead.
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7.2.

Data science in biomedical research
“Data science also holds tremendous potential, not only for enhancing the
efficiency of the conduct of science, but also for increasing the impact of
fundamental science, along with many other areas of biomedical
research.” NIH-Wide Strategic Plan 2016 – 2020, p16 (Collins 2016)

Biology and medicine are now firmly embedded in the age of algorithms, information,
and data science. There is a need for advanced computational tools in biomedical
research, especially image analysis, in order to automate quantification and extract
information from large, high-dimensional image datasets. The NIH has recognized this
need and highlighted data science in their recent fiscal plan and strategic outlook; in
addition to sponsoring “big data” and “data science” initiatives (Collins 2016)

7.2.1. Biomedical research in the 21st century
Immediate applications of artificial intelligence (AI) in basic research and medical image
analysis will likely focus on automating repetitive tasks and improving existing workflows.
Indeed, applications already include automating or improving segmentation, image
classification, and feature extraction (Carpenter et al. 2006; Jones et al. 2008; Litjens et
al. 2016; Sommer and Gerlich 2013; Sommer et al. 2011). These are important lines of
research and will advance research and medicine, automating routine tasks, allowing a
more granular assessment of image data, and improving reproducibility (discussed in
section 7.2.4). However, it would be a shame to relegate artificial intelligence to routine
tasks deemed too tedious for human attention (Granter et al. 2017).

173

Henry Ford is often misquoted as having said the following regarding the invention of the
automobile: “If I had asked people what they wanted, they would have said faster
horses.” (Vlaskovits 2011). Regardless of the quote origin, we can interpret the content
in light of developing new and innovative AI applications in biomedical research.
Engineers looking to develop the “killer app” for cell biologists or pathologists may
appropriately focus on the current needs of basic researchers and pathologists, which
include automated segmentation and classification to improve existing workflows. These
are useful applications that are urgently needed, but we should bear in mind that the
next most important application of AI in biomedical imaging, or society in general, likely
hasn’t even entered the public consciousness because it fills a need we do not know
exists or it is so fundamentally different from the current system of thought or practice.

7.2.2. Phenotypic profiling
In Chapter 4, we challenge the traditional approach of feature extraction and profiling in
high-content screening by posing the questions: “What if the features aren’t known or
what if the transforms are too difficult to formulate?” We attempt to address these
questions by developing and applying trained CNNs as deep feature extractors. We
show that deep features trained on one dataset encode image phenotypes sufficient to
cluster subcellular structures by type and separate drug compounds by the mechanism
of action. In the process, we develop Cell DECODER, a neural network toolbox for deep
feature extraction and phenotypic profiling using CNNs. Our hope is that this work will
enable more biologists to access the power of deep learning and that it will empower
basic researchers to develop computational skills, which are needed, now more than
ever, in scientific research.
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The field of computer vision in cell biology is an exciting and fast-paced field. Recently,
groups have started to apply CNNs for cell classification in flow cytometry (Eulenberg et
al. 2017), improved segmentation in high-throughput microscopy (Van Valen et al.
2016), and prediction of hematopoiesis lineage specification (Buggenthin et al. 2017).
Our work represents an early attempt to use the deep features or hidden-layer
representations in trained networks for phenotypic profiling on new datasets. Developing
and applying new neural network architectures, such as deep metric networks, are one
future direction for phenotypic profiling in high-throughput microscopy (Ando et al. 2017).

Another area of future research involves improving transparency in neural networks.
Deep learning is typically described as a ‘black box’ approach where the learned
representations and decision-making process of the network are difficult to interpret.
However, recent work has attempted to demystify the ‘black box’ using deconvolution
networks (Zeiler et al. 2010), synthesizing image patterns that maximally activate
‘neurons’ or sets of ‘neurons’ in the network (Mordvintsev et al. 2015; Yosinski et al.
2015), or generating saliency maps that highlight the regions of the image important for
classification (Simonyan et al. 2013). Applying these techniques to CNNs used in
phenotypic profiling will allow biologists to evaluate the learned image phenotypes and
may reveal novel image features.

Finally, another exciting future direction involves unsupervised learning or learning
without labels. There are numerous cellular images without labeled phenotypes. One
solution is to use active learning approaches in fluorescence microscopy (Jones et al.
2009; Naik et al. 2016), where a small set of images are labeled, and unlabeled images
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are clustered into existing labels by a similarity metric. Another solution involves
unsupervised deep learning, where data without human labels are input to the neural
network, and the network attempts to model the underlying data structure. This has the
potential to make use of large unlabeled datasets, but there are significant theoretical
and engineering challenges to overcome before unsupervised learning can reach the
performance of current supervised deep learning methods.
7.2.3. Digital pathology
In chapter five, we develop CNNs for automated tissue segmentation in cardiac
histopathology. This application involves the automation and improvement of traditional
tasks in pathology, such as annotation or quantification of histologic features. One future
direction is to bring this technology to the clinic. The recent FDA approval of imaging
systems for digital pathology is an esential first step in this process (Caccomo 2017).

In chapter six, we show that a CNN can be trained to classify clinical heart failure from
cardiac histopathology. Importantly, the deep learning approach outperformed a
traditional machine learning algorithm, a random decision forest, and two pathologists.
We acknowledge that the machine-human comparison was contrived because
pathologists usually interpret histopathological findings given a diagnosis of heart failure
and not the other way around. However, we felt that a fair comparison gives all agents
(algorithm or human) access to the same data. Our algorithms were trained on a subset
of regions of interest (ROIs) randomly sampled from the tissue, so we provided the
pathologists with the same data. We did group ROIs by patients for pathologists though,
as described in the methods. Thus, pathologists had the context of multiple samples
grouped by patient whereas the machine did not have this benefit.
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The fact that a deep learning classifier can outperform a random decision forest
classifier using traditional image features is not surprising in itself. Deep learning has
shown remarkable progress in medical imaging and can use images to classify diabetic
retinopathy (Gulshan et al. 2016), skin cancer (Esteva et al. 2017), and lung cancer
(Wang et al. 2017) to name a few recent applications. However, the relevance of
comparing the CNN to the random decision forest is that it demonstrates that the CNN
was able to learn representations that were not captured by a library of nearly 4000
image features (Orlov et al. 2008). One future application of CNNs in medical imaging is
to reverse-engineer the image features and decision-making process of the neural
network, using the methods described in section 7.2.2. If we are able to do this, we could
re-train pathologists to recognize subtle image features that were previously unidentified
or update diagnostic and grading criteria to include new decision rules.

Finally, a critical future direction for biomedical imaging involves integrating discoveries
at all scales of investigation from molecules to cells, tissues, and patients. For example,
recent work has shown that changes in microtubule detyrosination are a molecular
feature of heart disease that correlates with contractility and disease progression
(Robison et al. 2016). In the clinic, pathologists could use immunohistochemical or
immunofluorescence to highlight additional disease features, such as microtubule
detyrosination, which are not captured by routine hematoxylin and eosin staining.
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7.2.4. Methods reproducibility: An argument for computational image analysis
Reproducibility is one of the many arguments given in favor of computational image
analysis in biomedical research. However, we must first define our terms, because
reproducibility is referenced in many different contexts. Dr. Ioannidis, a leader in the field
of scientific reproducibility, has parsed the traditional terms of reproducibility and/or
replicability into three terms to describe the most common usages; the terms include
methods reproducibility, results reproducibility, and inferential reproducibility as shown in
Table 7.2 (Goodman et al. 2016).
Type of Reproducibility

Former term

Definition (Goodman et al. 2016)

Methods reproducibility

Reproducibility “…the ability to implement, as exactly as
possible, the experimental and computational procedures, with the same data
and tools, to obtain the same results.”
Replicability
“…the production of corroborating results
Results reproducibility
in a new study, having followed the same
experimental methods.”
“…making of knowledge claims of similar
Inferential reproducibility
strength from a study replication or
reanalysis.”
Table 7.2 Types of reproducibility in scientific research, per Goodman et al. (2016).

Advances in data science and image analysis software will enable scientists, even
without programming experience, to more accurately describe and quantify images.
Improved metrics will allow researchers to characterize cellular processes in more detail.
For example, we used our single-molecule image analysis pipeline in chapter 3 to show
that both alpha-tubulin tyrosination and active CLIP-170 increase landing rates without
affecting vesicle dwell time. This provided evidence that these regulatory mechanisms
increase on-rates without substantially affecting off-rates, a finding that reveals important
details about the molecular processes. An analysis with lower sensitivity could have
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missed this point. Another example includes the sub-classification of TDP-43 RNA
granules by morphology, which independently correlates with the granule biophysical
properties, although the area distributions are similar (Gopal et al. 2017).

The ability to extract more, high-quality information from image data is a reward in itself.
However, computational image analysis will also improve methods reproducibility in
biomedical imaging. A program, by definition, is an explicit sequence of instructions for
performing a task. Thus, image analysis pipelines partially fulfill methods reproducibility
because they are the tools and contain the computations to transform image data into
results. They are more than that though because software can also be executed, which
allows anyone to run the same data, computations, and tools to reproduce the results.

Most scientists agree this is good, but an argument for manual analysis may appeal to
the fact that a scientific finding is more convincing when a reanalysis observes findings
of similar magnitude, using different human interpretations of images and/or analysis
criteria. This is where defining terms is essential, because methods reproducibility, as
defined above, involves implementing the experimental and computational process “as
exactly as possible” using the “same data and tools.” In the case of manual analysis,
tools not only refer to software but also the human interpretation, which include the
domain expertise of an individual. Using the definitions in Table 7.2, this argument
seems to fit inferential reproducibility, where observations or findings of similar strength
are found on reanalysis. Nevertheless, an executable for precise methods reproducibility
does not prohibit reanalysis, manual or computational, for any other type of
reproducibility and science will benefit from as many forms of reproducibility as possible.
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7.2.5. Garbage In, Garbage Out: The GIGO principle in biomedical imaging
On two occasions I have been asked, "Pray, Mr. Babbage, if you put
into the machine wrong figures, will the right answer come out?”…
I am not able rightly to apprehend the kind of confusion of ideas that
could provoke such a question. Passages of a Philosopher, p67
(Babbage 1864)

Garbage In, Garbage Out (GIGO) refers to the principle in computing and mathematics
that the output quality is determined by the input quality. The concept underlying the
GIGO principle has been around since Charles Babbage’s first mechanical computer
(Babbage 1864) and the recent use in the 1950’s can either be attributed to an army
specialist, William Mellin, or an IBM programmer, George Fuechsel. Regardless, the
GIGO principle could not be more relevant in the current scientific environment.

7.2.5.1.

Respecting the GIGO principle

The massive growth in the scale of data collected in biology and medicine is both a
blessing and a curse. Is it possible to build a model from noisy or incorrect data? Yes,
according to the GIGO principle, but the output will reflect the quality. For the sake of
argument, a purely data-driven scientist might counter that informative patterns with
sufficient signal will emerge in a large enough dataset (Halevy et al. 2009). I believe
there is truth to this argument and in the future it will be critical to leverage the power of
very large, imperfect datasets using unsupervised learning or active learning
approaches. However, there are problems with naively accepting this approach in
biomedical imaging, since the size of public biomedical image datasets are orders of
magnitude smaller than existing collections of web images, such as ImageNet (Deng et
al. 2009). Another problem is that we do not know the amount of data required to
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overcome given levels of input noise. In natural language processing, experts posit that
a hundred to a million-fold increase in dataset size is likely sufficient for complex
linguistic patterns to emerge in noisy and incompletely labeled datasets (Halevy et al.
2009). This provides an estimate, but the amount of data required will likely depend on
the problem domain, the type and magnitude of input errors, and the learning algorithm.

In smaller datasets, the added noise may reduce one significant advantage of large,
computational approaches, which is the power to identify and discriminate complex or
subtle phenotypes. To further complicate the matter, training models using noisy data
assumes stochastic stability of the underlying noise or error-generating function over
time. Thus, future predictions may depend on an out-of-date noise or error model, which
is not unlikely given the rapid advances in imaging technology or improvements in data
standardization and data labeling, not to mention the multitude and variety of factors
beyond human control. Thus, it behooves researchers to respect GIGO principle.

At the individual level, experimentalists should adhere to guidelines for image
acquisition, annotation, and data analysis and sharing (Caicedo et al. 2017). At the
community level, there is the need to organize the rapidly accumulating data into largescale, standardized biological image databases with verified labels, similar to what
ImageNet did for the Google Image Search database (Deng et al. 2009). There are
already efforts underway to standardize image metadata, including the Open Microscopy
Environment (OME) file format (Linkert et al. 2010) and the Image Data Resource
(Williams et al. 2017).
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The development of large image databases that are easily accessible, publicly available,
and centralized or linked with other databases is another challenge. Currently, there are
many excellent public image databases including: The Cancer Imaging Archive (Clark et
al. 2013), The Human Protein Atlas (Thul et al. 2017; Uhlen et al. 2015; Uhlen et al.
2017), and the Image Data Resource (Williams et al. 2017) among others. However,
each database has its own set of licenses, restrictions, and methods for accessing
image data. Moreover, the image phenotypes or labels in each database may not be
complete or congruent with labels in other databases. Thus, phenotypes would ideally
be mapped to a common ontology, which—in information science—refers to the formal
representation of categories, concepts, and properties of entities as well as their
interrelationships. The Cellular Microscopy Phenotype Ontology (Jupp et al. 2016) is one
effort to provide a species-neutral ontology for cellular and sub-cellular phenotypes.
However, it would be useful to link this ontology with the existing gene, tissue, and
clinical ontologies to efficiently map phenotypes across multiple scales and systems.
Clearly, this is a herculean task meant for multiple groups, institutes, and the community
at large over the next decade or more. However, a large-scale image databases linked
to an ontology of biological phenotypes would be a boon to artificial intelligence and
bioimage informatics researchers attempting to parse relationships among genes,
cellular, and tissue level phenotypes expressed as images. The Image Data Resource,
an open-source platform for storing and annotating data from high content screens,
multidimensional microscopy images, and digital pathology is taking steps in the right
direction, and it is already integrated with the Cellular Microscopy Phenotype Ontology
project, but it needs to be adopted by the community in order to be successful.
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7.2.5.2.

Bias In, Bias Out

It is easy to dismiss the GIGO principle as simple to follow and only likely to be violated
in poorly constructed experiments or databases. It is also easy to fall into the trap of
believing that computational analysis is completely unbiased and objective. While
algorithms do not have irrational human biases or other subjective human traits, bias can
be introduced at multiple levels during computer analysis. We will focus our discussion
below on bias introduced at the level of the training dataset.

Training datasets that are imbalanced or do not accurately represent the population can
bias the model and ultimately predictions or inferences based on the model. One recent
and embarrassing example in popular culture were the results from the first Beauty.AI
contest, reported in The Guardian (Levin 2016). This was a beauty contest judged only
by deep learning algorithms trained on a database of headshots, and it was supposedly
trained to determine facial symmetry, wrinkles, etc. Although nearly 6,000 people
worldwide entered the contest, the majority of winners were white, and only one out of
the 44 winners had a dark complexion. As reported by The Guardian, Alex
Zharvoronkov, who is Beauty.AI’s chief scientific officer, admitted that the training
dataset likely did not include enough minorities (Levin 2016).

Let this be a cautionary tale for biomedical image databases. As an exercise, we can
ask how the frequency of cell lines referenced in biomedical research articles compares
to the frequency of images per cell line in The Human Protein Atlas. I performed a
Google Scholar search for articles mentioning one of 22 different human cell lines and
compared the search results to the image frequency in The Human Protein Atlas.
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The results are shown in Figure 7.1. It is no surprise that the HeLa cell line, broadly
defined, represents 41% of all search results. However, images of HeLa cells account
for less than 1% of images in the cell atlas. The imbalance is also apparent when we
examine the three cell lines that were initially used to establish The Human Protein Atlas
(A431, U251-MG, U2-OS). These cells lines account for nearly 73% of the Human
Protein Atlas cell images, but references to these cells are only found in 4% of search
results that mention any cell line in the Google Scholar database.

This is not to argue that we need more HeLa images in public databases or that A431
cells should be used in more research studies. Instead, as 21st-century scientists, in an
algorithm and data-driven world, we should ask ourselves the following questions:
What bias could result from our data or models built using this data, and how can we
mitigate this bias? How can we take advantage of existing data while developing
forward-compatible models that remain effective on different distributions of classes or
error-properties? Most importantly, are our datasets and models adequately
representing the population of interest or the fundamental biology, physiology, or
disease process that we intend to study?
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Figure 7.1 Frequency of cell lines referenced in biomedical research.
The fraction of images for each cell line in The Human Protein Atlas was recorded, after
downloading the dataset as described in chapter four. The number of results was
obtained by querying the database for articles with any mention of a cell line in the
abstract, keywords, title, or associated full text; the search terms included all
abbreviations, names, and synonyms recognized in the Cellosaurus database (Bairoch
2017). The search for each cell line was performed independently to allow articles that
used multiple cell lines to count toward more than one group. The total number of results
was obtained by searching for all cell lines. The Google Scholar database was accessed
on September 21st, 2017.
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7.3.

Concluding remarks
“…the question of whether machines can think …is about as relevant as
the question of whether submarines can swim.” Edsger W.Dijkstra (1984)

AI will play an increasing role in medicine, science, and society at large, without a doubt.
It will disrupt disciplines and conventional ways of thinking through a process that has
been aptly referred to as the “information revolution.” In the process, it will reduce
demand for specific jobs or technology, or make them altogether obsolete. At the same
time, it will propel new industries and jobs as well as new medical and scientific
discoveries. There will be anxiety and uncertainty, but also awe, excitement, and
remarkable progress in many disciplines. A challenge for 21st-century scientists will be
leveraging new technology in creative applications that transcend current limitations
while integrating these techniques with the strengths of traditional approaches.
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APPENDIX I
Supplemental figures for chapter 3

Figure S 1, related to Figure 3.1
Supplementary data for Figure 3.1. (A) Deconvolved max projection confocal images of
COS-7 cells transfected with HaloTag (HT) CLIP-170 (WT, A, E) and stained for the HT
epitope. Phosphodeficient CLIP-A comets are significantly longer than phosphomimetic
CLIP-E as shown previously (Lee et al. 2010); this comparison shows the dynamic range
of CLIP-170 phosphorylation (B) Bootstrapped mean and 95% confidence intervals (CI)
for line scans of CLIP-170 comets (n > 60 comets per condition from 4 cells, N = 2). (C)
Mean p150Glued intensity per cell for p150Glued WT or G71R shows similar levels of
recombinant protein expression (n > 40 cells, N=2). (D) Representative dSTORM image
of HT-CLIP-A comets decorated with myc-p150Glued WT.
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Figure S 2, related to Figure 3.2 and Figure 3.5
Western blot characterization of neuronal vesicles, related to Figure 3.2 and Figure 3.5.
Western blot of isolated neuronal vesicles shows a robust population of vesicles similar
to (Hendricks et al. 2010). Fractions were blotted for antibodies to dynein heavy chain
(DHC), dynein intermediate chain (DIC), p150Glued, p50-GFP, Lis1, kinesin-1 heavy chain
(KHC), kinesin-2, LAMP-1, synaptotagmin, beta-tubulin, and GAPDH. Cytosolic marker
GAPDH is not enriched in the vesicle fraction.
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Figure S 3, related to Figure 3.2
Supplementary data for Figure 3.2. (A) Standard curve of the absorbance (555nm) of
tetramethylrhodamine (TMR) in lysis buffer (mean + SD; n = 10, N = 3). (B) Spectrum
sweep showing the absorbance of TMR standard in lysis buffer vs mock-transfected cell
lysates at different wavelengths. At 555nm, cytosolic proteins in cell lysates have very
low absorbance and thus minimally interfere with TMR measurements used in the assay
to determine relative concentration of TMR-labeled proteins in cell lysates. (C) Western
blot of cell extract HSS for TMR labeled CLIP-WT, CLIP-A, and CLIP-E. Densitometry
analysis, normalized to WT condition, shows similar levels of HT-CLIP protein in cell
lysates (mean +SD). (D) Western blot of cell extract HSS shows similar levels of
expression of EB1, Lis1, and p150Glued regardless of the recombinant CLIP-170
construct. (E) Above, the still images from TIRF movies with 100nM unlabeled EB1 +
~100nM CLIP in the lysate HSS. CLIP-E shows very little microtubule decoration
whereas CLIP-A robustly decorates GMPCPP microtubules. Below, the still images from
TIRF show 100nM Rhodamine labeled EB1 decorating GMPCPP microtubules. (F)
Schematic of computational image analysis workflow. Additional details provided in the
Supplemental Experimental Procedures. (G) Parameter sweep of uTrack thresholds for
local maxima detection show a stable number of particles is detected with a local
maxima threshold of 0.01 for a single frame or 0.005 for over a window of 3 frames
(green line). At this threshold, the median SNR for detected particles is 4.1, which is
within acceptable limits for many single-particle tracking algorithms (Chenouard et al.
2014).
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Figure S 4, related to Figure 3.3
Supplementary data for Figure 3.3. Quantification of the median normalized intensity per
neuron for the Oregon Green-labeled CLIP rescue constructs. These data are from the
same neurons used for measuring retrograde flux in Figure 3.3B, C and demonstrate
that all rescue constructs expressed to similar levels. Intensity was normalized to the
min/max of the entire dataset of all conditions.
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Figure S 5, related to Figure 3.5
Supplementary data for Figure 3.5. (A) Histogram of the microtubule lengths for
GMPCPP microtubules polymerized with purified Tyr-/Detyr-tubulin. Each dataset was
normalized to its Probability Density Function (PDF); distributions were compared with a
two-sample KS test (p = 0.11; n > 1400 microtubules per condition total; N = 3). (B)
Quantification of landing rate for Tyr-/ Detyr microtubules, separated by the fluorescently
labeled tubulin used, shows a significant increase in landing rate on Tyr microtubules
regardless of labeled tubulin (n > 30 movies per condition, each movie with > 500
events; N = 3 independent vesicle isolations; Kruskal-Wallis one way ANOVA with
Tukey-Kramer post-tests). (C) Histogram of the normalized PDF of dwell times on TRITC
or AF647 labeled Detyr-microtubules show overlap of the distributions. (D) Histogram of
the normalized PDF of dwell times on TRITC or AF647 labeled Tyr-microtubules show
overlap of the distributions.
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Figure S 6, related to Figure 3.6
Supplementary data for Figure 3.6. Coomassie stained gel of purified proteins, including
EB1, CLIP-170-H2-GFP, p150Glued [1-210]-GFP, p150Glued ∆Basic [1-210]-GFP, p150Glued
∆CAP-Gly [1-210]-GFP, and CA-Kinesin-1[1-430]-GFP.
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Figure S 7, related to Figure 3.7
Supplementary data for Figure 3.7. (A) Pseudocode for Monte Carlo simulation of 2D
vesicle diffusion and microtubule capture. Parameters: timeStep = 0.1s, D = 0.006µm2/s,
D_Std= sqrt(2*D*timeStep), Prob(Tyr) = 1, Prob(Detyr) = 0.25, MaxDuration = 1200 s.
(B) Quantification of the median time to MT capture with Tyr probabilities and CLIP-E or
CLIP-A at diffusion coefficients 0.05 – 1.0µm2/s . (C) Scatter plot of the time to MT
capture given the initial starting distance from the microtubule with Tyr probabilities and
CLIP-E or CLIP-A at a diffusion constant 0.006µm2/s. There was a 2.4 fold increase in
the number of CLIP-E (red arrowhead) particles that never reach the microtubule within
a 20 minute simulation with as compared to CLIP-A (blue arrowhead). (D) The
bootstrapped mean and 95% confidence intervals for the time to MT at each starting
distance are plotted below. The two lines overlap and the time to capture in these
simulations is determined by the initial distance. Thus, the effect of CLIP-A is due to a
shift in the distribution of starting positions such that they are, on average, closer to the
effective microtubule capture zone.
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Supplemental tables for chapter 3
Table S 1, related to Figure 3.3
Kruskal-Wallis one-way ANOVA and Tukey-Kramer post-hoc tests between groups for
data in Figure 3C.
Kruskal-Wallis one-way analysis of variance
Chi-sq: 29.4
df: 4
p: 6.50x10-6
Tukey-Kramer post-hoc test between groups
Groups being compared:
p value
1
2
0.002107
1
3
0.999890
1
4
0.997870
1
5
0.216500
2
3
0.000094
2
4
0.000204
2
5
0.271370
3
4
0.999570
3
5
0.100470
4
5
0.155260
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Number
1
2
3
4
5

Condition
Mock siRNA
siRNA + Vector
siRNA + CLIP-WT
siRNA + CLIP-A
siRNA + CLIP-E

Table S 2, related to Figure 3.6
Kruskal-Wallis one-way ANOVA and Tukey-Kramer post-hoc tests between groups for
data in Figure 6B.
Kruskal-Wallis one-way analysis of variance
Chi-sq: 137.87
df: 7
p: 1.42x10-26
Tukey-Kramer post-hoc test between groups
Groups being compared:
1
2
1
3
1
4
1
5
1
6
1
7
1
2
2
2
2
2
2
3
3
3
3
3
4
4
4
4
5
5
5
6
6
7

8
3
4
5
6
7
8
4
5
6
7
8
5
6
7
8
6
7
8
7
8
8

p value
6.0033x10-8
0.99998
5.9893x10-8
0.99996
0.08692
0.00001

Numbe
r
1
2
3
4
5
6

Protein
CLIP-WT
CLIP-WT
CLIP-A
CLIP-A
CLIP-E
CLIP-E

0.00034

7

CA-Kinesin-1[560]

8

[560]

-8

6.0433x10
1.00000
5.9882x10-8
0.00040
0.56326
0.16285
5.9927x10-8
0.99633
0.17335
0.00003
0.00095
5.9881x10-8
0.00010
0.40957
0.08941
0.01853
4.8394x10-7
0.00002
0.23258
0.69481
0.99683
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CA-Kinesin-1

Tyr/ Detyr
Detyr
Tyr
Detyr
Tyr
Detyr
Tyr
Detyr
Tyr

Supplemental movies for chapter 3
Movie S 1, related to Figure 3.1
http://www.cell.com/cms/attachment/2079983007/2071442196/mmc2.mp4
STORM 3D reconstruction of WT p150Glued puncta associated with a CLIP-A comet at
the microtubule plus end, related to Figure 1. This represents a cropped view of a single
microtubule plus end (unlabeled) in COS-7 cells expressing myc-p150Glued WT and HTCLIP-A. CLIP-A decorates the microtubule plus end as long comets, which is shown in
magenta. Wild type p150Glued forms either discrete clusters of p150Glued that dock on the
CLIP-A comet and correspond to the p150Glued-positive puncta identified by confocal
microscopy. In addition, a soluble pool of point-localized p150Glued also localize to the
CLIP-A comet.
Movie S 2, related to Figure 3.5
http://www.cell.com/cms/attachment/2079983007/2071442197/mmc3.mp4
Robust p50-GFP-vesicle recruitment to Tyr microtubules. Alexa647-labeled Tyr
microtubules are shown in magenta, related to Figure 5. TRITC-labeled Detyr
microtubules are shown in red. The Green-Fire-Blue lookup table was applied to GFPvesicles for better visualization. Playback is 2x real time (20fps).
Movie S 3, related to Figure 3.5 and S5
http://www.cell.com/cms/attachment/2079983007/2071442198/mmc4.mp4
p50-GFP-vesicle recruitment to Tyr microtubules is independent of the fluorescent
tubulin label, related to Figures 5 and S5. TRITC-labeled Tyr microtubules are shown in
red. Alexa647-labeled Detyr microtubules are shown in blue. The Green-Fire-Blue
lookup table was applied to p50-GFP-vesicles for better visualization. Playback is 2x real
time (20fps).
Movie S 4, related to Figure 3.6
http://www.cell.com/cms/attachment/2079983007/2071442199/mmc5.mp4
Representative movies for CLIP-WT/ -A/ -E recruitment to Tyr or Detyr-microtubules.
TMR-HaloTag-CLIP-170 is shown in red; Alexa488 Tyr-microtubules in green; and
Alexa647 Detyr-microtubules in blue. The Alexa labeled tubulin used for Tyr/ Detyrmicrotubules was reversed for half of the experimental repeats with similar results.
Playback is 2x real time (20fps).
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Supplemental experimental procedures for chapter 3
Microscopy
Single-molecule imaging was performed on an inverted Nikon Ti Eclipse equipped for
total internal fluorescence (TIRF) microscope with a cooled Hamamatsu ImagEM
charge-coupled device (CCD) camera C9100-13 using a 1.45 N.A. x100 oil immersion
objective with an effective pixel size of 159nm. Single molecule imaging acquired the
channel of interest at a rate of 10 frames per second for 2 minutes, with still images of
microtubule captured at 0 and 2 minutes. Exposure times were 75ms and laser
intensities were kept constant whenever conditions were compared. Spinning disk
confocal microscopy was performed on an inverted Nikon Ti Eclipse with a Perkin-Elmer
Ultra VIEW Vox spinning disk confocal module and a PhotoKinesis accessory for
photobleaching. Images were acquired with a Hamamatsu ImagEM CCD camera
E9100-50 using a 1.45 N.A. x100 oil immersion objective with an effective pixel size of
71.5nm. STED microscopy was performed on a Leica DMI 6000 inverted microscope
equipped with 592nm and 660nm STED depletion lasers. Direct STORM was performed
on a Nikon STORM system.
Reagents
Antibodies: CLIP-170, rabbit polyclonal (CST #8977); anti-HaloTag, rabbit polyclonal
(Promega #G9281); anti-GAPDH, mouse monoclonal (Abcam ab9484); anti-Tyr-alphatubulin YL1/2, rat monoclonal (Milipore #1864); anti-Detyr-alpha-tubulin, rabbit polyclonal
(Milipore #AB3201); anti-beta-tubulin mouse monoclonal clone TUB2.1 (Sigma T5201);
anti-synaptotagmin, mouse monoclonal (StressGen SYA-130); anti-Rab7, mouse
monoclonal (Abcam ab50533); anti-LAMP-1, rabbit polyclonal (Abcam ab24170); GFPBooster (Chromotek gba488); anti-p150Glued CAP-Gly, mouse monoclonal (BD
Transduction 610474); anti-dynein heavy chain, rabbit polyclonal (sc-9115); anti-DIC
(Milipore #1618); anti-KIF5B, mouse monoclonal (Milipore #1614); anti-KIF3A (Abcam
ab24626); anti-GFP, chicken (Clontech JL-8); anti-Lis1, mouse (Sigma #L7391); antiEB1, mouse (BD Transduction 610534).
siRNA: Mouse CLIP1 siRNA (Dharmacon: J-054772-10, CUUCAAAGCUAACGAGGAA;
and J-054772-11 GCAGAAGAGUAUUGGCGAA). Control non-targeting siRNA pool
(Dharmacon: D001810-01-05).
DNA Constructs: LAMP-1-RFP (Addgene #1817). Rat CLIP-170 (AJ237670.1) was used
to generate a wild-type CLIP-1 construct fused to HaloTag® at the N terminus. Serine
residues (309, 311, 313, 319, 320) of this CLIP-170 construct were mutated to glutamate
(phosphomimetic, CLIP-E) or alanine (phosphodeficient, CLIP-A). Human p150Glued
(NM_004082.4) fused to an N-terminal myc tag. Human KIF5C amino acids 1-560 fused
to an N-terminal HaloTag®, derived from Addgene #15219.
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Cell culture and live-cell imaging
DRG neurons were transfected with LAMP-1-RFP (0.3ug), siRNA resistant rat HT-CLIP170 or HT-vector (0.5ug), Mouse CLIP-1 siRNA (20pmol) and then cultured for 4DIV.
The distal axon of DRG neurons were imaged in a temperature-controlled chamber at
37C. After identifying the distal axon, a 40µm region of axon that is 10µm proximal to the
growth cone tip was photobleached a 561nm laser at 100%, allowing measurement of
retrograde flux through a pre-defined region 3.5µm proximal to the distal edge of the
bleached region. Movies were acquired at 200ms per frame for 2fps for 5s pre-bleach
and 2fps for 120s post-bleach.
Protein biochemistry
Unlabeled tubulin was purified from bovine brain through two cycles of polymerization
and depolymerization in high-molarity PIPES buffer as described (Castoldi and Popov
2003). EB1, CLIP-170-H2, and GFP-p150Glued constructs were purified as described
(Lazarus et al. 2013). Protein concentrations were determined using BCA or A280nm
(tubulin).
Tyrosinated tubulin was obtained from Hela S3 cells (ATCC® CCL-2.2™) according to
the protocol adapted from (Barisic et al. 2015; Castoldi and Popov 2003). Cells were
grown in the spinner bottles for 1 week, then spun down and lysed in BRB80 (80 mM KPIPES pH 6.8, 1 mM MgCl2, 1 mM EGTA) supplemented with 1 mM βmercapthoethanol, 1 mM PMSF and protease inhibitors using a French Press at 4°C.
The soluble fraction was obtained after ultracentrifugation and the first tubulin
polymerization step was performed at 30°C for 30 min by adding 1 mM GTP and 30%
glycerol. Microtubules were pelleted by ultracentrifugation at 30°C, and then resuspended in BRB80 at 4°C; soluble tubulin was clarified by ultracentrifugation at 4°C.
Carboxypeptidase A (CPA, Sigma C9268, app 6U/mg of tubulin) was added to the
soluble tubulin for 5 min at 30°C to produce detyrosinated tubulin. The second
polymerization, this time in presence of high molarity PIPES, was performed for 30 min
at 30°C and the microtubule pellet was sedimented by ultracentrifugation. Microtubules
were then depolymerized in BRB80 at 4°C, and soluble tubulin clarified and snap frozen.
The tyrosination status of the tubulin was verified by Western blot using the antibodies
against tyrosinated (YL1/2) and detyrosinated (Millipore, AB3201) tubulin.
In vitro reconstitution of microtubule recruitment
Briefly, adult mouse brains were homogenized in ice-cold MAB with 1mM dithiothreitol
(DTT) and protease inhibitors. The homogenate was centrifuged first at 17K x g for 30
minutes, and then at 133K x g for 20min to pellet the lower density membrane fraction.
The membrane pellet was loaded onto the bottom of a sucrose step gradient (2.5M,
1.5M, 0.6M) and centrifuged at 274K x g, and vesicles were collected from the 1.5M 0.6M interface.
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Image analysis and machine learning classification of fixed particles
Our unbiased multi-particle tracking approach provides a robust, automated method to
determine landing rates while correcting for the background rate of particles randomly
entering the TIRF field. Particle tracking was performed in uTrack (v.2.1.3). The median
particle SNR was 4.1, which is within acceptable limits for most single-particle tracking
algorithms (Chenouard et al. 2014). Microtubule (MT) masks were generated by
applying a pixel classifier in ilastik (Sommer et al. 2011) to create a probability map,
which was further processed using custom MATLAB scripts to segment individual MT
from the background. Unambiguous labeling of events in the MT or background was
ensured by creating a buffer region of 10 pixels surrounding each MT; particles landing
in this region were excluded from analysis. Overlapping MTs were excluded from
analysis. Particle trajectories were mapped onto their positions within MT or background
masks to determine the landing rate, per square micron per minute. This gave one MT
landing rate and one background landing rate per movie and allowed the subtraction of
the background landing rate to obtain the normalized landing rate per square micron.
Since the microtubule has a fixed intensity profile width of ~3 pixels in our images, we
used a conversion factor to transform the landing rate per square micron to the landing
rate per micron length. Calculating the whole-field landing rate per movie gave more
precise values than calculating a per microtubule landing rate, which were subject to
extreme values. However, neither method of calculating landing rate significantly
changed the results. To minimize the contribution of random landing events on our
measurements we used a low density of microtubules in our flow chambers. On
average, less than 10% of the image field contained microtubules. Assuming that nonspecific landing events have a uniform random probability of landing at any given pixel,
this reduced the number of non-specific events relative to the total number of events
observed.
There was a class of particles landing in the background with long dwell times and little
displacement, which we label as particles fixed to the coverslip. These particles had the
potential to skew our dwell time analysis, and to correct for this we used a machine
learning approach to detect and exclude these fixed particles from analysis. In brief, we
used a Random Forest (Breiman 2001)classifier in MATLAB consisting of 2000 trees
and trained on 898 trajectories manually labeled as fixed to the coverslip (0) or not-fixed
(1) with 22 features derived from the XY coordinates and intensity for each trajectory.
The generalization error from held-out examples in the training set was ~ 5% and the
classifier had a 95.5% AUC on a held-out test set of 100 examples.
Stochastic simulation of 2D organelle diffusion and microtubule capture
Immunofluorescence images of tyrosinated microtubules and a cytosol-filling marker
were used to create the experimental space for simulated trajectories. Briefly, an ilastik
pixel-level classifier on the MT intensity image was used to segment microtubules in the
growth cone, which was manually refined for a best-fit segmentation. Similarly, ilastik
was used on the combined MT and GFP-LC3 intensity image to segment the neuron
outline. These two masks formed the experimental space for simulated vesicle diffusion
and microtubule capture. For each neuronal growth cone, 1000 trajectories were
generated and seeded at random starting indices. Each trajectory underwent simulated
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2D Brownian diffusion with a time interval of 0.1s for 1200 seconds simulated time. At
each time step, the current position of the trajectory in simulation space was evaluated
accordingly: cytosol = continue simulation; MT = end simulation for current trajectory;
plasma membrane = pause for 0.1s and then move away from PM in the next step. To
simulate the diffusion of a large organelle in the heterogeneous viscoelastic environment
of the cytoplasm, we used a diffusion constant, D = 0.006 µm2/s, taken from empirical
measurements of the diffusion of EGF-quantum-dot labeled endosomes in the Arpe-19
cell cytoplasm (Zajac et al. 2013). This value is similar to the diffusion of non-microtubule
bound melanosomes (D = 0.003 µm2/sec) in Xenopus melanophores (Semenova et al.
2008). We also simulated a range of diffusion constants from 0.001 to 1.0µm2/s (Figure
S7).
To simulate retrograde flux for comparison with our experimental observations, we first
measured the number of LAMP-1-RFP vesicles within of the 10µm distal axon growth
cone of WT DRG neurons expressing LAMP-1-RFP at low levels. The empirical
distribution of LAMP-1-RFP vesicles had a mean of 12 and SD of 6 and approximated a
normal distribution (n = 30 neurons; p > 0.1, one-sample KS test). We randomly sampled
this distribution to determine the random number of vesicles (nVesicles) we may expect
to find in any given growth cone. Next we sampled nVesicles, with replacement, from a
pool of 5,000 simulated vesicles per neuron and calculated the number of vesicles that
reach the microtubule within the duration of our neuronal live cell imaging experiment
(120 sec). Since we measure retrograde flux 3.5µm proximal to the bleached region, a
vesicle only counted toward retrograde flux if it reached the microtubule within 120 sec –
(3.5µm * 0.5µm/sec), or 113 sec, which assumes cargo undergoes continuous,
processive dynein driven transport at a velocity of 0.5µm/sec following microtubule
capture. As biological cargo may not capture with 100% efficiency or may exhibit
directional changes, these simulations may slightly overestimate retrograde flux. The
simulation for each neuron growth cone was repeated 5000 times per condition.
Statistics
Statistical tests and distribution fitting were performed in MATLAB R2015a. A Wilcoxon
Rank-Sum test was used to compare two sample medians and the Kruskal-Wallis oneway ANOVA with a Tukey-Kramer post-test was used to correct for multiple comparisons
between sample medians. A two sample Kolmogorov-Smirnov test was used to compare
two distributions, with Bonferroni correction for pairwise comparison of multiple
distributions. The 95% confidence intervals (CI) were calculated from 1000 bootstrapped
resamplings. Maximum likelihood estimation with 100 bootstrapped fits was used to fit
dwell times with a double exponential curve and obtain 95% CI on the curve parameters
amplitude, k1, and k2 (Woody et al. 2016). Box and whisker plots show the median (red
bar) and interquartile range (IQR, blue box) with the whiskers extending to the upper and
lower adjacent values. Statistical outliers, defined as data greater than median +/1.5*IQR, were included in all analysis, but are not shown in boxplots so that the outliers
do not compress the visualization of the majority of data.
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APPENDIX II
Supplemental movies for Chapter 4
Movie S 5. Phenotypic profiling of the IICBU 2008 binucleate dataset.
https://www.dropbox.com/s/qy7j70jgzopbwwi/binucleate_profiling_legend.avi?dl=0

Movie S 6. Phenotypic profiling of the HeLa structure dataset.
https://www.dropbox.com/s/ud2rpfj3g14h00m/hela-struct_profiling_legend.avi?dl=0
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APPENDIX III
Supplemental information for Chapter 6

Figure S 8 Example of normal and abnormal cardiac histopathology.
(a) Normal cardiac tissue shows regular, dense arrays of cardiomyocytes (green) with
stroma limited to perivascular regions (orange). (b) Patients with heart failure have an
expansion of the cellular and acellular stromal tissue (orange) that disrupts
cardiomyocyte arrays (green). Other features seen in heart failure include large
myocytes with enlarged, hyperchromatic, “boxcar” nuclei (arrowhead, enlarged 200µm
region shown in the inset). Images are 5x magnification and the scale bar is 1mm.
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Table S 3. Top 20 features in the training dataset identified by mRMR feature
selection
A complete list of features computed by WND-CHARM can be found in Orlov et al.
(2008)
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